<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress/2.1.3" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="2.7.1"  -->
<!-- Debug: Total comment count: 17608 -->
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84">
	<url>
		<loc>http://www.druginjuryblog.com/</loc>
		<lastmod>2012-02-02T21:20:39+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1</priority>
	</url>
<!-- Debug: Start Postings -->
<!-- Debug: Priority report of postID 1954: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/02/02/study-links-ppis-to-hip-fractures-in-post-menopausal-women/</loc>
		<lastmod>2012-02-02T17:20:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1955: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/02/02/glaxo-settles-more-avandia-lawsuits/</loc>
		<lastmod>2012-02-02T17:20:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1951: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/02/01/antiretrovirals-to-prevent-fetal-hiv-transmission-linked-to-oral-clefts/</loc>
		<lastmod>2012-02-01T17:38:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1953: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/02/01/birth-control-pills-recalled-by-pfizer/</loc>
		<lastmod>2012-02-01T17:17:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1952: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/02/01/adhd-drug-may-cause-suicidal-thoughts/</loc>
		<lastmod>2012-02-01T17:15:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1950: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/31/cephalon-issues-recall-on-treanda-injections-due-to-presence-of-glass-in-vials/</loc>
		<lastmod>2012-01-31T04:44:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1949: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/27/kenalog-deaths-tied-to-misuse/</loc>
		<lastmod>2012-01-27T16:55:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1948: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/27/fda-proposes-rules-for-pharmaceuticals-on-facebook-twitter/</loc>
		<lastmod>2012-01-27T05:23:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1947: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/25/massive-plavix-lawsuit-filed-by-72-consumers/</loc>
		<lastmod>2012-01-25T16:23:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1946: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/25/pfizer-asks-for-consolidation-of-zoloft-birth-defects-lawsuits/</loc>
		<lastmod>2012-01-25T05:24:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1945: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/25/novartis-health-canada-issue-new-treatment-guidelines-for-blood-pressure-drug-tekturna/</loc>
		<lastmod>2012-01-25T04:35:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1944: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/24/study-looks-at-zelboraf-skin-cancer-risk/</loc>
		<lastmod>2012-01-24T17:46:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1943: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/23/anti-jc-virus-jcv-antiboties-risk-factor-for-tysabri-pml/</loc>
		<lastmod>2012-01-23T17:15:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1942: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/23/gilenya-deaths-prompt-reviews-in-europe-us/</loc>
		<lastmod>2012-01-23T16:59:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1941: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/23/fda-orders-recall-of-vagifresh-products/</loc>
		<lastmod>2012-01-23T16:57:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1940: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/20/ya-yasmin-plaintiffs-want-to-introduce-evidence-of-fda-conflicts/</loc>
		<lastmod>2012-01-20T20:11:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1939: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/19/consumer-group-questions-fda-yaz-yasmin-conflicts/</loc>
		<lastmod>2012-01-19T17:45:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1938: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/19/review-raises-tamiflu-questions/</loc>
		<lastmod>2012-01-19T17:42:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1937: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/16/pradaxa-bleeding-reports-mount/</loc>
		<lastmod>2012-01-16T17:12:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1935: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/13/bedford-labs-updates-recall-statement-on-injected-drugs-with-glass-in-vials/</loc>
		<lastmod>2012-01-13T06:27:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1936: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/12/des-daughters-claim-drug-caused-breast-cancer/</loc>
		<lastmod>2012-01-12T23:36:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1934: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/11/dutch-regulators-tell-pip-implant-recipients-to-have-devices-removed/</loc>
		<lastmod>2012-01-11T17:38:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1932: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/11/pradaxa-may-increase-heart-attack-chances/</loc>
		<lastmod>2012-01-11T17:13:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1931: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/11/three-fda-yaz-yasmin-advisors-had-ties-to-bayer/</loc>
		<lastmod>2012-01-11T17:11:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1930: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/11/fda-warns-of-potential-opiate-mix-up-with-endo-pharmaceuticals-drugs/</loc>
		<lastmod>2012-01-11T06:48:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1929: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/11/health-canada-will-review-safety-of-tekturna-after-maker-halts-trial-due-to-injury-risk/</loc>
		<lastmod>2012-01-11T06:24:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1933: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/10/women-on-statins-may-be-at-risk-for-diabetes/</loc>
		<lastmod>2012-01-10T17:13:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1927: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/10/novartis-reveals-manufacturing-errors-recalls-excedrin-nodoz-bufferin-gas-x-products/</loc>
		<lastmod>2012-01-10T04:33:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1928: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/09/pa-court-orders-mediation-for-yaz-yasmin-lawsuits/</loc>
		<lastmod>2012-01-09T18:15:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1925: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/06/fda-restricting-use-of-some-antimicrobial-drugs-in-animals-to-increase-effectiveness-in-human-treatments/</loc>
		<lastmod>2012-01-06T03:56:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1926: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/05/another-win-for-prempro-plaintiffs/</loc>
		<lastmod>2012-01-05T23:08:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1924: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/05/phantom-recall-on-childrens-tylenol-led-to-death-of-2-year-old-according-to-lawsuit/</loc>
		<lastmod>2012-01-05T05:16:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1923: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/05/judge-in-yaz-yasmin-mdl-arranges-meeting-with-mediator-to-reach-settlement/</loc>
		<lastmod>2012-01-05T04:55:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1922: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/30/actos-bladder-cancer-lawsuit-mdl-established-in-western-district-of-louisiana/</loc>
		<lastmod>2011-12-30T22:46:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1921: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/30/novartis-blood-pressure-drug-under-review/</loc>
		<lastmod>2011-12-30T22:45:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1919: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/30/ohio-woman-claims-taking-zocor-led-to-life-threatening-kidney-disease/</loc>
		<lastmod>2011-12-30T05:26:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1920: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/28/chantix-study-undertaken-at-u-of-penn-in-spite-of-risks/</loc>
		<lastmod>2011-12-28T09:27:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1918: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/28/fda-warns-of-overdose-risks-of-new-concentrations-of-infant-liquid-acetaminophen-products/</loc>
		<lastmod>2011-12-28T05:11:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1916: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/22/12-million-bottles-of-motrin-in-latest-johnson-johnson-recall/</loc>
		<lastmod>2011-12-22T16:36:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1917: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/21/fda-announces-gilenya-safety-review/</loc>
		<lastmod>2011-12-21T16:36:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1915: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/20/pfizer-continues-to-settle-hormone-therapy-lawsuits/</loc>
		<lastmod>2011-12-20T16:16:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1914: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/20/fda-completes-multaq-safety-review/</loc>
		<lastmod>2011-12-20T16:15:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1913: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/20/canadians-warned-osteoporosis-drugs-may-cause-rare-femur-fractures/</loc>
		<lastmod>2011-12-20T16:13:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1912: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/20/pediatric-cancer-drugs-may-lead-to-congestive-heart-failure-later-in-life/</loc>
		<lastmod>2011-12-20T03:06:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1910: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/19/fda-says-male-sexual-supplement-capsules-contain-viagra-copycat-ingredient/</loc>
		<lastmod>2011-12-19T04:41:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1911: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/19/fda-says-male-sexual-supplement-capsules-contain-viagra-copycat-ingredient-2/</loc>
		<lastmod>2011-12-19T04:41:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1909: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/19/use-of-nsaid-painkillers-during-early-pregnancy-could-result-in-rare-birth-defect/</loc>
		<lastmod>2011-12-19T03:39:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1907: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/16/drug-shortages-the-fault-of-manufacturing-problems-powerless-fda/</loc>
		<lastmod>2011-12-16T03:26:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1908: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/15/studies-on-link-between-ssris-and-pphn-inconcusive-fda-says/</loc>
		<lastmod>2011-12-15T17:31:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1906: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/14/mdl-sought-for-propecia-lawsuits/</loc>
		<lastmod>2011-12-14T17:57:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1905: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/13/doctors-worried-about-byetta-januvia-pancreas-side-effects/</loc>
		<lastmod>2011-12-13T16:19:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1904: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/12/manufacturer-of-cancer-drug-doxil-already-in-short-supply-halts-production-due-to-safety-issues/</loc>
		<lastmod>2011-12-12T04:41:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1902: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/09/experts-call-for-more-blood-clot-info-for-yaz-yasmin-labels/</loc>
		<lastmod>2011-12-09T16:29:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1901: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/09/jury-awards-72m-to-three-women-who-developed-breast-cancer-after-taking-prempro/</loc>
		<lastmod>2011-12-09T04:03:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1903: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/08/pradaxa-bleeding-reports-prompt-fda-review/</loc>
		<lastmod>2011-12-08T16:29:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1898: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/08/fda-calls-for-independent-review-of-orthoevra-studies/</loc>
		<lastmod>2011-12-08T02:25:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1897: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/08/fda-warns-makers-of-hcg-weight-loss-supplements-over-unsupported-claims/</loc>
		<lastmod>2011-12-08T00:48:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1900: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/07/depakote-may-increase-risk-of-autism/</loc>
		<lastmod>2011-12-07T17:12:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1899: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/07/fda-may-order-strong-blood-clot-warnings-for-yaz-yasmin/</loc>
		<lastmod>2011-12-07T17:10:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1896: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/06/unsealed-yasmin-lawsuit-documents-show-bayer-hid-blood-clot-risks/</loc>
		<lastmod>2011-12-06T17:10:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1895: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/05/possible-blood-clot-risk-connected-to-prostate-cancer-therapy/</loc>
		<lastmod>2011-12-05T16:55:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1892: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/05/foster-children-prescribed-psychotropic-drugs-at-alarming-rate/</loc>
		<lastmod>2011-12-05T02:12:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1894: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/02/eight-couples-file-lawsuit-over-alleged-zoloft-birth-defects/</loc>
		<lastmod>2011-12-02T09:27:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1893: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/02/us-senators-want-answers-on-lipitor/</loc>
		<lastmod>2011-12-02T09:26:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1891: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/01/consumer-reports-raises-alaarm-on-arsenic-in-appe-juice/</loc>
		<lastmod>2011-12-01T15:53:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1890: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/01/10000-actos-bladder-cancer-lawsuits-a-possibility/</loc>
		<lastmod>2011-12-01T15:51:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1889: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/01/pending-depakote-settlement-irks-abbott-shareholders/</loc>
		<lastmod>2011-12-01T15:50:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1888: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/30/pfizer-tries-to-fend-off-lipitor-generics/</loc>
		<lastmod>2011-11-30T16:20:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1887: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/30/fda-shuts-pennsylvania-dietary-supplements-maker/</loc>
		<lastmod>2011-11-30T02:51:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1886: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/29/adverse-reactions-to-diabetes-blood-thinning-drugs-responsible-for-100000-er-visits/</loc>
		<lastmod>2011-11-29T04:41:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1885: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/28/harvard-study-sees-link-between-ppis-heart-defects/</loc>
		<lastmod>2011-11-28T17:07:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1884: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/23/merck-reaches-settlement-on-vioxx-marketing-charges/</loc>
		<lastmod>2011-11-23T20:56:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1883: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/22/bayer-documents-point-to-improper-yasmin-yaz-marketing/</loc>
		<lastmod>2011-11-22T16:02:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1882: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/22/pfizer-will-pay-60m-to-settle-bribery-charges/</loc>
		<lastmod>2011-11-22T03:27:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1881: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/21/breast-cancer-indication-removed-from-avastin/</loc>
		<lastmod>2011-11-21T16:38:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1880: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/21/drug-plant-shutdown-could-worsen-cancer-drug-shortage/</loc>
		<lastmod>2011-11-21T16:35:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1876: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/21/attorney-seeks-foia-request-for-information-on-thalidomide-birth-defects-trial/</loc>
		<lastmod>2011-11-21T05:10:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1878: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/18/pradaxa-benefits-still-outweigh-risks-europe-regulator-says/</loc>
		<lastmod>2011-11-18T09:50:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1877: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/18/bayer-documents-will-remain-confidential-yaz-judge-rules/</loc>
		<lastmod>2011-11-18T09:48:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1879: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/17/more-men-file-propecia-lawsuits/</loc>
		<lastmod>2011-11-17T09:51:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1875: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/17/deals-to-push-brand-name-lipitor-through-pharmacy-benefits-managers-criticized/</loc>
		<lastmod>2011-11-17T02:15:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1874: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/17/antidepressants-anti-psychotic-drugs-linked-to-sudden-cardiac-death-during-heart-attack-similar-event/</loc>
		<lastmod>2011-11-17T00:08:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1871: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/16/pradaxa-deaths-rise/</loc>
		<lastmod>2011-11-16T16:45:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1870: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/16/countries-with-more-women-on-the-pill-also-have-more-men-with-prostate-cancer-new-study-finds/</loc>
		<lastmod>2011-11-16T03:41:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1873: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/15/multaq-doubles-death-risk-among-patients-with-pemanent-a-fib/</loc>
		<lastmod>2011-11-15T16:47:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1872: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/15/cellcept-lawsuit-filed-following-fungal-infection/</loc>
		<lastmod>2011-11-15T16:45:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1865: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/11/some-common-drugs-carry-risk-of-life-threatening-stevens-johnson-syndrome/</loc>
		<lastmod>2011-11-11T04:26:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1869: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/10/canada-reports-blood-thinner-mix-ups/</loc>
		<lastmod>2011-11-10T15:32:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1868: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/10/fosamax-litigation-moving-forward/</loc>
		<lastmod>2011-11-10T15:31:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1867: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/08/evidence-mounts-against-yaz-yasmin/</loc>
		<lastmod>2011-11-08T15:29:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1866: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/08/proton-pump-inhibitors-overused/</loc>
		<lastmod>2011-11-08T15:27:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1863: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/08/fda-issues-inspection-report-from-genentech-attempts-to-explain-avastin-issues/</loc>
		<lastmod>2011-11-08T04:10:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1864: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/03/chantix-study-reinforces-suicide-depression-risks/</loc>
		<lastmod>2011-11-03T15:56:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1860: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/02/fda-to-address-drug-shortages/</loc>
		<lastmod>2011-11-02T16:37:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1859: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/02/tylenol-lawsuit-filed-over-liver-injury/</loc>
		<lastmod>2011-11-02T16:36:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1862: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/02/cdc-says-painkiller-ods-on-the-rise/</loc>
		<lastmod>2011-11-02T09:42:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1861: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/02/boehringer-ingelheim-reports-deaths-among-pradaxa-ptients/</loc>
		<lastmod>2011-11-02T09:40:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1858: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/01/pennsylvania-centralizes-topamax-lawsuits/</loc>
		<lastmod>2011-11-01T14:53:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1857: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/28/pradaxa-maker-says-patients-need-kidney-checks/</loc>
		<lastmod>2011-10-28T17:06:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1856: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/28/yaz-yasmin-raise-blood-clot-risk-in-fda-study/</loc>
		<lastmod>2011-10-28T17:03:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1855: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/27/is-heparin-supply-safe/</loc>
		<lastmod>2011-10-27T15:13:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1854: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/26/eli-lilly-issues-international-xigris-recall/</loc>
		<lastmod>2011-10-26T14:46:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1853: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/26/study-out-of-denmark-confirms-yaz-yasmin-blood-clot-danger/</loc>
		<lastmod>2011-10-26T14:44:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1852: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/26/depakote-lawsuit-claims-drug-caused-spina-bifida/</loc>
		<lastmod>2011-10-26T14:42:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1851: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/25/ema-gives-ok-to-use-of-actos-in-treating-type-2-diabetes/</loc>
		<lastmod>2011-10-25T20:06:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1849: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/25/rat-study-seeks-connection-between-ssris-autism/</loc>
		<lastmod>2011-10-25T14:17:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1848: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/25/amgen-set-aside-millions-to-settle-kickback-lawsuits/</loc>
		<lastmod>2011-10-25T14:15:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1850: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/24/zyvox-methylene-blue-interact-with-some-psych-meds/</loc>
		<lastmod>2011-10-24T14:18:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1843: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/20/federal-plavix-lawsuits-could-be-mdl/</loc>
		<lastmod>2011-10-20T08:32:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1842: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/20/fda-issues-warning-letter-to-california-maker-of-sleep-drug-xyrem/</loc>
		<lastmod>2011-10-20T03:12:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1841: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/19/pradaxa-side-effects-a-concern/</loc>
		<lastmod>2011-10-19T15:23:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1845: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/18/parents-file-zoloft-lawsuit-after-baby-dies-from-birth-defect/</loc>
		<lastmod>2011-10-18T08:36:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1844: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/18/fosamax-femur-fracture-case-study-raises-questions/</loc>
		<lastmod>2011-10-18T08:33:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1840: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/14/fda-seeks-outiside-guidance-on-yaz-and-yasmin-blood-clot-risks/</loc>
		<lastmod>2011-10-17T16:27:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1847: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/17/topamax-study-sees-link-to-birth-defects/</loc>
		<lastmod>2011-10-17T08:39:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1846: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/17/doctors-becoming-wary-of-avastin-eye-treatment/</loc>
		<lastmod>2011-10-17T08:37:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1839: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/14/millions-awarded-in-propofol-hepatitis-c-lawsuit/</loc>
		<lastmod>2011-10-14T16:22:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1838: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/13/new-jersey-levaquin-trial-winding-down/</loc>
		<lastmod>2011-10-13T18:37:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1837: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/13/actos-named-in-bladder-cancer-class-action-lawsuit/</loc>
		<lastmod>2011-10-13T18:35:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1835: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/12/leukemia-drug-may-cause-pah-fda-says/</loc>
		<lastmod>2011-10-12T15:30:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1834: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/12/public-citizen-warns-of-prostate-treatment-side-effects/</loc>
		<lastmod>2011-10-12T15:29:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1833: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/12/study-suggests-breast-cancer-drug-tamoxifen-exacerbates-diabetes-risks/</loc>
		<lastmod>2011-10-12T01:21:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1836: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/11/vitamin-supplements-potentially-dangerous-for-older-women/</loc>
		<lastmod>2011-10-11T15:31:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1832: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/11/schumer-exposes-gray-market-driving-up-costs-of-life-saving-drugs/</loc>
		<lastmod>2011-10-11T02:23:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1831: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/10/australian-regulators-issue-blood-clots-warning-for-yaz-yasmin/</loc>
		<lastmod>2011-10-10T02:07:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1830: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/07/paxil-malpractice-trial-ends-with-verdict-for-plaintiff/</loc>
		<lastmod>2011-10-07T17:33:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1829: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/07/cut-cantaloupe-recalled-by-fruit-fresh-up-inc-of-new-york/</loc>
		<lastmod>2011-10-07T17:31:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1828: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/07/c-diff-a-risk-for-ppi-users/</loc>
		<lastmod>2011-10-07T17:28:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1827: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/07/depo-provera-linked-to-hiv-transmission/</loc>
		<lastmod>2011-10-07T15:57:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1826: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/07/la-jury-awards-481m-to-stevens-johnson-syndrome-victim-who-took-motrin/</loc>
		<lastmod>2011-10-07T02:09:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1823: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/05/anencephaly-caused-by-zoloft-parents-claim/</loc>
		<lastmod>2011-10-05T16:00:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1822: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/05/plavix-stroke-trial-halted-over-bleeding/</loc>
		<lastmod>2011-10-05T15:57:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1821: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/05/avastin-may-cause-ovarian-failure/</loc>
		<lastmod>2011-10-05T15:53:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1824: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/04/another-actos-lawsuit-claims-bladder-cancer/</loc>
		<lastmod>2011-10-04T16:01:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1825: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/03/pradaxa-bleeding-concerns-grow/</loc>
		<lastmod>2011-10-03T16:04:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1820: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/03/study-finds-heightened-risk-of-birth-defects-with-epilepsy-drugs-keppra-lamictal/</loc>
		<lastmod>2011-10-03T03:20:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1819: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/29/heart-risks-increase-with-some-nsaids/</loc>
		<lastmod>2011-09-29T14:43:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1818: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/29/study-of-new-antipsychotics-sees-only-modest-benefits-from-off-label-use/</loc>
		<lastmod>2011-09-29T14:41:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1817: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/28/ssri-with-antiplatelet-therapy-raises-bleeding-risk/</loc>
		<lastmod>2011-09-28T15:31:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1816: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/28/yaz-yasmin-have-fda-worried/</loc>
		<lastmod>2011-09-28T15:20:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1815: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/28/jj-recalls-anemia-drug-eprex-due-to-potency-issues-in-doses/</loc>
		<lastmod>2011-09-28T03:05:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1813: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/27/fda-phasing-out-use-of-aerosol-inhalers-for-asthma-patients/</loc>
		<lastmod>2011-09-27T04:10:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1814: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/27/fda-phasing-out-use-of-aerosol-inhalers-for-asthma-patients-2/</loc>
		<lastmod>2011-09-27T04:10:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1812: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/27/new-zealand-regulators-taking-heat-for-approval-of-blood-thinner-pradaxa/</loc>
		<lastmod>2011-09-27T03:41:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1811: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/26/orlistat-focus-of-more-liver-concerns/</loc>
		<lastmod>2011-09-26T15:50:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1810: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/26/pediatrics-panel-advises-fda-to-investigate-link-between-antipsychotics-and-childhood-weight-gain-diabetes-3/</loc>
		<lastmod>2011-09-26T04:22:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1809: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/26/pediatrics-panel-advises-fda-to-investigate-link-between-antipsychotics-and-childhood-weight-gain-diabetes-2/</loc>
		<lastmod>2011-09-26T04:20:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1808: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/26/pediatrics-panel-advises-fda-to-investigate-link-between-antipsychotics-and-childhood-weight-gain-diabetes/</loc>
		<lastmod>2011-09-26T04:19:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1807: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/26/fda-targets-diet-supplement-manufacturer-over-therapeutic-claims-on-product-labels/</loc>
		<lastmod>2011-09-26T03:39:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1806: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/23/canadian-plavix-users-given-new-guidance-on-ppis/</loc>
		<lastmod>2011-09-23T16:00:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1805: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/23/european-regulator-acts-on-multaq/</loc>
		<lastmod>2011-09-23T15:57:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1804: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/23/another-study-links-ppi-heartburn-drugs-with-c-diff-diarrhea-2/</loc>
		<lastmod>2011-09-23T03:15:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1803: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/23/another-study-links-ppi-heartburn-drugs-with-c-diff-diarrhea/</loc>
		<lastmod>2011-09-23T03:14:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1802: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/22/avastin-eye-infections-prompt-va-to-stop-eye-injections/</loc>
		<lastmod>2011-09-22T16:21:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1801: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/22/multaq-safety-concerns-mount/</loc>
		<lastmod>2011-09-22T16:14:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1800: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/22/judge-denies-motion-to-dismiss-about-60-avandia-lawsuits-due-to-statute-of-limitations-2/</loc>
		<lastmod>2011-09-22T05:16:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1799: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/22/judge-denies-motion-to-dismiss-about-60-avandia-lawsuits-due-to-statute-of-limitations/</loc>
		<lastmod>2011-09-22T05:16:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1798: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/21/glp-1-diabetes-drugs-under-scrutiny-amid-cancer-concerns/</loc>
		<lastmod>2011-09-21T14:23:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1796: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/16/kentucky-health-clinic-stops-writing-new-xanax-prescriptions-due-to-abuse/</loc>
		<lastmod>2011-09-16T03:43:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1797: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/15/johnson-johnson-to-pay-85-million-to-settle-netrecor-marketing-charges/</loc>
		<lastmod>2011-09-15T10:32:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1795: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/15/public-misunderstands-fda-drug-approvals/</loc>
		<lastmod>2011-09-15T02:26:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1794: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/14/mdl-possible-for-actos-bladder-cancer-lawsuits/</loc>
		<lastmod>2011-09-14T15:20:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1793: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/14/harvard-study-links-nsaid-use-with-kidney-cancer/</loc>
		<lastmod>2011-09-14T04:28:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1792: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/13/new-diabetes-drugs-may-pose-cancer-risk/</loc>
		<lastmod>2011-09-13T15:58:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1791: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/13/autism-spectrum-disorder-linked-to-antidepressants-in-pregnancy/</loc>
		<lastmod>2011-09-13T15:55:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1790: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/12/fda-panel-backs-duration-of-use-limits-on-bone-drugs/</loc>
		<lastmod>2011-09-12T17:00:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1789: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/09/skin-cancer-a-risk-for-tnfa-blocker-patients/</loc>
		<lastmod>2011-09-09T16:39:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1788: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/09/infant-death-blamed-on-simplythick-digestive-aid/</loc>
		<lastmod>2011-09-09T04:04:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1785: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/08/tnfa-blockers-linked-to-listeria-legionella-infections/</loc>
		<lastmod>2011-09-08T15:47:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1784: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/08/fosamax-for-five-years-might-be-enough-to-prevent-fractures/</loc>
		<lastmod>2011-09-08T15:43:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1787: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/07/nsaid-study-sees-miscarriage-risk/</loc>
		<lastmod>2011-09-07T15:50:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1786: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/07/pwa-attorney-delivers-opening-statements-in-nj-levaquin-trial/</loc>
		<lastmod>2011-09-07T15:48:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1783: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/07/two-more-lawsuits-filed-by-google-shareholders-of-illegal-adwords-scheme/</loc>
		<lastmod>2011-09-07T03:41:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1782: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/06/depakote-may-hinder-cognitive-ability/</loc>
		<lastmod>2011-09-06T16:07:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1781: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/06/bisphosphonate-review-at-fda-slated-for-friday/</loc>
		<lastmod>2011-09-06T16:03:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1779: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/02/fda-issues-warning-for-avastin-eye-infections/</loc>
		<lastmod>2011-09-02T16:28:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1777: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/02/new-york-actos-lawsuit-blames-long-term-use-for-bladder-cance/</loc>
		<lastmod>2011-09-02T16:02:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1776: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/02/serious-allergic-reactions-reported-among-patients-taking-antipsychotic-saphira/</loc>
		<lastmod>2011-09-02T15:43:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1775: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/02/european-cardiologists-group-recommends-brilinta-over-plavix/</loc>
		<lastmod>2011-09-02T04:51:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1780: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/01/first-new-jersey-levaquin-trial-has-started/</loc>
		<lastmod>2011-09-01T16:39:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1778: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/01/florida-tennessee-eye-infections-tied-to-avastin-injections/</loc>
		<lastmod>2011-09-01T16:04:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1774: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/01/judge-dismisses-part-of-complaint-in-fourth-fosamax-bellwether-trial/</loc>
		<lastmod>2011-09-01T03:59:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1773: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/31/pah-warning-issued-for-leukemia-drug/</loc>
		<lastmod>2011-08-31T16:01:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1772: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/31/public-citizen-petitions-fda-to-change-label-update-rules-for-makers-of-generic-drugs/</loc>
		<lastmod>2011-08-31T04:19:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1771: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/30/initial-depositions-in-chantix-mdl-set-for-september/</loc>
		<lastmod>2011-08-30T03:31:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1770: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/29/brilinta-clinical-trial-records-more-deaths-among-plavix-patients/</loc>
		<lastmod>2011-08-29T15:25:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1769: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/29/california-lawsuit-claims-nursing-homes-forced-drugs-to-restrain-resident/</loc>
		<lastmod>2011-08-29T15:22:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1768: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/26/judge-says-he-will-push-for-yaz-yasmin-settlement-talks-after-bellwether-trials-next-year/</loc>
		<lastmod>2011-08-26T15:30:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1767: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/25/lawsuit-claims-propecia-led-to-permanent-sexual-problems/</loc>
		<lastmod>2011-08-25T17:27:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1766: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/25/fda-says-high-doses-of-celexa-dangerous-for-heart/</loc>
		<lastmod>2011-08-25T17:25:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1764: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/25/nurses-treating-cancer-patients-at-risk-of-exposure-to-chemotherapy-drugs/</loc>
		<lastmod>2011-08-25T02:37:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1765: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/24/petition-seeks-tougher-warnings-for-proton-pump-inhibitor-side-effects/</loc>
		<lastmod>2011-08-24T16:06:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1763: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/23/doctors-briefed-on-halted-multaq-study/</loc>
		<lastmod>2011-08-23T15:45:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1762: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/23/takeda-named-in-another-actos-bladder-cancer-lawsuit/</loc>
		<lastmod>2011-08-23T15:43:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1761: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/23/surgeon-equates-blistering-from-motrin-side-effects-to-second-degree-burn/</loc>
		<lastmod>2011-08-23T04:28:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1759: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/22/baldness-prostate-drugs-linked-to-persistant-erectile-dysfunction/</loc>
		<lastmod>2011-08-22T15:37:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1758: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/22/rick-perry-reverses-stance-on-gardasil-mandate-bowing-to-far-right-pressure/</loc>
		<lastmod>2011-08-22T02:14:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1757: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/22/ads-in-medical-journals-often-ignore-fda-standards/</loc>
		<lastmod>2011-08-22T01:36:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1760: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/19/yaz-yasmin-should-be-avoided-report-says/</loc>
		<lastmod>2011-08-19T15:38:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1756: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/19/motrin-side-effects-trial-begins-in-los-angeles/</loc>
		<lastmod>2011-08-19T02:14:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1755: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/18/federal-panel-rules-to-consolidate-darvon-darvocet-lawsuits/</loc>
		<lastmod>2011-08-18T15:55:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1754: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/18/chemotherapy-patients-should-avoid-some-herbal-supplements/</loc>
		<lastmod>2011-08-18T15:51:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1753: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/18/two-years-following-recall-dietary-supplement-still-on-the-market/</loc>
		<lastmod>2011-08-18T04:51:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1752: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/16/tylenol-cold-multi-symptom-nighttime-rapid-release-gelcaps-recalled/</loc>
		<lastmod>2011-08-16T15:52:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1751: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/16/senators-urge-cms-to-investigate-antipsychotic-drug-use-in-nursing-homes/</loc>
		<lastmod>2011-08-16T15:51:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1750: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/15/california-man-diagnosed-with-stevens-johnson-syndrome-after-taking-motrin-for-fever/</loc>
		<lastmod>2011-08-15T21:50:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1749: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/15/canadian-hormone-drug-lawsuit-permitted/</loc>
		<lastmod>2011-08-15T15:56:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1748: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/15/nigerian-families-receive-first-payments-in-failed-trovan-trial/</loc>
		<lastmod>2011-08-15T03:06:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1747: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/15/experts-issue-warning-on-dangers-of-transdermal-patches-as-use-increases/</loc>
		<lastmod>2011-08-15T02:46:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1745: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/12/medical-journals-need-rule-changes-regarding-use-of-ghost-writers/</loc>
		<lastmod>2011-08-12T03:44:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1746: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/11/bladder-cancer-warning-for-actos/</loc>
		<lastmod>2011-08-11T16:48:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1744: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/11/jj-settles-federal-criminal-charges-on-risperdal-marketing/</loc>
		<lastmod>2011-08-11T02:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1743: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/10/eight-in-texas-file-avandia-injury-lawsuits/</loc>
		<lastmod>2011-08-10T02:48:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1742: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/09/esa-cancer-drugs-pose-side-effects-risk-ineffective-in-large-group-of-recipients/</loc>
		<lastmod>2011-08-09T02:02:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1741: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/08/bladder-cancer-risk-could-spur-hundreds-of-actos-lawsuits/</loc>
		<lastmod>2011-08-08T21:15:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1740: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/05/psychiatric-drugs-being-prescribed-by-more-general-practicioners/</loc>
		<lastmod>2011-08-05T16:19:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1739: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/05/proscar-propecia-label-change-announced-in-canada/</loc>
		<lastmod>2011-08-05T15:47:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1738: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/05/depakote-sued-over-birth-defects/</loc>
		<lastmod>2011-08-05T15:45:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1737: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/05/american-regent-recalls-vasopressin-injections-due-to-diminished-potency-problems/</loc>
		<lastmod>2011-08-05T02:56:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1736: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/04/diflucan-at-high-dose-during-pregnancy-linked-to-birth-defects/</loc>
		<lastmod>2011-08-04T15:26:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1735: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/03/ssri-antidepressants-linked-to-more-side-effects-than-older-drugs/</loc>
		<lastmod>2011-08-03T15:43:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1734: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/03/fda-considers-relaxing-rules-to-fill-vacancies-on-advisory-panels/</loc>
		<lastmod>2011-08-03T03:31:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1733: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/02/circuit-court-gives-nod-to-amgen-whistleblower-lawsuit/</loc>
		<lastmod>2011-08-02T16:52:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1732: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/02/astrazeneca-settles-diabetes-claims-surrounding-seroquel/</loc>
		<lastmod>2011-08-02T03:38:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1728: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/01/merck-hears-criticism-from-fda-over-charred-plastic-found-in-vaccine-vials/</loc>
		<lastmod>2011-08-01T02:09:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1727: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/01/judge-allows-bayer-to-depose-yaz-plaintiffs-in-mdl/</loc>
		<lastmod>2011-08-01T01:55:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1731: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/29/chantix-label-updated/</loc>
		<lastmod>2011-07-29T15:58:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1726: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/29/slimforte-botanical-slimming-weight-loss-supplements-recalled-due-to-presence-of-sibutramine/</loc>
		<lastmod>2011-07-29T03:27:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1730: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/28/ema-recommends-new-wanings-for-actos/</loc>
		<lastmod>2011-07-28T15:56:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1729: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/28/qualiherb-dietary-supplements-recalled/</loc>
		<lastmod>2011-07-28T15:55:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1725: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/28/fda-says-cetero-research-conducted-flawed-tests-fixed-results/</loc>
		<lastmod>2011-07-28T02:55:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1721: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/26/chantix-implicated-in-two-vermont-murder-cases/</loc>
		<lastmod>2011-07-26T01:22:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1719: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/21/questions-raised-over-integrity-of-paxil-study/</loc>
		<lastmod>2011-07-24T21:04:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1724: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/22/fda-reviewing-multaq-after-study-halted/</loc>
		<lastmod>2011-07-22T15:03:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1723: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/22/health-canada-mandates-stronger-warnings-for-metoclopramide/</loc>
		<lastmod>2011-07-22T15:00:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1722: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/22/possible-esophageal-cancer-link-to-osteoporosis-drugs/</loc>
		<lastmod>2011-07-22T14:56:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1720: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/21/study-questions-plavix-ppis-for-pci-patients/</loc>
		<lastmod>2011-07-21T21:01:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1718: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/15/bellwether-yaz-yasmin-ocella-trials-set-for-september-in-new-jersey/</loc>
		<lastmod>2011-07-15T01:44:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1717: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/15/tennessee-woman-claims-plavix-caused-blood-clots-in-brain/</loc>
		<lastmod>2011-07-15T01:10:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1716: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/14/fda-developing-diagnostic-tests-to-prevent-prescription-drug-side-effects/</loc>
		<lastmod>2011-07-14T03:32:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1715: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/13/yaz-yasmin-lawsuits-continue/</loc>
		<lastmod>2011-07-13T16:11:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1714: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/13/black-box-warnings-ignored-on-antipsychotic-drugs-for-parkinsons-patients/</loc>
		<lastmod>2011-07-13T02:45:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1713: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/11/woman-sues-nexium-prilosec-maker-after-foot-fractures/</loc>
		<lastmod>2011-07-11T17:18:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1712: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/08/multaq-heart-concerns-halt-study/</loc>
		<lastmod>2011-07-08T15:18:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1711: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/08/makers-of-dietary-supplements-struggling-with-fda-disclosure-law/</loc>
		<lastmod>2011-07-08T02:40:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1710: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/07/fda-cracks-down-on-dietary-supplement-maker/</loc>
		<lastmod>2011-07-07T16:58:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1709: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/07/popular-painkillers-linked-to-irregular-heart-rhythm/</loc>
		<lastmod>2011-07-07T01:50:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1708: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/06/ssri-antidepressants-for-expecting-mothers-may-increase-autism-risk/</loc>
		<lastmod>2011-07-06T03:15:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1707: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/05/chantix-again-tied-to-heart-risks/</loc>
		<lastmod>2011-07-05T15:36:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1706: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/04/live-better-vitamins-recalled-due-to-lack-of-child-proof-cap/</loc>
		<lastmod>2011-07-04T23:56:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1704: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/01/depakote-other-epilepsy-drugs-linked-to-lower-iq-scores/</loc>
		<lastmod>2011-07-01T20:51:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1703: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/01/medicare-to-pay-for-avastin/</loc>
		<lastmod>2011-07-01T20:49:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1705: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/30/study-links-popular-antidepressants-to-birth-defects/</loc>
		<lastmod>2011-06-30T20:55:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1702: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/30/safet-labels-printed-information-inconsistent-from-pharmacy-to-pharmacy/</loc>
		<lastmod>2011-06-30T02:36:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1701: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/30/more-tylenol-recalled-due-to-musty-odor-in-bottles/</loc>
		<lastmod>2011-06-30T01:40:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1700: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/29/neurontin-study-called-a-sham/</loc>
		<lastmod>2011-06-29T16:22:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1699: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/28/fda-issues-recall-on-nature-ready-instant-wart-and-mole-remover-due-to-burn-risk/</loc>
		<lastmod>2011-06-28T19:37:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1698: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/28/canada-investigating-champix-heart-side-effects/</loc>
		<lastmod>2011-06-28T13:40:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1697: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/28/hearing-on-fda-avastin-decision-begins-today/</loc>
		<lastmod>2011-06-28T13:36:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1696: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/28/lawsuit-claims-nuvaring-caused-fatal-blood-clot/</loc>
		<lastmod>2011-06-28T02:04:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1695: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/28/experimental-diabetes-treatment-linked-to-bladder-breast-cancer/</loc>
		<lastmod>2011-06-28T00:35:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1694: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/27/eye-disease-more-likely-with-avandia-actos/</loc>
		<lastmod>2011-06-27T13:01:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1693: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/27/supreme-court-upholds-jury-award-in-prempro-premarin-cases/</loc>
		<lastmod>2011-06-27T03:34:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1690: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/26/rugby-childrens-pain-fever-drops-recalled-due-to-defective-dropper-overdose-risk/</loc>
		<lastmod>2011-06-26T16:47:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1692: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/24/high-court-nixes-generic-drug-lawsuits/</loc>
		<lastmod>2011-06-24T21:30:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1691: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/24/ema-puts-off-actos-bladder-cancer-decision/</loc>
		<lastmod>2011-06-24T21:27:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1689: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/24/eu-delays-actos-decision-until-july/</loc>
		<lastmod>2011-06-24T14:28:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1688: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/24/unitedhealth-group-wants-names-of-people-who-sued-gsk-over-paxil-avandia-injuries/</loc>
		<lastmod>2011-06-24T01:10:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1687: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/23/patients-on-high-doses-of-statins-may-face-diabetes-risk/</loc>
		<lastmod>2011-06-23T16:53:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1686: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/22/58-million-premarin-prempro-award-will-stand/</loc>
		<lastmod>2011-06-22T16:42:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1685: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/22/canada-updates-antipsychotic-drugs/</loc>
		<lastmod>2011-06-22T16:36:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1684: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/22/yasmin-ocella-wrongful-death-lawsuit-filed-in-north-carolina/</loc>
		<lastmod>2011-06-22T11:10:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1683: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/22/family%e2%80%99s-lawsuit-blames-darvocet-for-mother%e2%80%99s-death/</loc>
		<lastmod>2011-06-22T11:05:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1682: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/22/jury-rules-in-favor-of-drug-company-in-second-of-more-than-2500-levaquin-lawsuits/</loc>
		<lastmod>2011-06-22T03:40:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1681: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/20/jj-subsidiary-issues-recall-on-risperdal-bottles-with-foul-odor/</loc>
		<lastmod>2011-06-20T18:52:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1680: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/19/supreme-court-clears-way-for-baycol-class-action-lawsuits/</loc>
		<lastmod>2011-06-19T23:26:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1679: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/17/trial-dates-set-for-accutane-bowel-disease-cases/</loc>
		<lastmod>2011-06-17T14:38:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1678: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/17/heart-patients-should-be-wary-of-chantix/</loc>
		<lastmod>2011-06-17T14:29:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1677: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/17/diabetes-groups-comment-on-actos-bladder-cancer-risk/</loc>
		<lastmod>2011-06-17T14:25:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1676: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/17/actos-causes-bladder-cancer-fda-says/</loc>
		<lastmod>2011-06-17T10:11:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1675: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/17/class-action-lawsuit-claims-heart-problems-linked-to-avandia/</loc>
		<lastmod>2011-06-17T01:44:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1674: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/17/higher-vitamin-d-levels-increase-osteoporosis-drug-effectiveness/</loc>
		<lastmod>2011-06-17T01:17:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1673: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/16/over-use-of-antibiotics-in-home-care-settings-noted-in-new-canadian-study/</loc>
		<lastmod>2011-06-16T20:07:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1672: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/16/rotarix-vaccine-carries-risk-of-infant-bowel-obstruction/</loc>
		<lastmod>2011-06-16T18:27:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1671: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/16/risperdal-requip-often-mixed-up-fda-says/</loc>
		<lastmod>2011-06-16T14:01:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1670: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/16/mao-avandia-claims-dismissed/</loc>
		<lastmod>2011-06-16T13:57:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1668: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/15/spiriva-as-inhaled-mist-increases-risk-of-death-by-52-percent/</loc>
		<lastmod>2011-06-15T16:59:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1669: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/14/uk-regulators-to-meet-on-possible-actos-bladder-cancer-connection/</loc>
		<lastmod>2011-06-14T08:40:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1667: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/13/public-citizen-calls-for-ban-of-80mg-zocor/</loc>
		<lastmod>2011-06-13T16:17:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1666: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/12/jury-awards-in-625000-in-first-tainted-heparin-lawsuit/</loc>
		<lastmod>2011-06-12T22:15:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1665: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/12/bladder-cancer-fears-prompt-french-to-ban-actos/</loc>
		<lastmod>2011-06-12T22:11:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1664: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/12/hair-loss-med-prostate-drugs-may-raise-risk-of-high-grade-prostate-cancer/</loc>
		<lastmod>2011-06-12T22:08:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1663: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/09/high-dose-zocor-linked-to-muscle-damage/</loc>
		<lastmod>2011-06-09T15:14:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1662: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/09/study-confirms-link-between-ppi-drugs-and-hip-fractures/</loc>
		<lastmod>2011-06-09T01:58:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1661: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/08/canada-reviewing-yaz-yasmin/</loc>
		<lastmod>2011-06-08T11:28:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1660: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/07/type-2-diabetes-drug-victoza-named-in-growing-number-of-pancreatitis-reports/</loc>
		<lastmod>2011-06-07T23:29:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1659: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/07/methyldopate-injection-recalled/</loc>
		<lastmod>2011-06-07T13:52:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1658: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/07/ed-dietary-supplement-recalled/</loc>
		<lastmod>2011-06-07T13:50:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1657: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/07/illegal-risperdal-marketing-costs-jj-327-million-in-south-carolina/</loc>
		<lastmod>2011-06-07T01:00:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1656: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/06/clomid-study-may-confirm-birth-defect-suspicions/</loc>
		<lastmod>2011-06-06T14:50:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1655: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/06/abbott-in-talks-to-settle-illegal-marketing-charges-on-epilepsy-drug-depakote/</loc>
		<lastmod>2011-06-06T01:45:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1654: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/03/web-designer-sues-over-humira-eye-damage/</loc>
		<lastmod>2011-06-03T14:14:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1653: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/02/south-carolina-ag-files-lawsuit-over-avandia-claims-on-behalf-of-states-medicaid-recipients/</loc>
		<lastmod>2011-06-02T21:46:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1652: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/02/france-stops-payments-on-chantix-prescriptions-for-social-security-benefits-recipients/</loc>
		<lastmod>2011-06-02T00:13:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1651: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/01/fda-reviewing-yaz-and-yasmine-over-possible-blood-clot-risk/</loc>
		<lastmod>2011-06-01T14:26:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1650: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/30/prescription-drug-safety-labels-list-more-side-effects-increasingly-cumbersome/</loc>
		<lastmod>2011-05-30T16:12:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1649: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/30/lawsuits-claim-plavix-benefits-are-overstated/</loc>
		<lastmod>2011-05-30T15:56:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1648: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/27/accutane-lawsuits-now-number-more-than-3200/</loc>
		<lastmod>2011-05-27T11:34:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1647: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/27/fosamax-fracture-lawsuits-consolidated-in-new-jersey-federal-court/</loc>
		<lastmod>2011-05-27T11:05:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1646: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/26/astrazeneca-faces-new-nexium-fracture-lawsuit/</loc>
		<lastmod>2011-05-26T13:13:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1645: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/26/sanofi-spent-5m-lobbying-against-generic-forms-of-blood-thinner-levenox/</loc>
		<lastmod>2011-05-26T02:14:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1644: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/26/sudden-hearing-loss-reported-after-taking-viagra/</loc>
		<lastmod>2011-05-26T02:03:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1643: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/25/copd-drugs-may-put-men-at-risk-for-urinary-retention/</loc>
		<lastmod>2011-05-25T09:53:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1642: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/25/judge-unseals-documents-key-to-future-levaquin-tendon-rupture-cases/</loc>
		<lastmod>2011-05-25T01:59:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1641: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/24/two-deaths-15-cases-of-life-threatening-disorder-prompt-fda-warning-on-simplythick-for-premature-infants/</loc>
		<lastmod>2011-05-24T00:39:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1640: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/23/10-million-awarded-in-stevens-johnson-lawsuit/</loc>
		<lastmod>2011-05-23T14:00:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1639: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/23/jury-hearing-case-of-stevens-johnson-syndrome-victim-in-philadelphia-childrens-motrin-and-tylenol-are-blamed/</loc>
		<lastmod>2011-05-23T02:27:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1638: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/22/plavix-litigation-40-lawsuits-and-growing/</loc>
		<lastmod>2011-05-22T20:47:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1637: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/22/chantix-risks-underestimated/</loc>
		<lastmod>2011-05-22T20:33:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1636: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/20/study-inconclusive-on-determining-risk-of-birth-defects-while-taking-topamax/</loc>
		<lastmod>2011-05-20T15:13:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1635: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/20/public-citizen-petitions-fda-to-ban-highest-dose-of-alzheimers-drug-aricept/</loc>
		<lastmod>2011-05-20T02:13:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1634: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/19/after-november-avandia-will-be-harder-to-get/</loc>
		<lastmod>2011-05-19T12:41:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1633: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/19/fda-panel-makes-childrens-acetaminophen-recommendations/</loc>
		<lastmod>2011-05-19T12:34:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1632: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/19/south-africa-recalls-type-2-diabetes-drug-avandia/</loc>
		<lastmod>2011-05-19T03:01:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1631: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/19/louisiana-woman-files-injury-lawsuit-against-maker-of-darvocet/</loc>
		<lastmod>2011-05-19T02:51:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1630: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/18/anemia-drugs-found-harmful-to-heart-attack-patients/</loc>
		<lastmod>2011-05-18T16:14:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1629: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/18/antibiotics-for-infants-can-increase-risk-of-asthma-by-adulthood/</loc>
		<lastmod>2011-05-18T01:56:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1628: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/17/prempro-settlements-to-cost-at-least-772-million-pfizer-says/</loc>
		<lastmod>2011-05-17T14:06:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1627: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/17/fda-looks-at-new-dosing-guidelines-for-childrens-acetaminophen/</loc>
		<lastmod>2011-05-17T14:03:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1626: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/17/fda-counterfeit-extenze-can-cause-serious-harm-to-men-contain-hidden-pharmaceuticals/</loc>
		<lastmod>2011-05-17T02:32:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1625: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/16/more-evidence-of-actos-bladder-cancer-link/</loc>
		<lastmod>2011-05-16T12:05:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1624: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/16/feds-seek-1-billion-in-risperdal-settlement/</loc>
		<lastmod>2011-05-16T02:22:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1623: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/13/drugmakers-to-standardize-infants-childrens-acetaminophen/</loc>
		<lastmod>2011-05-13T10:48:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1622: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/13/recall-issued-on-hivaids-drug-prezista-due-to-musty-odor-inside-bottles/</loc>
		<lastmod>2011-05-13T02:09:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1621: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/12/yaz-blamed-for-young-womans-death/</loc>
		<lastmod>2011-05-12T11:15:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1620: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/12/jj-prepares-for-settlement-on-charges-of-illegally-marketing-antipsychotic-drug-risperdal/</loc>
		<lastmod>2011-05-12T02:36:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1619: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/11/possibly-mislabled-dietary-supplements-recalled/</loc>
		<lastmod>2011-05-11T12:23:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1618: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/11/ppi-drugs-again-linked-to-increased-risk-of-bone-fractures/</loc>
		<lastmod>2011-05-11T03:03:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1617: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/10/government-audit-finds-nursing-homes-overuse-antipsychotics/</loc>
		<lastmod>2011-05-10T14:28:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1616: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/10/statins-proven-ineffective-for-kidney-dialysis-patients/</loc>
		<lastmod>2011-05-10T03:52:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1615: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/08/decision-to-consolidate-darvon-darvocet-lawsuits-delayed-until-july/</loc>
		<lastmod>2011-05-08T22:59:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1614: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/06/american-regent-recalls-caffeine-and-sodium-benzoate-injections/</loc>
		<lastmod>2011-05-06T14:49:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1613: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/06/fda-says-teething-medications-can-be-harmful/</loc>
		<lastmod>2011-05-06T13:50:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1612: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/06/ftc-sees-spike-in-deals-to-extended-drug-patents/</loc>
		<lastmod>2011-05-06T13:05:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1611: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/06/omega-alpha-recalls-kidney-flush-in-canada-due-to-lack-of-safety-information/</loc>
		<lastmod>2011-05-06T02:02:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1610: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/05/new-study-confirms-bisphosphonate-thigh-fracture-risk/</loc>
		<lastmod>2011-05-05T14:00:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1609: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/05/more-avandia-heart-attack-stroke-lawsuits-to-be-settled/</loc>
		<lastmod>2011-05-05T13:42:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1608: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/05/rush-to-market-new-drugs-leads-to-incomplete-data/</loc>
		<lastmod>2011-05-05T13:22:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1607: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/05/combining-antidepressants-increases-likelihood-of-experiencing-side-effects/</loc>
		<lastmod>2011-05-05T03:23:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1606: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/04/glaxosmithkline-reportedly-settles-hundreds-of-poligrip-zinc-poisoning-lawsuits/</loc>
		<lastmod>2011-05-04T10:41:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1605: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/04/bristol-myers-squibb-recalls-overly-potent-coumadin-5mg-tablets/</loc>
		<lastmod>2011-05-04T03:27:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1604: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/03/regenerect-supplements-recalled-due-to-presence-of-ed-drug-analogue/</loc>
		<lastmod>2011-05-03T03:12:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1602: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/28/ohio-woman-sues-astrazeneca-over-fractures-caused-by-nexium/</loc>
		<lastmod>2011-05-01T20:04:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1600: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/28/lousiana-woman-sues-merck-co-over-fractures-caused-by-fosamax-use/</loc>
		<lastmod>2011-05-01T19:58:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1599: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/29/high-doses-of-synthetic-thyroid-hormone-increases-bone-fracture-risk-among-older-patients/</loc>
		<lastmod>2011-04-29T15:13:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1598: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/29/makers-of-plavix-want-cases-consolidated-centralized-in-mass-tort/</loc>
		<lastmod>2011-04-29T02:42:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1601: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/28/johnson-johnson-to-introduce-new-dosage-caps-to-medications/</loc>
		<lastmod>2011-04-28T19:58:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1597: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/28/federal-investigation-launched-into-gsk-marketing-of-antidepressant-wellbutrin/</loc>
		<lastmod>2011-04-28T01:54:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1603: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/27/american-regent-recalls-ammonium-molybdate-injection-vials-due-to-particulates/</loc>
		<lastmod>2011-04-27T20:16:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1596: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/27/otc-painkillers-have-negative-impact-on-ssri-antidepressant-effectiveness/</loc>
		<lastmod>2011-04-27T01:42:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1595: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/26/fda-updates-tysabri-warning-label-to-include-pml-risk/</loc>
		<lastmod>2011-04-26T20:46:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1594: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/25/four-deaths-reported-during-clinical-trial-of-proposed-pfizer-rheumatoid-arthritis-drug/</loc>
		<lastmod>2011-04-25T00:59:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1591: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/24/new-birth-control-pills-may-come-with-increased-blood-clot-risk/</loc>
		<lastmod>2011-04-24T19:49:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1590: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/21/ace-inhibitors-linked-to-recurrence-of-breast-cancer/</loc>
		<lastmod>2011-04-21T20:51:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1593: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/21/otc-medications-can-cause-rare-but-deadly-side-effect/</loc>
		<lastmod>2011-04-21T19:56:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1592: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/21/calcium-supplements-linked-to-increased-heart-attack-risk-in-post-menopausal-women/</loc>
		<lastmod>2011-04-21T19:49:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1589: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/21/health-care-providers-warned-of-improper-drug-usage/</loc>
		<lastmod>2011-04-21T15:25:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1588: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/21/fda-launches-program-to-curb-abuse-of-long-lasting-extended-release-opioid-painkillers/</loc>
		<lastmod>2011-04-21T00:19:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1587: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/19/fda-orders-asthma-medication-makers-to-conduct-safety-study/</loc>
		<lastmod>2011-04-19T16:42:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1586: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/17/xenical-linked-to-kidney-injuries/</loc>
		<lastmod>2011-04-17T09:53:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1585: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/17/crohn%e2%80%99s-disease-treatments-linked-to-rare-blood-cancer/</loc>
		<lastmod>2011-04-17T09:52:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1584: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/15/canada-issues-warning-of-blood-clots-linked-to-vivaglobin-injection/</loc>
		<lastmod>2011-04-15T13:51:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1582: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/13/risk-of-cleft-lip-cleft-palate-still-present-for-women-taking-corticosteroids-during-pregnancy/</loc>
		<lastmod>2011-04-13T01:39:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1583: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/12/stenting-study-shows-plavix-use-may-be-shortened/</loc>
		<lastmod>2011-04-12T20:25:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1581: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/12/revlimid-linked-to-secondary-cancer-during-clinical-trials-fda-reports/</loc>
		<lastmod>2011-04-12T02:06:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1578: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/08/updated-label-of-ms-drug-tysabri-includes-information-on-rare-brain-infection-pml/</loc>
		<lastmod>2011-04-08T13:23:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1580: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/08/government-shutdown-would-affect-fda-operations/</loc>
		<lastmod>2011-04-08T11:45:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1577: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/08/ppi-drugs-given-to-infants-prove-ineffective-not-much-better-among-older-children/</loc>
		<lastmod>2011-04-08T00:33:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1579: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/07/zinc-overdose-linked-to-denture-adhesives/</loc>
		<lastmod>2011-04-07T11:01:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1576: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/07/off-label-drug-marketing-in-us-rampant/</loc>
		<lastmod>2011-04-07T08:25:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1575: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/06/the-best-enhancement-supplement-recalled-due-to-presence-of-sildenafil-agent/</loc>
		<lastmod>2011-04-06T02:41:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1574: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/05/access-to-provigil-restricted-in-europe-due-to-risk-of-fatal-skin-reaction-psychotic-events/</loc>
		<lastmod>2011-04-05T02:49:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1573: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/01/pfizer-gsk-disclose-payments-to-doctors/</loc>
		<lastmod>2011-04-01T14:21:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1572: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/01/acetaminophen-during-pregnancy-may-increase-risk-of-asthma/</loc>
		<lastmod>2011-04-01T00:28:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1571: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/30/fda-warns-consumers-not-to-take-soladek-solution-due-to-dangerous-levels-of-vitamins-a-and-d/</loc>
		<lastmod>2011-03-30T02:34:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1570: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/30/x-hero-male-enhancer-supplements-contain-unapproved-drugs-recalled-by-fda/</loc>
		<lastmod>2011-03-30T01:48:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1569: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/29/greenstone-issues-recall-on-mislabeled-citalopram-finasteride/</loc>
		<lastmod>2011-03-29T01:48:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1568: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/24/supreme-court-allows-evidence-of-zicam-maker-hiding-reports-of-loss-of-smell/</loc>
		<lastmod>2011-03-24T02:58:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1567: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/22/florida-mans-death-linked-to-overdoses-of-otc-painkillers-used-to-treat-toothache/</loc>
		<lastmod>2011-03-22T13:31:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1566: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/21/male-baldness-drug-linked-to-more-severe-prolonged-sexual-dysfunction/</loc>
		<lastmod>2011-03-21T17:04:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1565: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/18/iv-osteoporosis-drugs-associated-with-jaw-problems-according-to-new-study/</loc>
		<lastmod>2011-03-18T20:26:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1564: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/18/mylan-recalls-antibiotics-distributed-in-canada-due-to-label-errors/</loc>
		<lastmod>2011-03-18T12:01:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1563: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/18/johnson-johnson-ceo-actually-saw-pay-increase/</loc>
		<lastmod>2011-03-18T02:26:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1562: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/18/double-dose-of-plavix-following-stent-surgery-has-no-impact-on-rate-of-side-effects/</loc>
		<lastmod>2011-03-18T01:59:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1561: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/14/nationwide-antacid-recalls-lead-generics-to-increase-production/</loc>
		<lastmod>2011-03-14T19:10:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1560: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/10/virginia-man-claims-enbrel-led-to-cancer-maker-amgen-hid-most-dangerous-side-effects/</loc>
		<lastmod>2011-03-10T04:17:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1559: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/09/prevnar-acthib-vaccines-suspended-in-japan-following-four-infant-deaths/</loc>
		<lastmod>2011-03-09T01:53:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1558: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/08/topamax-linked-to-cleft-lip-cleft-palates-in-children/</loc>
		<lastmod>2011-03-08T21:22:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1557: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/08/httpwwwyourlawyercomtopicsoverviewdenture-cream-zinc-poisoning/</loc>
		<lastmod>2011-03-08T04:24:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1555: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/04/prolonged-painkiller-use-possibly-linked-to-ed/</loc>
		<lastmod>2011-03-04T22:53:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1554: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/04/opioid-painkillers-other-than-codeine-linked-to-birth-defects/</loc>
		<lastmod>2011-03-04T14:42:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1482: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/03/thousands-have-already-inquired-about-darvocet-injuries-massive-mass-tort-expected/</loc>
		<lastmod>2011-03-04T11:10:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1494: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/13/makers-of-darvon-darvocet-seek-to-block-multi-district-litigation-of-increasing-number-of-injury-claims/</loc>
		<lastmod>2011-03-04T11:07:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1505: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/19/darvon-darvocet-bans-lead-to-lawsuits/</loc>
		<lastmod>2011-03-04T11:04:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1453: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/03/propoxyphene-painkillers-removed-from-market/</loc>
		<lastmod>2011-03-04T11:00:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 644: Comments: 159 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/30/fda-panel-considers-pulling-darvon-darvocet-off-market/</loc>
		<lastmod>2011-03-04T10:56:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 369: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/24/darvocet-should-be-pulled-public-citizen-reiterates/</loc>
		<lastmod>2011-03-04T10:51:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1439: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/23/popular-painkillers-darvon-darvocet-pulled-from-us-market/</loc>
		<lastmod>2011-03-04T10:46:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 645: Comments: 170 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/03/fda-advisors-urge-regulators-to-ban-darvocet/</loc>
		<lastmod>2011-03-04T10:42:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1476: Comments: 48 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/21/motion-filed-to-consolidate-darvon-darvocet-lawsuits/</loc>
		<lastmod>2011-03-04T10:39:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1544: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/24/darvon-darvocet-lawsuits-considered-for-consolidation/</loc>
		<lastmod>2011-03-04T10:30:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1515: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/28/darvocet-blamed-for-death-of-tennessee-man-lawsuit-filed/</loc>
		<lastmod>2011-03-04T10:16:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1441: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/25/darvon-darvocet-ban-comes-years-too-late/</loc>
		<lastmod>2011-03-04T10:11:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1553: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/04/fda-aims-to-remove-unapproved-prescription-cough-cold-allergy-medications-from-market/</loc>
		<lastmod>2011-03-04T03:43:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1552: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/04/ppi-drugs-linked-to-lowered-magnesium-levels/</loc>
		<lastmod>2011-03-04T02:01:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1556: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/03/supplements-lack-trials-no-warnings-for-side-effects-or-safety/</loc>
		<lastmod>2011-03-03T22:54:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1551: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/02/rep-wu-like-many-asians-have-genetic-variant-affecting-drug-metabolism/</loc>
		<lastmod>2011-03-02T22:02:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1550: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/01/multaq-linked-to-two-cases-of-liver-failure-in-ireland/</loc>
		<lastmod>2011-03-01T23:02:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1549: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/01/fda-implores-denture-cream-adhesive-makers-to-notify-public-of-zinc-toxicity-dangers/</loc>
		<lastmod>2011-03-01T02:40:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1548: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/25/fda-gives-roche-a-chance-to-defend-avastin-treating-breast-cancer/</loc>
		<lastmod>2011-02-25T13:18:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1547: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/25/nsaids-acetaminophen-harmful-to-kidneys-stomach-lining/</loc>
		<lastmod>2011-02-25T02:48:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1546: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/24/counterfeit-extenze-tablets-containing-undeclared-prescription-drugs-recalled-by-biotab/</loc>
		<lastmod>2011-02-24T22:53:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1545: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/24/antipsychotics-late-in-pregnancy-lead-to-tremors-withdrawal-in-newborns/</loc>
		<lastmod>2011-02-24T02:50:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1543: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/24/adding-proton-pump-inhibitors-to-aspirin-therapy-not-necessary/</loc>
		<lastmod>2011-02-24T00:12:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1542: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/23/at-least-900-adverse-reactions-linked-to-swine-flu-vaccine-in-ireland/</loc>
		<lastmod>2011-02-23T02:46:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1540: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/22/louisiana-files-avandia-lawsuit-against-glaxosmithkline/</loc>
		<lastmod>2011-02-22T21:03:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1539: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/22/new-report-amphetamines-linked-to-higher-risk-of-parkinsons-disease/</loc>
		<lastmod>2011-02-22T03:55:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1541: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/21/johnson-johnson-recalls-simponi-pens-due-to-dosage-error/</loc>
		<lastmod>2011-02-21T21:03:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1538: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/18/upsher-smith-labs-recalls-warfarin-due-to-dosage-mislabeling/</loc>
		<lastmod>2011-02-18T21:33:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1536: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/18/fda-warns-against-using-terbutaline-to-treat-pre-term-labor/</loc>
		<lastmod>2011-02-18T12:31:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1535: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/18/new-zealand-bans-use-of-avandia-to-treat-type-2-diabetes/</loc>
		<lastmod>2011-02-18T01:53:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1537: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/18/triad-group-recalls-lubricating-jelly-due-to-sterility-issues/</loc>
		<lastmod>2011-02-18T00:03:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1534: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/16/cephalon-the-focus-of-federal-investigation-over-fentora-marketing/</loc>
		<lastmod>2011-02-16T04:19:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1533: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/15/energy-drinks-pose-serious-health-risks-on-teen-drinkers/</loc>
		<lastmod>2011-02-15T01:25:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1531: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/11/ppi-drugs-linked-to-increased-risk-of-pneumonia/</loc>
		<lastmod>2011-02-11T14:01:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1530: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/11/makers-of-fixodent-face-criticism-over-study-linking-use-to-neurological-disorders/</loc>
		<lastmod>2011-02-11T02:59:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1532: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/10/who-asks-for-closer-look-at-gsk-swine-flu-vaccine/</loc>
		<lastmod>2011-02-10T22:48:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1528: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/10/fda-investigating-follow-up-studies-of-quickly-approved-cancer-drugs/</loc>
		<lastmod>2011-02-10T21:55:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1527: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/10/new-york-residents-enter-lawsuit-over-dilantin-injuries/</loc>
		<lastmod>2011-02-10T00:19:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1526: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/09/gsk-settles-more-than-5000-avandia-cases-for-250-million/</loc>
		<lastmod>2011-02-09T04:07:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1529: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/08/justice-department-to-take-lead-in-depakote-case/</loc>
		<lastmod>2011-02-08T21:56:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1525: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/08/label-mix-up-prompts-qualitest-pharmaceuticals-recall-of-two-prescription-drugs/</loc>
		<lastmod>2011-02-08T00:35:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1521: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/04/american-regent-recalls-sodium-thiosulfate-injections-due-to-presence-of-glass-in-vials/</loc>
		<lastmod>2011-02-04T13:34:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1524: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/04/shaping-beauty-inc-recalls-celerite-capsules-due-to-undeclared-ingredient/</loc>
		<lastmod>2011-02-04T12:05:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1523: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/04/penn-herb-company-sued-over-undeclared-side-effect-of-supplement/</loc>
		<lastmod>2011-02-04T12:04:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1522: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/02/parents-sue-abbott-labs-over-depakote-link-to-birth-defects/</loc>
		<lastmod>2011-02-02T21:10:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1520: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/02/nitrous-oxide-as-anesthetic-linked-to-higher-risk-of-heart-attack/</loc>
		<lastmod>2011-02-02T02:26:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1519: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/31/starting-hrt-early-in-menopause-linked-to-higher-risk-of-breast-cancer/</loc>
		<lastmod>2011-01-31T23:36:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1518: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/31/glaxosmithkline-settles-avandia-lawsuit-projects-falling-profits/</loc>
		<lastmod>2011-01-31T22:48:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1517: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/get-help/</loc>
		<lastmod>2011-01-31T10:41:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1516: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/28/court-of-appeals-says-adulterated-drug-claims-not-preempted/</loc>
		<lastmod>2011-01-30T20:33:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1514: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/25/ge-settles-omniscan-suit-keeps-disclosures-private/</loc>
		<lastmod>2011-01-26T20:41:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1513: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/26/drug-recalls-impacting-johnson-johnson-sales/</loc>
		<lastmod>2011-01-26T19:39:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1512: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/25/avandia-trial-begins-in-philadelphia/</loc>
		<lastmod>2011-01-25T23:58:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1511: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/24/ge-to-go-to-court-to-defend-omniscan/</loc>
		<lastmod>2011-01-24T20:29:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1510: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/21/regulators-warn-about-risk-of-seizures-from-pediatric-flu-vaccine-fluzone/</loc>
		<lastmod>2011-01-21T14:49:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1509: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/21/use-of-statin-drugs-among-low-risk-patients-questioned/</loc>
		<lastmod>2011-01-21T00:04:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1383: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/13/yaz-yasmin-bellwether-trial-dates-set/</loc>
		<lastmod>2011-01-20T04:01:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1056: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/11/yaz-pretrials-to-be-handled-in-east-st-louis/</loc>
		<lastmod>2011-01-20T03:58:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1428: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/12/yaz-maker-sued-over-death-of-new-jersey-teen/</loc>
		<lastmod>2011-01-20T03:55:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 990: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/10/yaz-lawsuits-may-be-consolidated-in-new-jersey/</loc>
		<lastmod>2011-01-20T03:53:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 949: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/29/yaz-related-death-leads-to-probe/</loc>
		<lastmod>2011-01-20T03:51:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1169: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/20/yaz-yasmin-subject-of-over-1000-lawsuits/</loc>
		<lastmod>2011-01-20T03:50:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 996: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/12/parker-waichman-alonso-llp-partner-appointed-to-yasmin-yaz-suits/</loc>
		<lastmod>2011-01-20T03:49:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1508: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/20/roche-appeals-fda-decision-to-remove-avastin-as-breast-cancer-treatment/</loc>
		<lastmod>2011-01-20T03:47:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1308: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/10/novartis-warned-over-use-of-facebook-to-promote-leukemia-drug/</loc>
		<lastmod>2011-01-20T03:47:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1083: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/29/michigan-woman-sues-bayer-over-serious-injuries-linked-to-yaz/</loc>
		<lastmod>2011-01-20T03:45:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1185: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/13/fda-unveils-program-targeting-deceptive-prescription-drug-ads/</loc>
		<lastmod>2011-01-20T03:43:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1130: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/11/canadian-women-file-lawsuit-over-bayer-side-effects-advertising/</loc>
		<lastmod>2011-01-20T03:41:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 932: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/20/birth-control-pill-yaz-may-cause-more-blood-clots-than-others/</loc>
		<lastmod>2011-01-20T03:39:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1134: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/19/california-woman-sues-bayer-for-yasmin-related-gall-bladder-failure/</loc>
		<lastmod>2011-01-20T03:37:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1119: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/26/new-jersey-yaz-lawsuits-combined-into-mass-tort/</loc>
		<lastmod>2011-01-20T03:36:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1158: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/13/bayer-includes-blood-clot-risk-on-yaz-yasmin-labels/</loc>
		<lastmod>2011-01-20T03:35:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1033: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/18/at-least-150-lawsuits-filed-against-bayer-over-yaz-side-effects/</loc>
		<lastmod>2011-01-20T03:34:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1507: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/20/repeated-doses-of-acetaminophen-could-result-in-infant-liver-failure/</loc>
		<lastmod>2011-01-20T03:11:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1506: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/19/fda-files-injuction-against-deltex-pharmaceuticals/</loc>
		<lastmod>2011-01-19T22:04:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1257: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/01/bayer-aims-to-market-via-unbranded-website/</loc>
		<lastmod>2011-01-19T08:13:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1504: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/18/dietary-supplements-may-often-be-adulterated-with-dangerous-levels-of-prescription-drugs/</loc>
		<lastmod>2011-01-18T21:48:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1503: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/18/avandia-legal-woes-hit-glaxo%e2%80%99s-bottom-line/</loc>
		<lastmod>2011-01-18T21:47:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1502: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/18/chantix-prozac-paxil-top-list-of-drugs-associated-with-violent-behavior/</loc>
		<lastmod>2011-01-18T15:37:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1501: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/17/new-warning-added-to-heart-drug-multaq/</loc>
		<lastmod>2011-01-17T21:54:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1500: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/17/propecia-linked-to-impotence-in-some/</loc>
		<lastmod>2011-01-17T16:46:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1499: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/17/ambien-linked-to-increase-risks-of-falling/</loc>
		<lastmod>2011-01-17T16:42:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1498: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/16/funding-disclosures-lacking-amongst-advocacy-groups/</loc>
		<lastmod>2011-01-16T23:43:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1497: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/14/fda-wants-to-limit-acetaminophen-in-prescription-combo-drugs/</loc>
		<lastmod>2011-01-14T12:53:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1496: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/14/oregon-ag-sues-johnson-johnson-over-phantom-motrin-recall/</loc>
		<lastmod>2011-01-14T03:22:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1495: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/13/nsaids-other-painkillers-linked-to-heart-problem-risks/</loc>
		<lastmod>2011-01-13T23:05:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1493: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/12/fracture-risk-higher-in-anti-epileptic-drug-use-by-older-patients/</loc>
		<lastmod>2011-01-12T09:30:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1492: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/12/depakote-carries-serious-risks-of-spina-bifida-other-side-effects/</loc>
		<lastmod>2011-01-12T02:44:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1491: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/12/roxane-fda-issue-warning-on-morphine-sulfate-solution-overdoses/</loc>
		<lastmod>2011-01-12T02:31:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1490: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/11/study-finds-most-antipsychotic-prescriptions-unnecessary/</loc>
		<lastmod>2011-01-11T04:36:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1488: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/07/teva-recalls-metronidazole-due-to-underweight-pills/</loc>
		<lastmod>2011-01-07T12:35:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1487: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/05/avastin-shown-to-increase-risk-of-heart-failure/</loc>
		<lastmod>2011-01-05T22:10:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1489: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/05/fda-deputy-commissioner-steps-down/</loc>
		<lastmod>2011-01-05T18:22:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1486: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/05/accutane-lawsuits-scheduled-in-new-jersey/</loc>
		<lastmod>2011-01-05T17:08:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1485: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/05/mislabeled-albuterol-inhaled-medicines-recalled/</loc>
		<lastmod>2011-01-05T02:24:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1484: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/03/fruta-planta-weight-loss-supplements-recalled-due-to-undeclared-ingredient/</loc>
		<lastmod>2011-01-03T23:36:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1483: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/03/cumberland-pharmaceuticals-recalls-six-lots-of-acetadote-injection/</loc>
		<lastmod>2011-01-03T22:53:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1481: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/03/sodium-bicarbonate-injection-recalled-due-to-presence-of-particulate-matter/</loc>
		<lastmod>2011-01-03T03:00:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1480: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/29/jj-shareholders-file-lawsuit-against-company-execs/</loc>
		<lastmod>2010-12-29T05:18:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1479: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/26/rockhard-laboratories-recalls-dietary-supplements-due-to-undeclared-ingredient/</loc>
		<lastmod>2010-12-26T15:53:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1478: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/23/increased-risk-of-death-noted-among-those-taking-growth-hormone-somatropin-for-short-stature/</loc>
		<lastmod>2010-12-23T13:05:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1477: Comments: 26 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/21/heartburn-drugs-linked-to-pneumonia-risk/</loc>
		<lastmod>2010-12-21T21:02:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1475: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/20/antipsychotic-drug-use-risks-in-nursing-homes-high/</loc>
		<lastmod>2010-12-21T19:49:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1474: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/21/roche-disputes-fda-claim-on-ineffective-dangerous-avastin-in-treating-breast-cancer/</loc>
		<lastmod>2010-12-21T12:05:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1473: Comments: 26 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/21/fda-adds-abnormal-heart-rhythm-risk-to-injectable-anzemet/</loc>
		<lastmod>2010-12-21T01:32:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1472: Comments: 123 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/17/inhaler-use-linked-to-higher-diabetes-risk/</loc>
		<lastmod>2010-12-17T23:36:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1470: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/17/fda-cites-mcneil-consumer-healthcare-over-conditions-at-pennsylvania-facility/</loc>
		<lastmod>2010-12-17T16:08:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1469: Comments: 48 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/17/fda-believes-avastin-not-effective-in-treatment-of-breast-cancer-wants-approval-revoked/</loc>
		<lastmod>2010-12-17T15:38:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1468: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/17/fda-warns-makers-of-dietary-supplements-on-dangers-of-including-pharmaceutical-agents/</loc>
		<lastmod>2010-12-17T14:05:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1471: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/16/elan-eisai-settle-zonegran-improper-marketing-suits/</loc>
		<lastmod>2010-12-16T23:30:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1466: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/15/fda-issues-overdose-warning-on-cough-medication-tessalon-benzonatate/</loc>
		<lastmod>2010-12-15T17:02:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1467: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/15/avandia-derivatives-treated-differently-in-us-than-europe/</loc>
		<lastmod>2010-12-15T09:15:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1465: Comments: 58 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/15/opioid-painkillers-have-risks-to-elderly-often-overlooked-by-physicians-patients/</loc>
		<lastmod>2010-12-15T02:27:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1464: Comments: 73 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/14/vioxx-caused-bloodclots-death-months-after-discontinued-use/</loc>
		<lastmod>2010-12-14T20:58:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1463: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/13/darvocet-makers-sued-over-near-fatal-cardiac-arrhythmia/</loc>
		<lastmod>2010-12-13T21:36:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1462: Comments: 30 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/13/otc-cold-medicines-recalled-due-to-incorrect-label-missing-safety-data/</loc>
		<lastmod>2010-12-13T19:14:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1461: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/10/breast-cancer-drugs-raise-heart-risks-study-finds/</loc>
		<lastmod>2010-12-10T19:01:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1460: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/10/recall-issued-on-13-million-packages-of-rolaids-due-to-foreign-particles-found/</loc>
		<lastmod>2010-12-10T11:34:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1459: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/10/jury-finds-johnson-johnson-hid-tendon-damage-dangers-of-levaquin/</loc>
		<lastmod>2010-12-10T02:57:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1457: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/07/allergan-told-to-stop-promoting-eye-drops-using-misleading-information/</loc>
		<lastmod>2010-12-08T18:04:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1456: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/08/actavis-to-pay-up-to-13-million-in-digitek-lawsuit-settlements/</loc>
		<lastmod>2010-12-08T17:57:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1458: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/07/duro-extend-capsules-recall-expanded/</loc>
		<lastmod>2010-12-07T18:04:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1455: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/06/accutane-lawsuits-in-new-jersey-continues-to-grow/</loc>
		<lastmod>2010-12-06T18:15:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1454: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/03/mylanta-alternagel-liquid-products-recalled/</loc>
		<lastmod>2010-12-03T22:23:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1452: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/03/tegretol-other-epilepsy-drugs-increase-risk-of-spina-bifida-birth-defect/</loc>
		<lastmod>2010-12-03T14:35:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1451: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/02/canada-recalls-darvon-n/</loc>
		<lastmod>2010-12-02T23:19:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1450: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/01/nyu-study-finds-otc-childrens-medications-have-confusing-dosage-instructions/</loc>
		<lastmod>2010-12-01T21:49:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1449: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/01/tricyclic-anti-depressants-linked-to-increased-risk-of-heart-disease/</loc>
		<lastmod>2010-12-01T21:39:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1448: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/01/doctor-indicted-for-submitting-fraudulent-fen-phen-claims/</loc>
		<lastmod>2010-12-01T21:38:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1446: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/30/fda-investigating-avodart-risks-benefits/</loc>
		<lastmod>2010-11-30T16:51:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1445: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/30/latest-recall-on-tylenol-another-mark-against-mcneil-consumer-healthcare-johnson-johnson/</loc>
		<lastmod>2010-11-30T02:54:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1443: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/29/accutane-use-linked-to-higher-suicide-rates/</loc>
		<lastmod>2010-11-29T17:56:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1440: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/24/johnson-johnson-issues-another-recall-on-otc-medications-due-to-manufacturing-errors/</loc>
		<lastmod>2010-11-24T02:50:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1442: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/23/iv-bisphosphonate-therapy-increases-risk-of-af-in-cancer-patients/</loc>
		<lastmod>2010-11-23T15:18:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1438: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/22/fda-investigating-vigor-25-for-undeclared-ingredient-possible-link-to-death/</loc>
		<lastmod>2010-11-22T21:45:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1437: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/19/illinois-court-says-baxter-blood-thinner-was-dangerous/</loc>
		<lastmod>2010-11-19T22:24:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1436: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/19/johnson-johnsons-recalled-childrens-medicines-back-on-shelves/</loc>
		<lastmod>2010-11-19T22:23:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1435: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/19/jj-takeda-recall-blood-cancer-drug-velcade/</loc>
		<lastmod>2010-11-19T12:09:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1434: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/19/fda-warnings-followed-differently-by-region-across-us/</loc>
		<lastmod>2010-11-19T01:47:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1433: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/18/is-the-fda-geting-tougher-on-drug-companies/</loc>
		<lastmod>2010-11-18T03:14:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1432: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/17/drug-used-to-stop-bleeding-has-little-beneft/</loc>
		<lastmod>2010-11-17T02:27:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1430: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/16/utah-sues-glaxo-over-avandia-medicaid-fraud/</loc>
		<lastmod>2010-11-16T21:23:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1429: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/16/diabetes-risk-noted-among-users-of-inhaled-steroids-treating-copd/</loc>
		<lastmod>2010-11-16T03:04:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1431: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/15/irish-medicine-board-not-concerned-with-reactions-to-gardasil/</loc>
		<lastmod>2010-11-15T21:30:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1427: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/12/fda-chief-critical-of-jjs-phantom-recall-on-motrin-worries-about-safety-record/</loc>
		<lastmod>2010-11-12T14:17:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1426: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/12/drug-companies-ignoring-safety-standards-consumers-losing-confidence/</loc>
		<lastmod>2010-11-12T01:37:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1425: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/10/former-glaxo-attorney-charged-in-falsifying-wellbutrin-info-to-fda/</loc>
		<lastmod>2010-11-10T20:36:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1424: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/10/singulair-side-effects-on-childrens-behavior-noted-by-investigation/</loc>
		<lastmod>2010-11-10T18:07:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1423: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/10/using-mild-painkillers-during-pregnancy-leads-to-male-fertility-problems/</loc>
		<lastmod>2010-11-10T00:25:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1422: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/09/johnson-johnson-glaxo-investigated-by-fda-house-committee/</loc>
		<lastmod>2010-11-09T22:15:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1419: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/08/doctors-recommending-patients-take-a-break-from-osteoporosis-meds/</loc>
		<lastmod>2010-11-08T23:19:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1421: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/05/intelli-health-recalls-duro-extend-capsules-due-to-unreported-ingredient/</loc>
		<lastmod>2010-11-05T23:28:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1420: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/05/fda-actavis-issues-reminder-of-fentanyl-patch-recall/</loc>
		<lastmod>2010-11-05T23:19:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1418: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/05/trial-of-rfvlla-to-treat-bleeding-highlights-blood-clot-risk/</loc>
		<lastmod>2010-11-05T14:21:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1417: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/05/big-pharma-settlements-top-2010-government-fraud-list/</loc>
		<lastmod>2010-11-05T02:56:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1416: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/05/fda-warns-of-purple-glove-syndrome-risk-with-iv-dilantin/</loc>
		<lastmod>2010-11-05T02:44:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1415: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/04/gardasil-use-by-older-women-denied-approval-by-fda/</loc>
		<lastmod>2010-11-04T21:56:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1414: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/04/gadolinium-based-contrast-agent-use-on-dramatic-decline/</loc>
		<lastmod>2010-11-04T16:48:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1413: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/04/genentech-offering-secret-rebates-to-eye-doctors/</loc>
		<lastmod>2010-11-04T16:44:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1412: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/03/drug-recalls-skyrocket-during-2009-up-four-times-over-previous-year/</loc>
		<lastmod>2010-11-03T02:02:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 6: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/subscribe/</loc>
		<lastmod>2010-11-02T05:28:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1411: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/02/big-pharma-profits-abuses-fda-laws/</loc>
		<lastmod>2010-11-02T02:33:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1410: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/01/kidney-drug-feraheme-linked-to-serious-adverse-events/</loc>
		<lastmod>2010-11-01T22:09:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1409: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/01/more-heparin-recalled/</loc>
		<lastmod>2010-11-01T22:07:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1408: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/28/red-yeast-rice-supplements-may-contain-toxic-agent/</loc>
		<lastmod>2010-10-29T23:22:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1407: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/29/sandoz-inc-issues-recall-on-methotrexate-injections-due-to-presence-of-glass-particles/</loc>
		<lastmod>2010-10-29T12:57:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1406: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/28/bayer-will-pay-33m-to-settle-deceptive-ad-charges-on-one-a-day-mens-vitamins/</loc>
		<lastmod>2010-10-28T19:47:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1403: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/28/glaxosmithkline-will-pay-750m-to-settle-defective-drugs-lawsuit/</loc>
		<lastmod>2010-10-28T01:37:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1404: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/27/bristol-myers-gets-warning-from-fda/</loc>
		<lastmod>2010-10-27T08:27:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1402: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/27/stevens-johnson-syndrome-sufferer-says-childrens-motrin-caused-disease/</loc>
		<lastmod>2010-10-27T01:06:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1405: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/26/hormone-creams-pose-risks-for-pets/</loc>
		<lastmod>2010-10-26T08:28:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1401: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/25/hylands-teething-tablets-recalled-due-to-manufacturing-error/</loc>
		<lastmod>2010-10-25T22:22:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1400: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/25/low-doses-of-aspirin-may-reduce-colon-cancer/</loc>
		<lastmod>2010-10-25T21:19:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1399: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/21/texas-mother-sues-digitek-maker-for-sons-death/</loc>
		<lastmod>2010-10-24T19:14:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1398: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/22/actavis-recalls-fentanyl-patches-due-to-accelerated-ingredient-release/</loc>
		<lastmod>2010-10-22T19:06:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1397: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/22/fda-warns-of-combining-hiv-drugs-invirase-and-norvir/</loc>
		<lastmod>2010-10-22T13:05:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1396: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/22/prostate-cancer-drugs-to-get-warnings-on-heart-attack-diabetes-risks/</loc>
		<lastmod>2010-10-22T01:15:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1395: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/21/new-study-links-prempro-to-higher-cancer-mortality-rate/</loc>
		<lastmod>2010-10-21T00:34:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1394: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/20/wyeth-hired-ghostwriters-to-mislead-manipulate-articles/</loc>
		<lastmod>2010-10-20T22:25:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1393: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/20/patient-dies-in-multiple-sclerosis-drug-trials/</loc>
		<lastmod>2010-10-20T22:23:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1392: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/19/more-bottles-of-tylenol-recalled-due-to-musty-odor/</loc>
		<lastmod>2010-10-19T23:22:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1390: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/14/fda-finds-violations-by-heparin-maker/</loc>
		<lastmod>2010-10-19T21:19:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1388: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/18/prescription-drugs-harming-in-ways-theyre-designed-to-prevent-more-testing-needed/</loc>
		<lastmod>2010-10-18T23:28:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1389: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/15/otc-chelation-products-illegal-says-fda/</loc>
		<lastmod>2010-10-15T21:13:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1387: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/15/osteoporosis-drugs-linked-to-rare-femur-fractures/</loc>
		<lastmod>2010-10-15T00:39:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1391: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/14/illegal-drugs-present-in-many-herbal-weight-loss-supplements/</loc>
		<lastmod>2010-10-14T21:19:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1386: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/14/bisphosphonate-drugs-linked-to-irregular-heartbeat-stroke-among-cancer-patients/</loc>
		<lastmod>2010-10-14T02:00:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1385: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/14/negative-drug-study-data-needs-to-be-published-new-study-urges/</loc>
		<lastmod>2010-10-14T01:49:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1382: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/13/hormone-therapy-lawsuit-appeal-rejected/</loc>
		<lastmod>2010-10-13T21:28:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1381: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/13/supreme-court-weighing-potential-bellwhether-for-vaccine-injury-cases/</loc>
		<lastmod>2010-10-13T01:14:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1384: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/12/meridia-ingredient-still-present-on-nutritional-supplements/</loc>
		<lastmod>2010-10-12T21:32:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1380: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/12/abbott-pulls-meridia-from-us-market/</loc>
		<lastmod>2010-10-12T01:04:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1379: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/11/more-deaths-linked-to-abortion-drug-ru-486/</loc>
		<lastmod>2010-10-11T16:31:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1378: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/08/gaspari-nutrition-recalls-novedex-xt-due-to-ingredient/</loc>
		<lastmod>2010-10-08T19:38:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1377: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/08/pfizer-recalls-191000-bottles-of-lipitor-due-to-musty-odor/</loc>
		<lastmod>2010-10-08T11:04:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1376: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/08/botox-maker-receives-375-million-fine-for-off-label-marketing-scheme/</loc>
		<lastmod>2010-10-08T01:26:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1375: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/07/ppi-drugs-linked-to-another-side-effect-clostridium-difficile-associated-diarrhea/</loc>
		<lastmod>2010-10-07T00:53:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1374: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/04/antipsychotic-drug-marketing-spurs-false-claims-lawsuits/</loc>
		<lastmod>2010-10-04T21:36:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1373: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/04/ppis-are-over-prescribed-studies-show-most-prescriptions-are-unnecessary/</loc>
		<lastmod>2010-10-04T20:03:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1371: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/01/novartis-to-pay-422-million-for-off-label-drug-promotion/</loc>
		<lastmod>2010-10-01T20:47:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1370: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/01/house-committee-says-fda-johnsonjohnson-relationship-was-too-cozy/</loc>
		<lastmod>2010-10-01T14:12:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1369: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/01/bristol-myers-squibb-must-recall-blood-pressure-medication-avalide/</loc>
		<lastmod>2010-10-01T02:09:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1368: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/01/regulators-warn-of-dangers-linked-to-infant-sleep-positioning-devices/</loc>
		<lastmod>2010-10-01T01:39:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1372: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/30/johnson-johnson-ceo-admits-to-recall-errors/</loc>
		<lastmod>2010-09-30T20:48:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1367: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/29/johnson-johnson-quality-control-methods-investigated/</loc>
		<lastmod>2010-09-30T16:32:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1366: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/30/gardasil-linked-to-16-more-deaths-since-may-2009/</loc>
		<lastmod>2010-09-30T02:30:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1365: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/30/fda-issues-new-rules-on-reporting-safety-data-from-clinical-trials/</loc>
		<lastmod>2010-09-30T02:05:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1363: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/28/octagam-removed-from-us-market/</loc>
		<lastmod>2010-09-28T03:28:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1362: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/28/epogen-procrit-recalled-due-to-presence-of-glass-particles-in-vials/</loc>
		<lastmod>2010-09-28T03:14:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1364: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/27/terlipressin-may-reduce-serum-sodium-study-finds/</loc>
		<lastmod>2010-09-27T08:34:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1359: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/24/uti-treatment-can-lead-to-liver-failure-liver-disease/</loc>
		<lastmod>2010-09-24T14:55:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1358: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/24/avandia-sales-expected-to-plummet-under-new-access-restrictions/</loc>
		<lastmod>2010-09-24T14:40:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1357: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/24/did-jj-hid-safety-data-on-orthoevra/</loc>
		<lastmod>2010-09-24T00:13:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1356: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/23/fda-to-limit-access-to-avandia-patients-physicians-must-sign-off-on-risks/</loc>
		<lastmod>2010-09-23T19:27:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1361: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/23/securities-law-violations-suit-filed-against-johnson-johnson/</loc>
		<lastmod>2010-09-23T08:59:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1360: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/23/fda-says-rotarix-vaccine-linked-to-bowel-problems/</loc>
		<lastmod>2010-09-23T08:58:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1355: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/23/antipsychotic-drugs-dramatically-increase-risk-of-developing-deep-vein-thrombosis/</loc>
		<lastmod>2010-09-23T01:27:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1354: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/23/house-panel-wants-to-know-if-fda-okd-phantom-recall-of-defective-motrin/</loc>
		<lastmod>2010-09-23T01:17:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1353: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/22/justice-department-joins-pfizer-whistle-blower-suit/</loc>
		<lastmod>2010-09-22T16:32:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1352: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/22/details-on-motrin-buy-back-program-emerge/</loc>
		<lastmod>2010-09-22T02:31:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1351: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/21/fda-postpones-expanded-approval-for-avastin/</loc>
		<lastmod>2010-09-21T21:01:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1349: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/20/new-study-links-the-pill-with-aggressive-form-of-breast-cancer/</loc>
		<lastmod>2010-09-20T17:20:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1350: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/20/actos-investigated-for-bladder-cancer-link/</loc>
		<lastmod>2010-09-20T16:17:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1348: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/17/johnson-johnsons-consumer-chief-to-retire-amidst-recalls/</loc>
		<lastmod>2010-09-17T16:28:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1347: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/17/ppi-drugs-linked-to-cardiovascular-events-stroke-within-first-month-after-heart-attack/</loc>
		<lastmod>2010-09-17T13:35:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1346: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/16/fda-panel-says-otc-cough-syrup-abuse-troubling-refuses-to-limit-access-to-teens/</loc>
		<lastmod>2010-09-16T01:35:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1345: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/15/fda-weighing-options-on-diet-drug-meridia-following-negative-report/</loc>
		<lastmod>2010-09-15T01:09:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1344: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/14/bone-drugs-may-prompt-fractures/</loc>
		<lastmod>2010-09-14T21:03:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1343: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/13/denture-cream-lawsuit-scheduled-for-june-2011/</loc>
		<lastmod>2010-09-13T21:47:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1342: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/10/fda-issues-new-warnings-on-magnevist-omniscan-optimark-contrast-dyes-for-mri-tests/</loc>
		<lastmod>2010-09-10T13:33:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1341: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/09/mercks-gardasil-didnt-live-up-to-promise/</loc>
		<lastmod>2010-09-09T20:32:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1340: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/08/british-panel-says-avandia-should-be-removed-from-uk-market/</loc>
		<lastmod>2010-09-08T00:27:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1337: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/03/osteoporosis-drugs-linked-to-esophogeal-cancer-risk-by-new-uk-study/</loc>
		<lastmod>2010-09-03T11:50:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1336: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/02/scout-study-shows-meridia-increases-heart-attack-stroke-risk/</loc>
		<lastmod>2010-09-02T23:24:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1339: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/02/tygacil-linked-to-increase-risk-fda-warns/</loc>
		<lastmod>2010-09-02T20:52:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1338: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/02/allergan-to-pay-600-million-over-unapproved-botox-uses/</loc>
		<lastmod>2010-09-02T20:51:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1335: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/02/avandia-dangers-discussed-online-as-early-as-2003/</loc>
		<lastmod>2010-09-02T03:38:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1334: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/01/abbott-labs-recalls-contact-lens-solutions-due-to-sterility-hazard/</loc>
		<lastmod>2010-09-01T17:13:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1333: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/31/seroquel-use-questioned-in-death-of-vets/</loc>
		<lastmod>2010-08-31T16:31:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1332: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/31/fda-limiting-use-of-clinical-trials-proving-drug-is-no-worse-than-another/</loc>
		<lastmod>2010-08-31T02:42:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1330: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/26/new-study-says-avandia-actos-risks-about-the-same/</loc>
		<lastmod>2010-08-26T18:39:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1329: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/26/masxtreme-supplement-recalled-due-to-presence-of-prescription-drug/</loc>
		<lastmod>2010-08-26T02:28:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1328: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/20/denture-cream-lawsuit-to-go-to-trial/</loc>
		<lastmod>2010-08-20T20:17:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1327: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/20/johnson-johnson-restructuring-after-recalls/</loc>
		<lastmod>2010-08-20T15:25:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1326: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/20/glaxosmithklines-avandia-letter-biased-misleading/</loc>
		<lastmod>2010-08-20T12:47:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1325: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/19/group-calls-for-immediate-investigation-into-gardasil-safety/</loc>
		<lastmod>2010-08-19T21:23:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1324: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/19/louisiana-lawsuit-blames-gardasil-for-seizures-other-injuries/</loc>
		<lastmod>2010-08-19T00:37:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1323: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/18/bayer-ag-to-pay-60-million-in-trasylol-settlements/</loc>
		<lastmod>2010-08-18T16:51:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1321: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/18/fda-wants-to-pull-low-blood-pressure-drug-from-market-after-fast-track-approval/</loc>
		<lastmod>2010-08-18T00:51:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1322: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/17/prescription-otc-drug-recalls-surge-in-2009/</loc>
		<lastmod>2010-08-17T16:14:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1320: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/16/acetaminophen-linked-to-heightened-risk-of-asthma-eczema/</loc>
		<lastmod>2010-08-16T21:58:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1319: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/16/drug-device-makers-face-overseas-bribery-investigation/</loc>
		<lastmod>2010-08-16T16:49:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1318: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/13/gsk-investigated-over-avandia-safety-disclosures/</loc>
		<lastmod>2010-08-13T15:13:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1317: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/13/prolatis-recalled-due-to-undeclared-ingredient/</loc>
		<lastmod>2010-08-13T15:12:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1316: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/13/fda-warns-of-aseptic-meningitis-risk-linked-to-lamictal/</loc>
		<lastmod>2010-08-13T13:23:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1315: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/12/state-attorneys-general-wants-documents-from-jj-regarding-otc-drug-recalls/</loc>
		<lastmod>2010-08-12T17:42:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1314: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/12/older-patients-warned-against-overuse-long-term-use-of-antacids/</loc>
		<lastmod>2010-08-12T17:17:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1313: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/12/hrt-linked-to-increased-breast-cancer-risk-among-women-on-estrogen-therapy/</loc>
		<lastmod>2010-08-12T01:25:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1312: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/11/novacare-recalls-male-enhancement-supplements-due-to-undeclared-ingredient/</loc>
		<lastmod>2010-08-11T19:42:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1311: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/11/astrazeneca-pays-198-million-to-settle-seroquel-claims/</loc>
		<lastmod>2010-08-11T00:33:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1310: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/10/solo-slim-solo-slim-extra-strength-recalled-due-to-undeclared-ingredient/</loc>
		<lastmod>2010-08-10T21:38:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1309: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/09/revivexxx-recalled-due-to-undeclared-ingredient/</loc>
		<lastmod>2010-08-09T21:36:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1307: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/06/johnson-johnson-recall-may-result-in-brand-boycott/</loc>
		<lastmod>2010-08-06T16:02:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1306: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/06/a-few-good-men-actor-claims-accutane-cut-his-career-short-seeks-11m-in-damages/</loc>
		<lastmod>2010-08-06T12:33:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1305: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/06/new-study-links-zicam-products-to-loss-in-sense-of-smell/</loc>
		<lastmod>2010-08-06T02:24:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1304: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/05/most-americans-doubt-safety-of-chinese-indian-drugs/</loc>
		<lastmod>2010-08-05T17:57:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1303: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/05/colorado-senator-wants-to-give-fda-more-power-over-drug-makers/</loc>
		<lastmod>2010-08-05T00:21:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1300: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/04/sales-down-after-zicam-recall-for-matrixx/</loc>
		<lastmod>2010-08-04T15:10:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1299: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/03/fda-reiterates-warning-on-intravenous-use-of-nimodipine/</loc>
		<lastmod>2010-08-03T15:52:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1302: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/03/industry-funded-drug-trials-more-likely-to-yield-positive-results/</loc>
		<lastmod>2010-08-03T15:15:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1301: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/03/fda-urged-to-regulate-dietary-supplements/</loc>
		<lastmod>2010-08-03T15:14:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1298: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/02/neoprofen-recall-could-result-in-temporary-drug-shortage/</loc>
		<lastmod>2010-08-02T18:05:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1297: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/02/fda-changes-labeling-for-csl-flu-vaccine-due-to-risks/</loc>
		<lastmod>2010-08-02T16:06:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1295: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/30/fda-says-antibiotic-cubicin-may-cause-pneumonia/</loc>
		<lastmod>2010-07-30T20:16:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1294: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/30/nutraloid-recalls-supplements-due-to-undeclared-ed-ingredient/</loc>
		<lastmod>2010-07-30T20:15:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1293: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/30/study-shows-bone-fracture-risks-with-diabetes-drugs-avandia-and-actos/</loc>
		<lastmod>2010-07-30T13:35:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1292: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/29/risk-evaluation-reports-on-dangerous-prescription-drugs-debated/</loc>
		<lastmod>2010-07-29T23:44:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1296: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/29/norvatis-to-give-away-triaminic-during-tylenol-recall/</loc>
		<lastmod>2010-07-29T20:17:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1291: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/28/bausch-lomb-recalls-eye-vitamins-due-to-difficulty-in-swallowing/</loc>
		<lastmod>2010-07-28T19:04:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1290: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/27/glaxosmithkline-admits-errors-in-paid-journal-supplement/</loc>
		<lastmod>2010-07-27T14:31:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1289: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/27/new-study-adds-to-confusion-over-suicide-risks-with-epilepsy-drugs/</loc>
		<lastmod>2010-07-27T12:24:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1285: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/23/weight-loss-supplement-recalled-due-to-undeclared-ingredient/</loc>
		<lastmod>2010-07-23T21:11:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1284: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/23/european-board-will-decide-avandias-fate-in-september/</loc>
		<lastmod>2010-07-23T13:04:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1283: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/23/harvard-adopts-conflict-of-interest-policy/</loc>
		<lastmod>2010-07-23T01:21:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1282: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/22/fda-inspections-revealed-12-different-violations-at-jjs-pennsylvania-facility/</loc>
		<lastmod>2010-07-22T23:41:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1288: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/22/glaxosmithkline-to-pay-more-than-1-billion-in-paxil-settlements/</loc>
		<lastmod>2010-07-22T21:18:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1287: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/22/china-never-investigated-tainted-heparin/</loc>
		<lastmod>2010-07-22T21:17:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1286: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/22/glaxosmithkline-ordered-to-stop-recruiting-for-avandia-trials/</loc>
		<lastmod>2010-07-22T21:11:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1281: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/21/fda-panel-votes-to-revoke-breast-cancer-drug-avastin-approval/</loc>
		<lastmod>2010-07-21T18:31:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1280: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/20/glaxosmithkline-reaches-settlement-in-paxil-related-infant-death-suit-in-south-dakota/</loc>
		<lastmod>2010-07-20T20:51:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1279: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/20/columbia-university-pet-scan-center-shut-by-fda-after-repeated-violations/</loc>
		<lastmod>2010-07-20T19:45:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1276: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/20/panelist-who-backed-avandia-was-paid-speaker-for-gsk/</loc>
		<lastmod>2010-07-20T15:50:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1275: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/19/clinical-trial-shows-avastin-useless-in-fight-against-breast-cancer/</loc>
		<lastmod>2010-07-19T18:52:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1278: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/19/slim-30-herb-supplement-recalled-due-to-undeclared-ingredient/</loc>
		<lastmod>2010-07-19T15:57:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1277: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/19/another-johnson-johnson-plant-under-fda-scrutiny/</loc>
		<lastmod>2010-07-19T15:50:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1274: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/16/johnson-johnson-lays-off-employees-over-recent-recalls/</loc>
		<lastmod>2010-07-16T15:52:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1273: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/16/fda-will-investigate-cancer-risk-among-blood-pressure-medications/</loc>
		<lastmod>2010-07-16T13:26:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1272: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/15/glaxosmithkline-to-take-charge-over-avandia-paxil-lawsuits/</loc>
		<lastmod>2010-07-15T16:14:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1269: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/15/fda-panel-delivers-mixed-vote-on-avandias-future/</loc>
		<lastmod>2010-07-15T11:23:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1268: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/15/record-study-on-avandia-called-garbage-in-first-day-of-fda-hearings/</loc>
		<lastmod>2010-07-15T01:54:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1271: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/14/coumadin-recalled-due-to-changes-levels-of-active-ingredients/</loc>
		<lastmod>2010-07-14T16:09:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1270: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/14/anti-rheumatic-gets-new-boxed-warning/</loc>
		<lastmod>2010-07-14T16:09:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1267: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/14/lawsuit-claims-nuvaring-led-to-death-of-omaha-woman/</loc>
		<lastmod>2010-07-14T00:27:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1266: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/13/initial-reports-on-avandia-were-negative-hidden-for-11-years/</loc>
		<lastmod>2010-07-13T21:26:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1265: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/13/drug-residue-discovered-in-ohio-river/</loc>
		<lastmod>2010-07-13T16:11:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1264: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/13/bausch-lomb-recalls-one-lot-of-renu-multiplus-solution-in-europe-middle-east/</loc>
		<lastmod>2010-07-13T02:59:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1263: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/13/lawsuits-demand-cash-refunds-for-jjs-recalled-otc-childrens-medicines-not-coupons/</loc>
		<lastmod>2010-07-13T02:49:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1262: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/09/fda-issues-700-page-critical-review-of-avandia-studies-ahead-of-next-weeks-meeting/</loc>
		<lastmod>2010-07-09T16:55:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1261: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/09/fda-warns-consumers-against-que-she-weight-loss-supplement/</loc>
		<lastmod>2010-07-09T16:17:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1260: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/09/jj-discloses-doctor-payments/</loc>
		<lastmod>2010-07-09T16:16:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1259: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/09/mcneil-expands-recall-on-tylenol-motrin-benadryl-again/</loc>
		<lastmod>2010-07-09T12:01:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1258: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/09/fda-warns-against-taking-malaria-drug-for-leg-cramps/</loc>
		<lastmod>2010-07-09T11:33:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1256: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/30/two-more-studies-find-heart-death-risk-linked-to-avandia/</loc>
		<lastmod>2010-06-30T00:20:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1255: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/29/fda-issues-guidance-to-reduce-drug-use-in-food-producing-animal/</loc>
		<lastmod>2010-06-29T15:34:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1254: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/28/risk-from-denture-creams-still-persists-more-victims-file-injury-claims/</loc>
		<lastmod>2010-06-28T22:18:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1253: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/25/congressional-report-urges-tighter-reins-on-medical-ghostwriting/</loc>
		<lastmod>2010-06-25T19:11:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1252: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/25/johnson-johnson-probably-wont-open-mcneil-facility-in-pa-before-2011/</loc>
		<lastmod>2010-06-25T10:48:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1251: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/24/advisory-warns-against-using-three-gadolinium-agents-during-mris/</loc>
		<lastmod>2010-06-24T23:24:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1249: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/24/fda-wanted-johnson-johnson-to-recall-childrens-motrin-after-february-inspection/</loc>
		<lastmod>2010-06-24T22:56:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1248: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/24/nbas-manute-bol-died-from-kidney-disease-stevens-johnson-syndrome/</loc>
		<lastmod>2010-06-24T01:29:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1246: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/23/gsk-settles-close-to-200-paxil-lawsuits/</loc>
		<lastmod>2010-06-23T16:32:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1245: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/23/fda-faulted-for-not-tracking-foreign-drug-trials/</loc>
		<lastmod>2010-06-23T16:31:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1244: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/23/leukemia-drug-mylotarg-removed-from-us-market-by-pfizer-at-fda-request/</loc>
		<lastmod>2010-06-23T00:47:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1243: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/23/canada-family-claims-paxil-led-to-teen-suicide/</loc>
		<lastmod>2010-06-23T00:32:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1247: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/22/supreme-court-allows-prempro-premarin-lawsuits-to-proceed/</loc>
		<lastmod>2010-06-22T16:32:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1242: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/21/german-committee-says-no-more-payments-for-avandia-actos-prescriptions/</loc>
		<lastmod>2010-06-21T13:37:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1239: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/18/fda-warns-consumers-regarding-generic-tamiflu/</loc>
		<lastmod>2010-06-18T19:54:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1238: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/18/depomed-recalls-diabetes-drug-due-to-smell-in-bottle-taste-of-tablets/</loc>
		<lastmod>2010-06-18T11:10:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1237: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/17/fda-posting-post-market-drug-safety-studies-online/</loc>
		<lastmod>2010-06-17T21:00:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1240: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/17/fda-extends-review-of-gardasil-use-for-older-women/</loc>
		<lastmod>2010-06-17T19:55:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1236: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/16/johnson-products-were-omitted-on-jan-15/</loc>
		<lastmod>2010-06-16T17:08:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1235: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/16/head-of-johnson-johnson-unit-knew-of-and-urged-motrin-buyback/</loc>
		<lastmod>2010-06-16T16:07:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1234: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/15/fda-to-ban-chicago-hiv-doctor-after-falsifying-forms/</loc>
		<lastmod>2010-06-15T16:05:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1233: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/14/popular-blood-pressure-medications-may-have-cancer-risk/</loc>
		<lastmod>2010-06-14T19:42:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1232: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/14/house-will-look-at-wyeths-marketing-of-transplant-drug-rapamune/</loc>
		<lastmod>2010-06-14T19:18:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1231: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/14/johnson-johnson-recall-investigation-deepens/</loc>
		<lastmod>2010-06-14T16:19:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1230: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/14/fda-to-review-blood-pressure-medicine-benicars-risks/</loc>
		<lastmod>2010-06-14T16:18:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1222: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/11/jj-uncooperative-in-fda-congressional-recall-probe/</loc>
		<lastmod>2010-06-11T19:32:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1221: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/11/unpublished-study-points-to-increased-health-risks-linked-to-diabetes-drug-avandia/</loc>
		<lastmod>2010-06-11T11:49:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1220: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/10/fda-warns-pfizer-over-safety-data-tracking-reporting-on-viagra-lipitor-lyrica/</loc>
		<lastmod>2010-06-10T22:19:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1224: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/10/warning-issued-over-smoking-cessation-medication/</loc>
		<lastmod>2010-06-10T19:40:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1223: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/10/epilepsy-drugs-linked-to-birth-defects/</loc>
		<lastmod>2010-06-10T19:34:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1225: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/09/pain-relievers-raise-risk-of-heart-related-death/</loc>
		<lastmod>2010-06-09T19:41:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1219: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/09/johnson-johnson-misses-deadline-for-documents-on-phantom-recall-of-motrin/</loc>
		<lastmod>2010-06-09T02:04:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1229: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/08/sagent-recalls-injectable-medication-due-to-non-sterility/</loc>
		<lastmod>2010-06-08T19:56:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1228: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/08/members-of-tobacco-safety-panel-challenges-by-ethics-group/</loc>
		<lastmod>2010-06-08T19:52:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1227: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/08/parkinson-drug-makers-sued-over-sex-gambling-addiction-side-effects/</loc>
		<lastmod>2010-06-08T19:51:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1226: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/08/pfizer-discloses-disbursement-of-drug-samples/</loc>
		<lastmod>2010-06-08T19:47:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1218: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/08/who-advice-to-stockpile-treatments-for-swine-flu-influenced-by-big-pharma-money/</loc>
		<lastmod>2010-06-08T00:48:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1215: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/07/baxter-recalling-iv-solution-after-several-adverse-reports/</loc>
		<lastmod>2010-06-07T12:17:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1214: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/04/rep-wants-fda-to-have-mandatory-recall-authority-on-tainted-drugs/</loc>
		<lastmod>2010-06-04T11:26:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1217: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/03/johnson-johnson-probe-widens-to-other-products/</loc>
		<lastmod>2010-06-03T17:27:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1216: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/03/clarins-recalls-injectable-medications-due-to-possible-contamination/</loc>
		<lastmod>2010-06-03T17:27:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1213: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/03/gsk-forced-to-update-labels-on-advair-serevent-again/</loc>
		<lastmod>2010-06-03T13:53:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1212: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/03/glaxosmithkline-announces-settlement-on-at-least-5000-avandia-injury-lawsuits/</loc>
		<lastmod>2010-06-03T02:10:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1209: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/01/more-childrens-otc-liquid-medicines-manufactured-at-pa-facility-are-recalled/</loc>
		<lastmod>2010-06-01T16:47:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1211: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/01/fda-warns-against-use-of-iv-antibiotics-antiemitic-due-to-contamination/</loc>
		<lastmod>2010-06-01T15:39:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1210: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/01/antidepressants-linked-to-miscarriages/</loc>
		<lastmod>2010-06-01T15:39:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1208: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/01/hospira-expands-recall-on-propofol-and-liposyn-injectables-due-to-presence-of-particulate-matter/</loc>
		<lastmod>2010-06-01T15:16:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1203: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/28/johnson-johnson-hid-motrin-recall-from-public-regulators/</loc>
		<lastmod>2010-05-28T21:25:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1202: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/28/fda-warns-of-liver-injuries-among-people-taking-weight-loss-drug-orlistat/</loc>
		<lastmod>2010-05-28T02:39:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1201: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/28/house-will-investigate-childrens-otc-drug-recall-injuries-deaths/</loc>
		<lastmod>2010-05-28T01:46:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1205: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/27/fda-warns-perrigo-reviews-tainted-ibuprofen/</loc>
		<lastmod>2010-05-27T21:32:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1204: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/27/fda-action-leads-to-another-genzyme-drug-shortage/</loc>
		<lastmod>2010-05-27T21:26:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1206: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/26/nearly-all-herbal-supplements-found-to-have-contaminants/</loc>
		<lastmod>2010-05-26T21:33:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1200: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/26/fda-warning-heartburn-ulcer-drugs-linked-to-hip-wrist-spine-fractures/</loc>
		<lastmod>2010-05-26T15:20:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1207: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/25/fda-to-investigate-skin-lightening-creams/</loc>
		<lastmod>2010-05-25T21:38:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1197: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/21/avandia-trials-hit-recruiting-problems/</loc>
		<lastmod>2010-05-23T21:20:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1195: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/21/uk-agency-issues-birth-defect-warning-linked-to-prozac-paxil/</loc>
		<lastmod>2010-05-21T21:14:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1194: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/21/baxter-recalling-injection-solution-after-finding-glass-particles-in-stored-vials/</loc>
		<lastmod>2010-05-21T12:36:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1198: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/20/pfizer-settles-neurontin-suicide-lawsuit/</loc>
		<lastmod>2010-05-20T21:20:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1196: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/20/wal-mart-pulls-miley-cyrus-jewelry-due-to-cadmium-levels/</loc>
		<lastmod>2010-05-20T21:15:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1193: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/20/fda-task-force-says-agency-must-disclose-more-information-to-public/</loc>
		<lastmod>2010-05-20T16:12:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1192: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/20/viagra-linked-to-long-term-hearing-loss-in-new-study/</loc>
		<lastmod>2010-05-20T00:12:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1199: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/19/fda-widens-jj-probe/</loc>
		<lastmod>2010-05-19T21:21:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1191: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/18/sagent-recalling-claris-lifesciences-antimicrobial-iv-injections-due-to-possible-contamination/</loc>
		<lastmod>2010-05-18T19:26:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1190: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/14/oklahoma-jury-awards-physician-16m-for-botox-injuries/</loc>
		<lastmod>2010-05-14T13:47:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1189: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/13/antidepressant-use-linked-to-newborn-heart-defects/</loc>
		<lastmod>2010-05-13T23:48:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1188: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/13/gsk-settles-nearly-700-avandia-lawsuits/</loc>
		<lastmod>2010-05-13T23:48:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1186: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/13/fda-issues-warning-on-otc-benadryl-anti-itch-gel/</loc>
		<lastmod>2010-05-13T13:54:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1187: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/12/fda-urged-to-halt-avandia-trials-2/</loc>
		<lastmod>2010-05-12T23:46:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1184: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/12/fda-urged-to-halt-avandia-trials/</loc>
		<lastmod>2010-05-12T16:06:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1183: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/11/pa-woman-walks-with-cane-lost-job-due-to-super-poligrip-use/</loc>
		<lastmod>2010-05-11T22:26:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1182: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/07/house-set-to-investigate-company-behind-otc-drug-recall-fda-procedures/</loc>
		<lastmod>2010-05-07T02:04:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1180: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/06/judge-allows-wide-plaintiff-latitude-in-omniscan-lawsuits/</loc>
		<lastmod>2010-05-06T16:37:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1179: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/06/mcneil-ignored-complaints-on-tainted-drugs-had-more-than-20-violations-at-pa-facility/</loc>
		<lastmod>2010-05-06T01:20:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1181: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/05/novartis-to-pay-725-million-to-settle-off-label-marketing-charges/</loc>
		<lastmod>2010-05-05T16:37:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1176: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/04/prostate-cancer-drugs-may-lead-to-heart-disease-diabetes/</loc>
		<lastmod>2010-05-04T22:13:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1178: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/04/fda-to-review-safety-of-cough-medicine-ingredient/</loc>
		<lastmod>2010-05-04T16:02:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1177: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/04/alburquerque-woman-files-lawsuit-against-gardasil/</loc>
		<lastmod>2010-05-04T16:02:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1174: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/03/mcneil-healthcare-issues-massive-recall-on-otc-childrens-drugs/</loc>
		<lastmod>2010-05-03T17:34:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1175: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/03/consumers-warned-against-vita-breath-due-to-excessive-lead-content/</loc>
		<lastmod>2010-05-03T17:17:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1173: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/28/astrazeneca-to-pay-520-million-to-settle-seroquel-case/</loc>
		<lastmod>2010-04-28T15:50:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1172: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/22/genzyme-expecting-175-million-fine-by-fda/</loc>
		<lastmod>2010-04-22T16:03:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1170: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/22/lawsuit-claims-16-year-old-girl-died-two-days-after-final-gardasil-shot/</loc>
		<lastmod>2010-04-22T03:11:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1171: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/21/fda-warns-pfizer-over-lax-drug-testing-oversight/</loc>
		<lastmod>2010-04-21T15:59:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1168: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/20/unsealed-document-show-ge-hid-safety-data-on-omniscan/</loc>
		<lastmod>2010-04-20T00:14:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1167: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/19/fda-says-gsk-ads-misleading/</loc>
		<lastmod>2010-04-19T16:32:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1166: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/19/fda-may-stop-avandia-safety-study/</loc>
		<lastmod>2010-04-19T16:31:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1164: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/16/apotex-warned-by-fda-again-regarding-manufacturing-violations/</loc>
		<lastmod>2010-04-16T15:53:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1163: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/16/sexual-enhancement-products-recalled-due-to-undeclared-drug/</loc>
		<lastmod>2010-04-16T02:00:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1162: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/15/louisiana-official-testifies-merck-hid-side-effects-associated-with-vioxx/</loc>
		<lastmod>2010-04-15T21:59:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1165: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/15/ranbaxy-recalls-antibiotics-due-to-color-complaints/</loc>
		<lastmod>2010-04-15T15:53:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1161: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/15/study-links-neurontin-depakota-others-to-suicidal-behavior/</loc>
		<lastmod>2010-04-15T03:52:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1159: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/14/anti-depressants-leading-to-suicidal-thoughts-and-behavior-in-children/</loc>
		<lastmod>2010-04-14T03:52:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1155: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/09/fda-warns-two-drug-makers-over-claims-made-in-ads-webcasts/</loc>
		<lastmod>2010-04-09T02:02:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1154: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/08/anti-psychotics-lead-to-potentially-fatal-pneumonia-in-elderly-unnecessary-prescriptions-rampant/</loc>
		<lastmod>2010-04-08T14:08:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1153: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/08/prescription-drug-poisoning-deaths-at-crisis-level-new-study-finds/</loc>
		<lastmod>2010-04-08T13:05:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1157: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/07/faa-considers-allowing-pilots-to-take-anti-depressants/</loc>
		<lastmod>2010-04-07T14:48:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1156: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/07/oftalmi-recalls-eye-nasal-drops-due-to-sterility-issues/</loc>
		<lastmod>2010-04-07T14:47:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1152: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/06/us-marshals-raid-seize-beehive-botanicals-products-over-false-claims/</loc>
		<lastmod>2010-04-06T22:44:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1150: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/06/fen-phen-caused-massive-heart-failure-23-years-later-for-idaho-woman/</loc>
		<lastmod>2010-04-06T03:10:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1151: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/05/dietary-supplement-recalled-due-to-undeclared-ingredient/</loc>
		<lastmod>2010-04-05T15:12:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1149: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/02/multivitamins-may-increase-breast-cancer-risk/</loc>
		<lastmod>2010-04-02T21:04:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1146: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/02/toddlers-death-blamed-on-heparin-overdose/</loc>
		<lastmod>2010-04-02T11:10:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1145: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/02/clinical-trial-suggests-link-between-parkinsons-drug-stalevo-and-prostate-cancer/</loc>
		<lastmod>2010-04-02T02:04:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1160: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/01/abbott-labs-told-to-hand-over-emails-in-depakote-investigation/</loc>
		<lastmod>2010-04-01T16:17:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1147: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/01/pfizer-comes-clean-on-payouts-to-doctors-medical-centers/</loc>
		<lastmod>2010-04-01T13:15:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1144: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/31/masxtreme-capsules-recalled-due-to-undeclared-drugs/</loc>
		<lastmod>2010-03-31T23:43:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1148: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/31/new-crestor-marketing-meeting-with-criticism/</loc>
		<lastmod>2010-03-31T13:15:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1143: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/29/wisconsin-man-settles-claims-against-roche-over-accutane-side-effects/</loc>
		<lastmod>2010-03-29T17:00:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1142: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/26/pfizer-found-guilty-of-off-label-promotion-of-epilepsy-drug/</loc>
		<lastmod>2010-03-26T21:00:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1141: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/25/canadian-regulators-warn-about-avelox-liver-injury-risk/</loc>
		<lastmod>2010-03-25T14:57:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1140: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/25/clinical-trials-ending-early-producing-misleading-results/</loc>
		<lastmod>2010-03-25T03:17:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1138: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/23/fda-advises-doctors-to-temporarily-stop-using-rotarix-vaccine/</loc>
		<lastmod>2010-03-23T16:19:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1139: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/23/plavix-may-not-work-for-some-fda-warns/</loc>
		<lastmod>2010-03-23T15:26:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1137: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/22/big-pharma-money-influencing-safety-reviews-on-avandia/</loc>
		<lastmod>2010-03-22T17:18:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1135: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/19/eczema-drugs-may-need-even-stronger-warnings-for-kids/</loc>
		<lastmod>2010-03-19T08:30:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1136: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/18/tylenol-maker-changes-procedures-after-moldy-odor-problems/</loc>
		<lastmod>2010-03-18T15:33:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1133: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/18/cleviprex-recall-expanded-due-to-presence-of-foreign-matter/</loc>
		<lastmod>2010-03-18T14:48:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1132: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/17/parker-waichman-alonso-wants-full-recall-from-pg-on-fixodent-with-zinc/</loc>
		<lastmod>2010-03-17T17:58:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1131: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/15/possible-cataract-risk-found-with-ssri-use/</loc>
		<lastmod>2010-03-15T15:31:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1129: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/11/fda-to-review-osteoporosis-drugs/</loc>
		<lastmod>2010-03-11T17:19:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1125: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/10/public-citizen-urges-fda-to-ban-avandia-one-more-time/</loc>
		<lastmod>2010-03-10T20:05:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1126: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/10/supreme-court-to-decide-on-lawsuits-against-vaccine-makers/</loc>
		<lastmod>2010-03-10T16:57:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1124: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/09/paxil-birth-defects-claims-expected-to-rise-after-plaintiff-victory-in-texas/</loc>
		<lastmod>2010-03-09T19:24:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1128: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/09/painkillers-increase-hearing-loss-risk-in-men/</loc>
		<lastmod>2010-03-09T17:13:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1127: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/09/avandia-risks-increase-additional-critiques-stock-slips/</loc>
		<lastmod>2010-03-09T16:58:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1123: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/02/merck-makes-final-vioxx-settlement-payment/</loc>
		<lastmod>2010-03-02T20:38:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1122: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/02/ada-releases-statement-on-denture-adhesives/</loc>
		<lastmod>2010-03-02T20:37:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1121: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/02/california-county-sues-gsk-over-avandia-deaths-injuries/</loc>
		<lastmod>2010-03-02T03:35:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1120: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/26/kv-pharmaceutical-shuts-generic-company-pleads-guilty-to-criminal-charges/</loc>
		<lastmod>2010-02-26T14:56:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1117: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/25/gsk-submits-official-rebuttal-of-senate-claims-of-avandia-risks/</loc>
		<lastmod>2010-02-25T17:22:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1116: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/25/fda-warns-of-heart-risk-for-hiv-drugs-interaction/</loc>
		<lastmod>2010-02-25T01:48:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1118: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/24/avandia-approval-comes-with-criticism-of-bias/</loc>
		<lastmod>2010-02-24T17:22:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1114: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/24/wyeth-to-pay-alabama-woman-945-million-over-prempro-suit/</loc>
		<lastmod>2010-02-24T17:03:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1111: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/23/hospital-acquired-infections-skyrocketing-costing-billions-in-healthcare/</loc>
		<lastmod>2010-02-23T17:41:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1113: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/23/survey-exposes-drug-company-payments-to-residency-programs/</loc>
		<lastmod>2010-02-23T17:01:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1112: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/23/doctor-pleads-guilty-to-research-fraud/</loc>
		<lastmod>2010-02-23T17:00:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1110: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/23/fda-reviewing-avandia-study-making-no-formal-statement-until-july/</loc>
		<lastmod>2010-02-23T15:33:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1109: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/23/us-urges-gsk-to-drop-avandia-diabetes-drug/</loc>
		<lastmod>2010-02-23T02:01:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1115: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/22/zicam-makers-sued-over-loss-of-smell/</loc>
		<lastmod>2010-02-22T17:03:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1104: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/10/fda-to-impose-new-safety-controls-over-asthma-meds/</loc>
		<lastmod>2010-02-21T21:49:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1105: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/19/ge-healthcare-pulls-ominscan-libel-suit/</loc>
		<lastmod>2010-02-19T21:49:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1106: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/18/gardasil-effective-for-older-women-and-gay-men-says-merck/</loc>
		<lastmod>2010-02-18T21:57:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1103: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/18/gsk-stops-manufacturing-selling-and-advertising-super-poligrip-products-with-zinc/</loc>
		<lastmod>2010-02-18T12:45:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1108: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/17/omniscan-critic-sued-critic-countersues/</loc>
		<lastmod>2010-02-17T21:59:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1107: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/17/adverse-reactions-lead-to-added-accutane-warnings/</loc>
		<lastmod>2010-02-17T21:57:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1102: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/17/alabama-man-awarded-25-million-over-accutane-side-effects/</loc>
		<lastmod>2010-02-17T20:52:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1101: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/16/another-study-links-avandia-actos-to-bone-fractures/</loc>
		<lastmod>2010-02-16T22:06:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1100: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/16/2008-selenium-poisoning-result-of-dietary-supplements/</loc>
		<lastmod>2010-02-16T17:55:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1098: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/11/herbal-products-may-contain-heavy-metals-pharmaceutical-products/</loc>
		<lastmod>2010-02-11T03:02:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1097: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/10/ny-cervical-cancer-legislation-meets-criticism/</loc>
		<lastmod>2010-02-10T17:09:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1096: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/09/women-with-breast-cancer-taking-paxil-more-likely-to-relapse/</loc>
		<lastmod>2010-02-09T22:27:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1095: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/09/26-year-old-joins-denture-cream-poisoning-plaintiffs/</loc>
		<lastmod>2010-02-09T17:03:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1094: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/09/young-texas-woman-paralyzed-by-poligrip-denture-cream/</loc>
		<lastmod>2010-02-09T02:55:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1093: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/09/fda-updates-label-on-tysabri-to-note-risk-of-brain-infection/</loc>
		<lastmod>2010-02-09T02:41:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1092: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/05/ranbaxy-plants-scrutinized-by-fda/</loc>
		<lastmod>2010-02-05T21:21:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1091: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/05/childhood-asthma-linked-to-acetaminophen-use-during-pregnancy/</loc>
		<lastmod>2010-02-05T21:20:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1090: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/03/study-says-ginkgo-leads-to-seizures-in-epilepsy-patients/</loc>
		<lastmod>2010-02-03T23:07:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1089: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/03/liver-injury-us-death-linked-to-hydroxycut-hardcore-causes-australia-to-consider-ban/</loc>
		<lastmod>2010-02-03T16:23:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1088: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/01/anti-hiv-drugs-come-with-risks/</loc>
		<lastmod>2010-02-02T21:53:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1086: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/02/heart-drugs-made-risky-when-mixed-with-herbal-remedies/</loc>
		<lastmod>2010-02-02T21:48:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1085: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/02/vaccine-causes-serious-complication/</loc>
		<lastmod>2010-02-02T21:48:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1084: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/02/novartis-settles-charges-over-trileptal-marketing/</loc>
		<lastmod>2010-02-02T04:31:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1087: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/01/fda-warns-cosmetic-doctor-for-promotion-of-unapproved-drug/</loc>
		<lastmod>2010-02-01T21:49:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1082: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/29/ssri-drugs-linked-to-slow-breast-milk-development/</loc>
		<lastmod>2010-01-29T04:35:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1081: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/28/rotavirus-vaccine-risky-for-immune-deficient-infants/</loc>
		<lastmod>2010-01-28T17:44:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1080: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/28/mother-sues-over-alleged-botox-induced-death-of-child/</loc>
		<lastmod>2010-01-28T17:43:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1079: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/27/drug-advertisement-on-tv-facing-scrutiny/</loc>
		<lastmod>2010-01-27T17:41:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1078: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/27/tysabri%e2%80%99s-pml-risk-numbers-provided-to-doctors/</loc>
		<lastmod>2010-01-27T16:14:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1077: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/27/new-york-considering-restrictions-on-drug-companies-doctors/</loc>
		<lastmod>2010-01-27T16:14:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1076: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/27/miami-death-may-be-linked-to-denture-adhesive/</loc>
		<lastmod>2010-01-27T16:13:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1075: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/27/doctor-quits-harvard-medical-school-in-favor-of-speaking-money-from-big-pharmaceuticals/</loc>
		<lastmod>2010-01-27T01:04:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1074: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/25/ge-healthcare-told-to-remove-visipaque-claims/</loc>
		<lastmod>2010-01-25T21:26:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1073: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/25/antidepressant-use-linked-to-birth-complications/</loc>
		<lastmod>2010-01-25T21:25:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1072: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/23/public-citizen-asking-fda-to-pull-savella-off-market/</loc>
		<lastmod>2010-01-23T22:44:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1070: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/22/fda-adds-warning-doesnt-ban-meridia-sibutramine/</loc>
		<lastmod>2010-01-22T13:09:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1069: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/21/parker-sentenced-to-20-years-for-infecting-people-with-hepatitis-c/</loc>
		<lastmod>2010-01-21T20:54:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1071: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/21/british-teen-battling-peeling-skin-blindness-after-taking-tamiflu/</loc>
		<lastmod>2010-01-21T17:32:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1068: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/21/canadian-case-claims-vioxx-led-to-strokes-fatal-heart-attack/</loc>
		<lastmod>2010-01-21T03:44:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1067: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/20/salon-owner-sentenced-for-using-fake-botox-restylane/</loc>
		<lastmod>2010-01-20T16:42:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1066: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/19/fda-warns-consumers-to-be-wary-of-counterfeit-alli-products-available-on-web/</loc>
		<lastmod>2010-01-19T22:50:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1065: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/19/network-established-to-alert-correct-medication-errors/</loc>
		<lastmod>2010-01-19T16:28:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1062: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/19/fda-warns-mcneil-about-slow-reaction-to-smell-in-tylenol-motrin-bottles/</loc>
		<lastmod>2010-01-19T04:10:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1061: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/19/musclemastercom-recalls-dietary-supplements-containing-known-steroids/</loc>
		<lastmod>2010-01-19T03:56:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1064: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/18/skin-lighteners-come-with-serious-risks/</loc>
		<lastmod>2010-01-18T16:19:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1063: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/16/johnson-johnson-omnicare-in-kickback-allegations/</loc>
		<lastmod>2010-01-16T16:19:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1060: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/15/anethesiologist-falsified-results-of-celebrex-study-for-pfizer/</loc>
		<lastmod>2010-01-15T12:35:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1059: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/15/another-lawsuit-filed-against-matrixx-over-zicam/</loc>
		<lastmod>2010-01-15T04:05:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1058: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/14/drug-makers-warned-over-content-of-ads/</loc>
		<lastmod>2010-01-14T04:17:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1057: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/13/ny-settles-with-health-care-facilities-over-drug-flushing/</loc>
		<lastmod>2010-01-13T17:26:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1054: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/08/fda-asks-outside-panel-to-review-procrit-epogen-safety-this-year/</loc>
		<lastmod>2010-01-08T04:19:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1055: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/07/appeals-court-reopens-prempro-breast-cancer-cases/</loc>
		<lastmod>2010-01-07T17:17:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1053: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/07/fda-warnings-up-from-2008-approvals-flat/</loc>
		<lastmod>2010-01-07T17:12:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1052: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/07/antidepressants-ineffective-in-treatment-of-mild-to-moderate-symptoms/</loc>
		<lastmod>2010-01-07T04:36:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1051: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/06/new-rules-curb-fees-paid-to-physicians-execs-by-drug-companies/</loc>
		<lastmod>2010-01-06T17:48:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1050: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/06/maryland-woman-claims-prempro-premarin-caused-her-breast-cancer/</loc>
		<lastmod>2010-01-06T04:35:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1049: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/05/zicam-problems-lead-to-lawsuit/</loc>
		<lastmod>2010-01-05T17:02:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1048: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/31/study-finds-ginkgo-has-no-impact-on-alzheimers-dementia/</loc>
		<lastmod>2009-12-31T04:50:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1047: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/30/tylenol-arthritis-caplets-recalled-due-to-moldy-smell-in-bottles/</loc>
		<lastmod>2009-12-30T03:14:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1046: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/29/four-file-suit-against-makers-of-osmoprep-due-to-kidney-damage/</loc>
		<lastmod>2009-12-29T01:46:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1045: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/25/fda-call-for-more-byetta-safety-studies-causes-amylin-stock-to-drop/</loc>
		<lastmod>2009-12-25T04:52:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1044: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/24/nih-to-propose-new-ethics-rules-for-paid-researchers-2/</loc>
		<lastmod>2009-12-24T13:52:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1043: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/24/ex-cdc-director-gerberding-to-head-merck%e2%80%99s-vaccine-division-2/</loc>
		<lastmod>2009-12-24T13:51:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1042: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/24/more-swine-flu-vaccines-recalled-fda-still-not-worried/</loc>
		<lastmod>2009-12-24T05:10:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1041: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/23/meridia-may-increase-risks-for-heart-attack-stroke/</loc>
		<lastmod>2009-12-23T16:12:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1040: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/23/ge-healthcare-attempts-to-stop-omniscan-criticism/</loc>
		<lastmod>2009-12-23T16:09:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1039: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/23/nih-to-propose-new-ethics-rules-for-paid-researchers/</loc>
		<lastmod>2009-12-23T15:44:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1038: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/23/ex-cdc-director-gerberding-to-head-merck%e2%80%99s-vaccine-division/</loc>
		<lastmod>2009-12-23T15:43:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1037: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/23/teva-recalls-all-ketamine-animal-sedative-due-to-increased-adverse-reactions/</loc>
		<lastmod>2009-12-23T01:25:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1036: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/22/vicks-dayquil-cold-flu-liquicaps-recalled-due-to-packaging-error/</loc>
		<lastmod>2009-12-22T02:21:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1035: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/18/report-finds-cdc-failed-to-screen-medical-experts-properly/</loc>
		<lastmod>2009-12-18T20:18:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1034: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/17/cleviprex-injectables-recalled-due-to-particulate-matter/</loc>
		<lastmod>2009-12-17T20:17:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1032: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/17/pharmaceutical-companies-start-to-disclose-payments/</loc>
		<lastmod>2009-12-17T16:39:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1031: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/17/swine-flu-vaccine-recall-concerns-few-but-it-should/</loc>
		<lastmod>2009-12-17T02:31:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1030: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/16/study-finds-antidepressant-use-linked-to-stroke-risk/</loc>
		<lastmod>2009-12-16T14:55:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1029: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/16/dietary-supplements-recalled-due-to-presence-of-ed-drug/</loc>
		<lastmod>2009-12-16T04:20:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1028: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/15/more-gardasil-issues-emerge/</loc>
		<lastmod>2009-12-15T16:24:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1027: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/15/gsk-has-paid-more-than-1-billion-to-settle-paxil-lawsuits/</loc>
		<lastmod>2009-12-15T04:16:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1026: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/11/new-zealand-girl%e2%80%99s-death-may-be-linked-to-gardisil/</loc>
		<lastmod>2009-12-11T22:04:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1025: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/11/paxil-led-to-birth-defects-in-three-children-texas-lawsuit-claims/</loc>
		<lastmod>2009-12-11T12:59:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1024: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/10/fda-yet-to-make-changes-after-vioxx-scandal/</loc>
		<lastmod>2009-12-10T16:19:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1023: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/10/omniscan-optimark-linked-to-nsf/</loc>
		<lastmod>2009-12-10T04:06:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1022: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/09/valproate-other-aeds-linked-to-birth-defects/</loc>
		<lastmod>2009-12-09T01:50:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1021: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/08/grassley-seeks-payment-details-from-medical-groups/</loc>
		<lastmod>2009-12-08T16:56:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1020: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/08/voltaren-gel-1-gets-fda-update-on-warning-label-after-patient-deaths/</loc>
		<lastmod>2009-12-08T05:48:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1019: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/07/antipsychotic-drugs-weight-gain-link-studied/</loc>
		<lastmod>2009-12-07T16:32:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1018: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/06/new-jersey-surrounding-states-impose-regulations-on-doctors/</loc>
		<lastmod>2009-12-06T21:11:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1017: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/06/consumer-group-urges-ban-on-meridia/</loc>
		<lastmod>2009-12-06T21:10:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1014: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/01/connecticut-sues-cvs-over-expired-product-sales/</loc>
		<lastmod>2009-12-04T14:46:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1013: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/04/lexiva-linked-to-high-blood-pressure/</loc>
		<lastmod>2009-12-04T13:57:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1012: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/03/zyprexa-seroquel-linked-to-heart-problems-diabetes/</loc>
		<lastmod>2009-12-03T04:06:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1016: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/02/cat-food-recalled-due-to-deficiency/</loc>
		<lastmod>2009-12-02T15:17:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1015: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/02/medication-disposal-recommendations-posted/</loc>
		<lastmod>2009-12-02T15:17:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1011: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/30/nsf-contrast-agent-link-to-be-reviewed/</loc>
		<lastmod>2009-11-30T17:15:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1010: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/27/mrsa-infections-on-the-rise/</loc>
		<lastmod>2009-11-27T15:41:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1009: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/25/gsk-advises-against-using-one-batch-of-swine-flu-vaccine/</loc>
		<lastmod>2009-11-25T14:23:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1008: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/24/antidepressants-sleep-aids-lead-to-falls-among-elderly/</loc>
		<lastmod>2009-11-24T23:37:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1007: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/24/pfizer-ordered-to-pay-punitive-damages-in-breast-cancer-suits/</loc>
		<lastmod>2009-11-24T20:28:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1006: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/24/merck-data-showed-vioxx-dangers-earlier/</loc>
		<lastmod>2009-11-24T20:26:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1005: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/23/pfizer-units-liable-for-63-million-in-breast-cancer-case/</loc>
		<lastmod>2009-11-23T16:55:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1004: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/20/pg-recalls-vicks-sinex-sprays/</loc>
		<lastmod>2009-11-20T12:58:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1003: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/18/interaction-warning-issued-on-plavix-prilosec/</loc>
		<lastmod>2009-11-18T19:30:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1001: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/18/cdc-decides-to-remove-gardisil-from-requirement-list-for-immigrants/</loc>
		<lastmod>2009-11-18T16:17:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1000: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/18/fda-finds-risks-in-mri-contrast-agents/</loc>
		<lastmod>2009-11-18T16:14:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 999: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/18/fda-warns-shire-about-promo-card-for-dacogen/</loc>
		<lastmod>2009-11-18T00:43:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 1002: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/17/weight-loss-supplement-recalled-by-gmp-fda/</loc>
		<lastmod>2009-11-17T16:17:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 998: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/16/niacin-outperforms-vytorin-zetia-in-new-study/</loc>
		<lastmod>2009-11-16T22:17:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 997: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/16/genzyme-drugs-have-foreign-substances-fda-warns/</loc>
		<lastmod>2009-11-16T21:58:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 993: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/13/acetaminophen-may-increase-risk-of-asthma-especially-in-children/</loc>
		<lastmod>2009-11-13T14:47:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 995: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/12/virginia-teen-suffers-guillain-barre-after-receiving-h1n1-vaccine/</loc>
		<lastmod>2009-11-12T20:13:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 994: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/12/fda-looks-into-internet-rules-for-drugs-devices/</loc>
		<lastmod>2009-11-12T20:11:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 992: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/11/anemia-drugs-linked-to-blood-clots/</loc>
		<lastmod>2009-11-11T17:29:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 991: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/10/hospira-recalls-injectables-due-to-particulate-matter/</loc>
		<lastmod>2009-11-10T17:26:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 989: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/06/fda-says-stiff-nights-has-undeclared-ingredient/</loc>
		<lastmod>2009-11-06T14:16:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 988: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/06/dutch-authorities-suspend-use-of-a-batch-of-prevnar-vaccine/</loc>
		<lastmod>2009-11-06T14:06:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 987: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/05/justice-dept-says-kickbacks-settlement-doesnt-mean-end-to-investigation/</loc>
		<lastmod>2009-11-05T16:17:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 986: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/05/dietary-supplements-sold-at-bodybuildingcom-contain-steroids-recalled/</loc>
		<lastmod>2009-11-05T03:46:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 985: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/04/american-regent-recalls-injectables-due-to-particulate-matter/</loc>
		<lastmod>2009-11-04T16:09:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 984: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/03/fda-revises-byetta-information-to-include-renal-failure-risks/</loc>
		<lastmod>2009-11-03T14:35:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 983: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/03/antibiotics-may-lead-to-birth-defects/</loc>
		<lastmod>2009-11-03T14:34:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 982: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/29/lead-researcher-on-gardasil-cervarix-says-vaccines-hardly-effective/</loc>
		<lastmod>2009-10-29T22:27:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 981: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/29/matrixx-says-fda-standing-firm-on-zicam-stance/</loc>
		<lastmod>2009-10-29T02:36:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 980: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/28/ibd-drugs-increase-risk-of-skin-cancer/</loc>
		<lastmod>2009-10-28T03:08:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 979: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/27/fda-poor-at-drug-approval-follow-up-gao-says/</loc>
		<lastmod>2009-10-27T15:55:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 978: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/27/gao-says-fda-lax-on-follow-up-studies-for-drugs-on-fast-track/</loc>
		<lastmod>2009-10-27T12:29:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 977: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/26/third-pml-case-linked-to-rituxan/</loc>
		<lastmod>2009-10-26T18:34:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 976: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/26/tysabri-risks-reviewed-by-european-panel/</loc>
		<lastmod>2009-10-26T15:46:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 975: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/22/pharmaceutical-companies-shouldnt-be-in-charge-of-safety-information/</loc>
		<lastmod>2009-10-22T22:05:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 974: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/22/foreign-matter-found-in-injections-of-ketorolac-tromethamine-prompts-recall/</loc>
		<lastmod>2009-10-22T21:43:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 973: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/22/birth-control-patch-blamed-for-death/</loc>
		<lastmod>2009-10-22T15:57:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 972: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/22/cdc-rejects-gardasil-requirement-for-boys/</loc>
		<lastmod>2009-10-22T15:56:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 971: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/22/most-doctors-ignoring-heart-drug-guidelines/</loc>
		<lastmod>2009-10-22T04:34:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 970: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/16/fda-revokes-its-letter-to-procter-gamble-over-dayquil-nyquil/</loc>
		<lastmod>2009-10-16T11:31:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 969: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/15/dayquil-nyquil-with-vitamin-c-must-have-labels-changed-fda-warns/</loc>
		<lastmod>2009-10-15T21:30:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 967: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/14/inhaled-steroid-treatment-for-copd-may-be-risky/</loc>
		<lastmod>2009-10-14T15:57:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 966: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/14/glaxo-to-pay-25-million-in-first-paxil-lawsuit/</loc>
		<lastmod>2009-10-14T15:53:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 965: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/14/amended-vytorin-lawsuit-names-names-in-vytorin-scandal/</loc>
		<lastmod>2009-10-14T02:27:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 964: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/13/hrt-may-be-linked-to-breast-cancer/</loc>
		<lastmod>2009-10-13T20:47:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 963: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/13/fda-gsk-report-patient-death-from-unauthorized-relenza-use/</loc>
		<lastmod>2009-10-13T02:16:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 962: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/12/pfizer-halts-figitumumab-trial-enrollment/</loc>
		<lastmod>2009-10-12T15:46:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 961: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/09/gardasil-not-cost-effective-for-boys-researchers-say/</loc>
		<lastmod>2009-10-09T14:58:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 960: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/09/safety-of-hepatitis-b-vaccine-questioned/</loc>
		<lastmod>2009-10-09T10:27:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 959: Comments: 33 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/02/elan-gets-sec-subpoena-over-tysabri/</loc>
		<lastmod>2009-10-02T16:01:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 958: Comments: 24 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/02/allergan-claims-fda-violated-free-speech-rights/</loc>
		<lastmod>2009-10-02T16:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 957: Comments: 26 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/02/new-heparin-formula-could-lead-to-dosing-errors/</loc>
		<lastmod>2009-10-02T12:42:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 956: Comments: 33 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/02/bayer-sued-over-prostate-health-claims-in-mens-vitamins/</loc>
		<lastmod>2009-10-02T12:09:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 955: Comments: 31 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/01/merck-loses-appeal-in-new-jersey-vioxx-death-verdict/</loc>
		<lastmod>2009-10-01T20:46:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 954: Comments: 35 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/01/new-drug-industry-guidelines-go-into-effect/</loc>
		<lastmod>2009-10-01T16:07:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 953: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/29/vioxx-lawsuit-filed-in-kentucky/</loc>
		<lastmod>2009-10-01T16:02:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 952: Comments: 32 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/01/diabetes-drug-may-carry-risk-of-bone-fractures/</loc>
		<lastmod>2009-10-01T16:00:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 951: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/01/memories-of-76-swine-flu-scare-raises-concerns-over-new-vaccine/</loc>
		<lastmod>2009-10-01T03:08:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 950: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/29/more-than-half-million-kids-suffer-side-effects-from-drugs/</loc>
		<lastmod>2009-09-29T22:33:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 948: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/29/cervarix-investigation-launched-after-death/</loc>
		<lastmod>2009-09-29T21:57:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 946: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/29/avastin-study-halted-after-reports-of-heart-failure/</loc>
		<lastmod>2009-09-29T03:24:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 945: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/29/claims-on-vioxx-settlement-include-more-than-3100-deaths/</loc>
		<lastmod>2009-09-29T02:54:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 944: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/29/fda-issues-warning-on-exjade-for-adverse-reactions-death/</loc>
		<lastmod>2009-09-29T02:17:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 947: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/28/study-reveals-avandia-link-to-heart-failure/</loc>
		<lastmod>2009-09-28T21:54:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 943: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/25/antidepressants-lead-to-birth-defects-study-finds/</loc>
		<lastmod>2009-09-25T16:09:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 942: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/25/woman-denied-citizenship-over-gardasil-shot/</loc>
		<lastmod>2009-09-25T13:15:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 941: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/25/fda-warns-about-tamiflu-dosing-errors/</loc>
		<lastmod>2009-09-25T13:01:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 940: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/25/problem-with-inactive-ingredient-spurs-recall-of-childrens-tylenol-syrups/</loc>
		<lastmod>2009-09-25T03:02:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 939: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/24/gsk-reworks-medical-education-funding-amidst-criticism/</loc>
		<lastmod>2009-09-24T16:29:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 938: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/24/gardisil-risk-concerns-continue/</loc>
		<lastmod>2009-09-24T16:27:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 937: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/23/tysabri-risks-affect-biogen-stocks/</loc>
		<lastmod>2009-09-23T16:49:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 936: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/22/medical-journals-crack-down-on-ghostwriting/</loc>
		<lastmod>2009-09-22T16:04:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 935: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/22/gsk-files-show-paxil-risks-known/</loc>
		<lastmod>2009-09-22T16:03:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 934: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/22/zinc-in-denture-creams-lead-to-lawsuits/</loc>
		<lastmod>2009-09-22T16:01:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 933: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/22/hearing-could-result-in-consolidated-zicam-lawsuit/</loc>
		<lastmod>2009-09-22T00:43:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 931: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/18/fda-warns-against-using-stolen-inhaler-solutions/</loc>
		<lastmod>2009-09-18T09:42:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 930: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/17/paxil-lawsuit-alleges-gsk-ignored-risk/</loc>
		<lastmod>2009-09-17T16:28:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 929: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/17/fda-requires-black-box-warning-for-promethazine/</loc>
		<lastmod>2009-09-17T16:27:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 928: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/17/latisse-risks-omitted-from-allergan-site-fda-says/</loc>
		<lastmod>2009-09-17T16:26:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 927: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/17/fosamax-trial-in-new-york-ends-in-mistrial/</loc>
		<lastmod>2009-09-17T08:18:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 926: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/17/protonix-linked-to-hospital-acquired-pneumonia-deaths/</loc>
		<lastmod>2009-09-17T01:53:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 925: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/17/fda-warns-bayer-over-conditions-at-german-facility/</loc>
		<lastmod>2009-09-17T01:35:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 924: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/15/fewer-women-getting-gardasil-vaccine/</loc>
		<lastmod>2009-09-15T20:43:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 923: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/15/matrixx-waiting-for-return-of-zicam-products/</loc>
		<lastmod>2009-09-15T04:20:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 922: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/15/sales-of-alli-dropping-fast-on-heels-of-fda-investigation/</loc>
		<lastmod>2009-09-15T04:08:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 921: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/11/paxil-birth-defects-case-begins-in-philadelphia/</loc>
		<lastmod>2009-09-11T13:27:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 920: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/11/gardasil-one-step-closer-to-approval-for-use-in-men/</loc>
		<lastmod>2009-09-11T02:21:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 919: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/10/parker-waichman-alonso-llp-represented-pfizer-whistleblower/</loc>
		<lastmod>2009-09-10T15:54:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 918: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/09/care-tech-agrees-to-stop-selling-manufacturing-antimicrobial-products/</loc>
		<lastmod>2009-09-09T20:17:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 917: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/09/antibiotics-linked-to-double-vision/</loc>
		<lastmod>2009-09-09T19:37:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 916: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/09/lawsuit-filed-against-pfizer-in-chantix-related-death/</loc>
		<lastmod>2009-09-09T15:22:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 915: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/09/many-%e2%80%9cnatural%e2%80%9d-supplements-contain-dangerous-ingredients/</loc>
		<lastmod>2009-09-09T15:21:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 914: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/08/fda-continues-support-for-gardasil-says-its-ok-for-men/</loc>
		<lastmod>2009-09-08T22:35:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 913: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/04/denture-cream-overuse-may-lead-to-toxicity/</loc>
		<lastmod>2009-09-04T14:38:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 912: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/04/fda-warns-of-anemia-risk-with-transplant-drug-myfortic/</loc>
		<lastmod>2009-09-04T11:22:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 911: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/03/pfizer-to-pay-23-billion-for-illegally-marketing-drugs-including-bextra/</loc>
		<lastmod>2009-09-03T22:20:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 910: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/03/single-statin-drugs-just-as-effective-as-combo-cholesterol-pills/</loc>
		<lastmod>2009-09-03T15:55:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 909: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/03/jurors-hear-closing-arguments-in-fosamax-trial/</loc>
		<lastmod>2009-09-03T15:52:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 908: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/02/singulair-will-get-updated-warning-addressing-neuropsychiatric-events/</loc>
		<lastmod>2009-09-02T22:14:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 907: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/02/trasylol-side-effects-results-in-lawsuit-against-bayer/</loc>
		<lastmod>2009-09-02T15:10:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 906: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/02/virginia-dc-take-steps-towards-hpv-vaccination-requirement/</loc>
		<lastmod>2009-09-02T14:59:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 905: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/02/more-questions-than-answers-in-antidepressants-during-pregnancy-debate/</loc>
		<lastmod>2009-09-02T00:07:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 904: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/28/fda-says-johnson-johnson-misleading-consumers-about-athletes-foot-cream/</loc>
		<lastmod>2009-08-28T02:33:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 903: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/26/prostate-cancer-hormone-therapy-higher-risk-for-those-with-heart-problems/</loc>
		<lastmod>2009-08-26T16:03:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 902: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/25/fda-investigating-liver-damage-reports-from-alli-consumers/</loc>
		<lastmod>2009-08-25T22:14:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 901: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/25/swine-flu-vaccine-raises-concerns/</loc>
		<lastmod>2009-08-25T19:20:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 900: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/24/gsk-used-ghostwriting-program-to-promote-paxil/</loc>
		<lastmod>2009-08-24T16:32:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 899: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/24/physicians-prescribing-drugs-for-off-label-uses-are-often-misinformed/</loc>
		<lastmod>2009-08-24T12:16:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 898: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/24/dietary-supplement-recall-expanded-to-include-another-brand-name/</loc>
		<lastmod>2009-08-24T12:02:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 897: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/21/fda-cracks-down-on-ibuprofen-gel-marketing/</loc>
		<lastmod>2009-08-21T13:51:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 896: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/21/lilly-settles-zyprexa-suits-for-225m/</loc>
		<lastmod>2009-08-21T13:32:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 895: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/21/merck-researcher-speaks-out-on-gardasil/</loc>
		<lastmod>2009-08-21T12:16:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 894: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/19/criticism-of-hpv-vaccine-gardisil-continues/</loc>
		<lastmod>2009-08-19T15:41:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 893: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/19/for-injured-kids-ibuprofen-is-better/</loc>
		<lastmod>2009-08-19T15:41:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 892: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/18/cellcept-gets-anemia-warning/</loc>
		<lastmod>2009-08-18T02:21:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 891: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/17/low-estrogen-birth-control-pill-safer-studies-find/</loc>
		<lastmod>2009-08-17T15:19:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 890: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/14/texas-man-claims-vytorin-caused-stress-injury-to-heart-brain-and-muscles/</loc>
		<lastmod>2009-08-14T12:53:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 889: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/13/another-study-links-tzds-to-fractures/</loc>
		<lastmod>2009-08-13T22:12:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 888: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/12/fda-drug-chief-accused-of-conflict-of-interest-in-drug-approval/</loc>
		<lastmod>2009-08-12T16:25:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 887: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/12/antidepressants-raise-suicide-risk-in-youth/</loc>
		<lastmod>2009-08-12T16:24:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 886: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/11/british-study-says-children-should-not-take-flu-drugs/</loc>
		<lastmod>2009-08-11T23:57:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 885: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/11/congress-pushes-to-ban-consumer-prescription-drug-ads/</loc>
		<lastmod>2009-08-11T16:01:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 884: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/10/fentanyl-patches-recalled-due-to-leaking-problem/</loc>
		<lastmod>2009-08-10T22:43:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 883: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/07/merck-schering-plough-settle-cholestrol-drug-suit/</loc>
		<lastmod>2009-08-07T15:19:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 882: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/07/fda-commissioner-sets-more-aggressive-approach/</loc>
		<lastmod>2009-08-07T15:18:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 881: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/06/letter-exposes-big-pharmas-lobbying-to-keep-generics-off-market/</loc>
		<lastmod>2009-08-06T20:24:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 880: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/06/spinal-cement-no-better-than-placebo-treatment-in-trial/</loc>
		<lastmod>2009-08-06T19:20:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 879: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/05/wyeth-ghostwriting-practices-to-become-public/</loc>
		<lastmod>2009-08-05T15:27:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 878: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/05/tnf-blockers-get-cancer-warning/</loc>
		<lastmod>2009-08-05T12:50:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 877: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/05/merck-will-pay-80-million-settling-more-vioxx-claims/</loc>
		<lastmod>2009-08-05T00:08:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 876: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/03/fda-seizes-skin-sanitizers-from-utah-lab/</loc>
		<lastmod>2009-08-03T22:39:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 875: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/31/antipsychotics-may-be-risky-for-elderly-diabetic-patients/</loc>
		<lastmod>2009-07-31T11:39:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 874: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/31/steam-diet-aid-recalled-because-it-contains-ed-drug/</loc>
		<lastmod>2009-07-31T02:32:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 873: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/30/fda-warns-not-to-use-cellular-labs-body-building-products/</loc>
		<lastmod>2009-07-30T02:01:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 872: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/28/public-citizen-report-links-avandia-to-liver-failure-death/</loc>
		<lastmod>2009-07-28T22:20:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 871: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/28/fda-investigating-mylan-plant/</loc>
		<lastmod>2009-07-28T15:47:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 870: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/27/another-tysabri-patient-develops-brain-infection/</loc>
		<lastmod>2009-07-27T23:55:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 869: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/27/report-shows-mylan-workers-overrode-drug-quality-controls/</loc>
		<lastmod>2009-07-27T16:25:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 868: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/24/pfizer-has-court-date-next-week-on-neurontins-link-to-suicide/</loc>
		<lastmod>2009-07-24T14:49:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 867: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/23/anti-epilepsy-drugs-lead-to-lower-iqs-in-offspring/</loc>
		<lastmod>2009-07-23T00:10:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 866: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/22/wife-of-victim-wins-settlement-in-vioxx-lawsuit/</loc>
		<lastmod>2009-07-22T15:07:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 865: Comments: 27 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/21/stockerholders-file-suit-against-matrixx/</loc>
		<lastmod>2009-07-21T21:24:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 864: Comments: 31 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/17/herbal-male-enhancement-products-recalled-as-unapproved-drugs/</loc>
		<lastmod>2009-07-17T14:09:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 863: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/17/teva-pharmaceuticals-recalls-anesthetic-due-to-elevated-endotoxins/</loc>
		<lastmod>2009-07-17T14:07:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 862: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/17/fda-still-investigating-trouble-with-xolair-trial/</loc>
		<lastmod>2009-07-17T11:25:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 861: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/16/merck-schering-plough-settle-charges-of-delaying-vytorin-study/</loc>
		<lastmod>2009-07-16T13:02:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 860: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/15/kidney-transplant-drugs-will-feature-increased-warning-for/</loc>
		<lastmod>2009-07-15T23:22:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 859: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/15/concentrated-acetaminophen-drops-recalled-due-to-overdose-hazard/</loc>
		<lastmod>2009-07-15T15:24:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 858: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/14/new-york-woman-sues-congress-over-vioxx-heart-attacks-strokes/</loc>
		<lastmod>2009-07-14T23:39:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 857: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/14/haloteco-recalls-libipower-plus-due-to-mislabeling/</loc>
		<lastmod>2009-07-14T15:05:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 856: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/13/sodium-chromate-injections-recalled-on-subpotency-fears/</loc>
		<lastmod>2009-07-13T22:10:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 855: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/13/fda-files-to-stop-three-dietary-supplement-companies/</loc>
		<lastmod>2009-07-13T15:21:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 854: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/10/fda-requires-stricter-guides-for-patients-taking-propoxyphene/</loc>
		<lastmod>2009-07-10T14:41:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 853: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/09/grassley-wants-ghostwriting-details-from-medical-journals/</loc>
		<lastmod>2009-07-09T21:46:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 852: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/07/acid-reflux-drugs-linked-to-dependency/</loc>
		<lastmod>2009-07-07T22:31:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 851: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/07/matrixx-stocks-slide-11-percent-as-lawsuits-are-disclosed/</loc>
		<lastmod>2009-07-07T22:16:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 850: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/07/sen-grassley-pushes-for-uniform-disclosure-policy-with-drug-makers-medical-schools/</loc>
		<lastmod>2009-07-07T22:02:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 849: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/07/levaquin-lawsuit-designated-mass-tort/</loc>
		<lastmod>2009-07-07T15:37:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 848: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/07/study-finds-gardisil-not-as-cost-effective-for-boys/</loc>
		<lastmod>2009-07-07T15:35:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 847: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/07/liver-damage-linked-to-diet-drug-alli/</loc>
		<lastmod>2009-07-07T03:29:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 846: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/06/tysabri-use-results-in-13th-sick-patient/</loc>
		<lastmod>2009-07-06T08:11:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 845: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/06/fda-panel-urges-ban-restrictions-on-acetaminophen-based-drugs/</loc>
		<lastmod>2009-07-06T08:09:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 844: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/06/medical-cost-effectiveness-studies-being-considered/</loc>
		<lastmod>2009-07-06T08:08:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 843: Comments: 87 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/02/chantix-zyban-get-black-box-warnings-from-fda/</loc>
		<lastmod>2009-07-02T12:59:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 842: Comments: 73 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/01/fda-wants-smaller-doses-of-otc-acetaminophen/</loc>
		<lastmod>2009-07-01T12:10:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 841: Comments: 101 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/30/denmark-case-shows-swine-flu-resistant-to-tamiflu/</loc>
		<lastmod>2009-06-30T23:24:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 840: Comments: 106 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/29/accutane-pulled-from-us-market/</loc>
		<lastmod>2009-06-29T22:49:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 839: Comments: 113 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/29/artificial-insulin-may-have-cancer-link/</loc>
		<lastmod>2009-06-29T16:26:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 838: Comments: 77 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/29/phenobarbital-recalled-in-canada-due-to-overdose-risk/</loc>
		<lastmod>2009-06-29T16:25:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 837: Comments: 102 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/26/us-marshals-seize-drugs-at-caraco-facilities/</loc>
		<lastmod>2009-06-26T12:48:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 836: Comments: 104 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/26/canada-warns-against-using-piroxicam-for-short-term-pain/</loc>
		<lastmod>2009-06-26T11:47:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 835: Comments: 92 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/25/watchdog-says-28-died-after-getting-gardasil-treatments-last-year/</loc>
		<lastmod>2009-06-25T12:31:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 834: Comments: 117 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/24/sec-wants-information-from-matrixx/</loc>
		<lastmod>2009-06-24T17:29:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 833: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/23/obama-gives-fda-power-to-regulate-tobacco-industry/</loc>
		<lastmod>2009-06-23T21:08:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 832: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/22/contact-lens-solution-maker-knew-of-problems/</loc>
		<lastmod>2009-06-22T16:02:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 831: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/22/zicam-controversy-puts-bad-light-on-homeopathic-industry/</loc>
		<lastmod>2009-06-22T12:25:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 830: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/21/cspi-tells-bayer-to-stop-deceptive-advertising/</loc>
		<lastmod>2009-06-21T21:03:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 829: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/21/regional-manager-sentenced-for-wrongful-marketing-of-bextra/</loc>
		<lastmod>2009-06-21T21:00:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 828: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/19/matrixx-held-800-side-effects-reports-from-fda/</loc>
		<lastmod>2009-06-19T11:55:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 827: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/17/fda-warns-against-certain-zicam-products/</loc>
		<lastmod>2009-06-17T17:26:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 826: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/16/report-links-adhd-stimulants-to-childhood-heart-attacks/</loc>
		<lastmod>2009-06-16T19:19:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 825: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/16/ms-drug-tysabri-leads-to-rare-brain-infection/</loc>
		<lastmod>2009-06-16T16:11:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 824: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/16/children%e2%80%99s-multivitamins-recalled-for-dosage-misprint/</loc>
		<lastmod>2009-06-16T16:09:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 823: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/16/stamina-rx-recalled-due-to-undeclared-ingredient/</loc>
		<lastmod>2009-06-16T16:09:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 822: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/15/stolen-insulin-being-re-sold/</loc>
		<lastmod>2009-06-15T21:05:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 821: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/15/fda-wants-warning-on-singulair-for-psychiatric-problems/</loc>
		<lastmod>2009-06-15T21:00:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 820: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/12/fda-investigates-increased-death-caused-by-rapamune/</loc>
		<lastmod>2009-06-12T15:29:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 819: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/12/lilly-ghostwrote-articles-on-zyprexa/</loc>
		<lastmod>2009-06-12T10:49:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 818: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/11/gardisil-fainting-risks-strengthened-by-fda/</loc>
		<lastmod>2009-06-11T15:42:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 817: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/11/seroquel-zyprexa-geodon-approved-for-use-on-children/</loc>
		<lastmod>2009-06-11T12:09:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 816: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/10/anti-infectives-leaching-into-waterways-worldwide/</loc>
		<lastmod>2009-06-10T15:19:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 815: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/10/testing-shows-one-quarter-of-supplements-tainted/</loc>
		<lastmod>2009-06-10T12:15:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 814: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/09/clarcon-recalls-skin-products-due-to-bacterial-contamination/</loc>
		<lastmod>2009-06-09T15:54:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 813: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/09/fda-considers-adult-antipsychotics-use-by-children/</loc>
		<lastmod>2009-06-09T15:53:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 812: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/09/avandia-has-some-risks-some-benefits/</loc>
		<lastmod>2009-06-09T15:52:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 811: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/09/merck-planned-loyalty-program-for-vioxx-patients/</loc>
		<lastmod>2009-06-09T11:51:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 810: Comments: 31 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/08/otc-meds-affect-aging-brains/</loc>
		<lastmod>2009-06-08T21:58:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 809: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/05/fda-committee-to-vote-on-psychotropics-for-youths/</loc>
		<lastmod>2009-06-05T16:11:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 808: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/05/heart-drug-combinations-increase-gastrointestinal-bleeding/</loc>
		<lastmod>2009-06-05T16:10:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 807: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/05/fda-lists-drugs-on-watch-list-for-safety-problems/</loc>
		<lastmod>2009-06-05T10:56:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 806: Comments: 108 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/04/ages-old-graves-disease-drug-more-likely-to-cause-fatal-liver-damage/</loc>
		<lastmod>2009-06-04T17:11:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 805: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/03/cafepharmacom-posts-will-be-allowed-in-lawsuit/</loc>
		<lastmod>2009-06-03T21:04:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 804: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/03/fda-warning-results-in-drop-in-depression-diagnoses-in-children/</loc>
		<lastmod>2009-06-03T19:35:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 803: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/02/fda-to-act-on-tamoxifen-report/</loc>
		<lastmod>2009-06-02T21:49:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 802: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/02/hormone-therapy-worsens-lung-cancer-study-shows/</loc>
		<lastmod>2009-06-02T14:48:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 801: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/02/fda-considers-rituxan-risks/</loc>
		<lastmod>2009-06-02T14:46:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 800: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/01/breast-cancer-drugs-not-as-effective-on-antidepressants/</loc>
		<lastmod>2009-06-01T14:18:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 799: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/29/dementia-medication-comes-with-serious-risks/</loc>
		<lastmod>2009-05-29T16:44:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 798: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/29/ranbaxy-files-corrective-plan-with-fda/</loc>
		<lastmod>2009-05-29T16:43:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 797: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/29/nearly-200-join-avandia-lawsuit/</loc>
		<lastmod>2009-05-29T11:26:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 796: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/29/fungal-infections-possibly-fatal-not-recognized-while-on-simponi-fda-warns/</loc>
		<lastmod>2009-05-29T11:11:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 795: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/28/fda-wants-tougher-warnings-on-acetaminophen/</loc>
		<lastmod>2009-05-28T11:29:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 794: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/27/acid-blockersproton-pump-inhibitors-linked-to-hospital-acquired-pneumonia-deaths/</loc>
		<lastmod>2009-05-27T15:07:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 793: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/26/cardiologist-testifies-vioxx-contributed-to-heart-attack/</loc>
		<lastmod>2009-05-26T20:31:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 792: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/26/study-confirms-avastin%e2%80%99s-risks/</loc>
		<lastmod>2009-05-26T20:29:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 791: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/26/doctor-at-aussie-trial-claims-vioxx-caused-heart-attack/</loc>
		<lastmod>2009-05-26T20:16:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 790: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/22/fda-approves-new-regulations-for-sunscreen-labels/</loc>
		<lastmod>2009-05-22T11:41:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 789: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/20/flomax-in-men-after-cataract-surgery-linked-to-serious-problems/</loc>
		<lastmod>2009-05-20T22:32:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 788: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/19/merck-paid-nurses-to-comb-patient-records-for-potential-vioxx-customers/</loc>
		<lastmod>2009-05-19T21:05:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 787: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/19/morphine-patch-can-lead-to-addiction/</loc>
		<lastmod>2009-05-19T13:13:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 786: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/15/fda-tests-heparin-finds-nothing/</loc>
		<lastmod>2009-05-15T15:11:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 785: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/15/evidence-suggests-link-between-antidepressants-antipsychotics-to-cardiac-death/</loc>
		<lastmod>2009-05-15T13:55:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 782: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/14/experts-call-for-stop-to-free-drug-samples/</loc>
		<lastmod>2009-05-14T21:03:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 781: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/14/mercks-misleading-lying-tactics-exposed-in-australian-trial-continent-in-uproar-over-revelations/</loc>
		<lastmod>2009-05-14T15:21:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 780: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/13/digoxin-tablets-recalled-due-to-size-error/</loc>
		<lastmod>2009-05-13T12:55:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 779: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/12/tarceva-comes-with-new-safety-information/</loc>
		<lastmod>2009-05-12T15:02:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 778: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/12/recent-heparin-deaths-investigated/</loc>
		<lastmod>2009-05-12T15:01:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 777: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/12/condemned-dietary-supplements-seized-by-federal-authorities/</loc>
		<lastmod>2009-05-12T13:36:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 776: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/11/groups-call-for-review-of-dshea-after-hydroxycut-recall/</loc>
		<lastmod>2009-05-11T19:20:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 775: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/11/fda-issues-new-warnings-on-cancer-drug/</loc>
		<lastmod>2009-05-11T19:18:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 774: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/11/canadians-join-class-action-suit-against-maker-of-hydroxycut/</loc>
		<lastmod>2009-05-11T09:55:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 773: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/11/five-incidents-at-delaware-hospital-may-be-linked-to-heparin/</loc>
		<lastmod>2009-05-11T09:50:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 772: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/08/elsevier-admits-to-publishing-bogus-journals/</loc>
		<lastmod>2009-05-08T13:23:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 771: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/07/grassley-stays-on-speaks-with-president-about-health-reform/</loc>
		<lastmod>2009-05-07T16:12:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 770: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/07/medxl-receives-complaints-of-particulates-in-syringes/</loc>
		<lastmod>2009-05-07T16:11:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 769: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/07/plavix-may-cause-problems-when-used-with-ppis/</loc>
		<lastmod>2009-05-07T16:10:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 768: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/07/avastin-approved-for-brain-cancer-treatment/</loc>
		<lastmod>2009-05-07T16:09:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 767: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/07/merck-enters-publishing-biz-journal-will-publish-its-favorable-data/</loc>
		<lastmod>2009-05-07T01:36:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 766: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/06/md-discusses-dietary-supplement-problems/</loc>
		<lastmod>2009-05-06T16:06:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 765: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/06/fda-updates-epilepsy-drug-warning-labels/</loc>
		<lastmod>2009-05-06T16:05:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 764: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/04/gardasil-may-raise-risk-of-guillain-barre-syndrome/</loc>
		<lastmod>2009-05-04T20:28:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 763: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/04/methadone-education-campaign-launched/</loc>
		<lastmod>2009-05-04T20:27:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 762: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/04/hydroxycut-products-recalled/</loc>
		<lastmod>2009-05-04T10:35:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 761: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/01/fda-adds-black-box-warning-to-all-botox-products/</loc>
		<lastmod>2009-05-01T11:26:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 760: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/30/dietary-supplement-libimax-recalled/</loc>
		<lastmod>2009-04-30T18:09:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 759: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/30/institute-urges-strict-changes-to-medical-industry-gifts/</loc>
		<lastmod>2009-04-30T16:13:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 758: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/29/panel-recommends-avoiding-epilepsy-drugs-in-pregnant-women/</loc>
		<lastmod>2009-04-29T15:33:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 757: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/29/fda-says-some-internet-pharma-ads-not-clear/</loc>
		<lastmod>2009-04-29T15:32:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 756: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/29/fda-orders-otc-pain-reliever-makers-to-update-labels-with-new-dangers/</loc>
		<lastmod>2009-04-29T10:01:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 755: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/28/fda-takes-emergency-measures-to-combat-swine-flu-outbreak/</loc>
		<lastmod>2009-04-28T15:42:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 754: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/27/biogen-waits-until-after-shareholders-meeting-to-announce-sixth-pml-case-from-tysabri/</loc>
		<lastmod>2009-04-27T20:13:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 753: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/24/senior-vp-at-merck-wrote-about-vioxx-concerns-in-emails/</loc>
		<lastmod>2009-04-24T15:19:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 752: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/24/nicotine-gums-increase-risk-of-mouth-cancer/</loc>
		<lastmod>2009-04-24T10:28:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 751: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/23/fda-forces-brooklyn-company-to-recall-dietary-supplements-with-undeclared-drug/</loc>
		<lastmod>2009-04-23T18:39:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 750: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/23/avastin-fails-in-cancer-trial-for-early-stage-cancer/</loc>
		<lastmod>2009-04-23T16:22:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 749: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/22/prescription-cough-and-cold-products-recalled/</loc>
		<lastmod>2009-04-22T16:09:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 748: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/21/actavis-given-go-ahead-to-distribute-oxycodone-from-totowa-plant/</loc>
		<lastmod>2009-04-21T00:52:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 747: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/21/drugmakers-dumping-into-sewage-lines/</loc>
		<lastmod>2009-04-21T00:09:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 746: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/20/two-chinese-companies-found-to-have-shipped-contaminated-heparin/</loc>
		<lastmod>2009-04-20T15:52:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 745: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/18/doctors-resisting-pharmaceutical-sales-rep-visits/</loc>
		<lastmod>2009-04-18T11:47:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 744: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/17/newer-anti-psychotic-drugs-can-cause-weight-gain-in-elderly/</loc>
		<lastmod>2009-04-17T10:33:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 743: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/17/mothers-who-took-valproate-have-lower-iqs/</loc>
		<lastmod>2009-04-17T01:25:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 742: Comments: 38 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/16/cough-and-cold-products-recalled-due-to-potency-problems/</loc>
		<lastmod>2009-04-16T15:30:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 741: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/16/bayer-settles-some-magnevist-lawsuits/</loc>
		<lastmod>2009-04-16T15:28:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 740: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/16/botox-competitors-approval-delayed/</loc>
		<lastmod>2009-04-16T00:01:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 739: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/15/aspirin-leading-to-microbleeds-in-brain-dutch-study-finds/</loc>
		<lastmod>2009-04-15T15:54:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 738: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/14/birth-control-pills-leading-to-lupus/</loc>
		<lastmod>2009-04-14T21:36:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 737: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/14/parkinson%e2%80%99s-medication-may-trigger-compulsive-behavior/</loc>
		<lastmod>2009-04-14T15:24:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 736: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/13/fda-gets-permanent-injunction-against-two-makers-of-unapproved-drugs/</loc>
		<lastmod>2009-04-13T17:09:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 735: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/13/experimental-use-of-botox-on-the-rise/</loc>
		<lastmod>2009-04-13T16:46:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 734: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/13/hospitals-start-limiting-drug-company-access-to-doctors/</loc>
		<lastmod>2009-04-13T16:35:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 733: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/13/researcher-faked-data-in-sleep-apnea-study/</loc>
		<lastmod>2009-04-13T16:34:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 732: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/13/fda-allows-unapproved-painkiller-to-stay-on-market/</loc>
		<lastmod>2009-04-13T08:26:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 731: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/09/raptiva-pulled-from-us-market/</loc>
		<lastmod>2009-04-09T23:58:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 730: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/09/thyroid-drug-can-cause-liver-failure-in-children/</loc>
		<lastmod>2009-04-09T13:57:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 729: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/07/hospital-subpoenaed-for-doctor%e2%80%99s-fake-studies/</loc>
		<lastmod>2009-04-07T16:08:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 728: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/07/lamisil-leads-to-liver-failure-death-toll-at-11/</loc>
		<lastmod>2009-04-07T11:40:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 727: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/07/fda-to-consider-seroquel-for-depression/</loc>
		<lastmod>2009-04-07T08:49:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 726: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/06/biogen-and-sanofi-aventis-get-warned-by-fda-over-web-ads/</loc>
		<lastmod>2009-04-06T22:34:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 725: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/03/study-suggests-potent-link-between-gadolinium-agents-nsfnsd/</loc>
		<lastmod>2009-04-03T14:40:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 724: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/03/taking-class-of-diabetes-drugs-could-lead-to-vision-trouble-blindness/</loc>
		<lastmod>2009-04-03T10:46:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 723: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/02/polio-victim-finally-wins-lawsuit-after-30-years/</loc>
		<lastmod>2009-04-02T16:21:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 722: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/01/doctors-researchers-urge-limits-on-funding-by-drug-companies/</loc>
		<lastmod>2009-04-01T16:13:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 721: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/01/heart-medication-recalled-by-caraco-pharmaceuticals/</loc>
		<lastmod>2009-04-01T16:12:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 720: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/01/fda-orders-nine-companies-to-stop-marketing-narcotics/</loc>
		<lastmod>2009-04-01T14:21:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 719: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/31/glaxosmithkline-submits-final-application-for-approval-of-cervarix/</loc>
		<lastmod>2009-03-31T22:35:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 718: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/30/ama-investigates-threats-made-by-jama-editors/</loc>
		<lastmod>2009-03-30T16:29:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 717: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/30/fda-unsure-of-avastin-after-showing-little-in-tests/</loc>
		<lastmod>2009-03-30T15:06:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 716: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/27/michigan-state-house-votes-to-repeal-drugmaker-immunity-law/</loc>
		<lastmod>2009-03-27T16:37:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 715: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/27/gsk-reaches-settlement-over-paxil-defects/</loc>
		<lastmod>2009-03-27T11:05:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 714: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/27/psychiatrists-agree-to-end-drug-company-sponsored-meetings-meals/</loc>
		<lastmod>2009-03-27T02:34:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 713: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/26/herbal-painkiller-causes-liver-failure-fsai-warns/</loc>
		<lastmod>2009-03-26T14:21:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 712: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/25/judge-orders-fda-to-re-think-age-restriction-on-plan-b-contraceptive/</loc>
		<lastmod>2009-03-25T16:47:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 711: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/24/shire-recalls-adhd-patch-for-non-safety-reasons/</loc>
		<lastmod>2009-03-24T16:19:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 710: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/24/watson-pharma-recalls-cardiac-drug/</loc>
		<lastmod>2009-03-24T16:18:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 709: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/24/lexapro-approved-for-adolescents-despite-ongoing-investigation/</loc>
		<lastmod>2009-03-24T14:46:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 708: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/24/merck-target-of-vioxx-grand-jury-probe/</loc>
		<lastmod>2009-03-24T14:28:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 707: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/23/fda-may-split-in-two-may-speed-drug-approvals/</loc>
		<lastmod>2009-03-23T16:16:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 706: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/23/zencore-tabs-recalled-due-to-undeclared-ingredients/</loc>
		<lastmod>2009-03-23T16:15:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 705: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/23/more-weight-loss-products-declared-unsafe/</loc>
		<lastmod>2009-03-23T11:52:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 704: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/20/fda-panel-backs-anti-clotting-drug-rivaroxaban/</loc>
		<lastmod>2009-03-20T15:26:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 703: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/20/janssen-ortho-updates-information-on-birth-control-patch/</loc>
		<lastmod>2009-03-20T11:33:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 702: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/18/suicide-risk-drug-cymbalta-prescribed-for-minor-conditions/</loc>
		<lastmod>2009-03-18T16:05:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 701: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/18/wakefulness-drug-may-be-more-addictive-than-thought/</loc>
		<lastmod>2009-03-18T16:04:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 700: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/18/new-blood-clot-drug-causing-bleeding-in-clinical-trials/</loc>
		<lastmod>2009-03-18T12:45:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 699: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/13/massachusetts-rules-to-ban-company-gifts-to-doctors/</loc>
		<lastmod>2009-03-13T21:48:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 698: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/11/antidepressants-increase-risk-for-cardiac-death-in-women/</loc>
		<lastmod>2009-03-11T13:41:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 697: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/11/nurse-practitioners-unaware-of-marketing-influences/</loc>
		<lastmod>2009-03-11T13:40:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 696: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/11/pain-expert-fabricated-data-for-vioxx-celebrex-other-drugs/</loc>
		<lastmod>2009-03-11T13:39:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 695: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/11/canadians-warned-of-kidney-injuries-from-bowel-cleanser/</loc>
		<lastmod>2009-03-11T00:46:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 693: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/09/preterm-labor-meds-linked-to-complications/</loc>
		<lastmod>2009-03-09T15:41:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 692: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/09/merck-will-buy-schering-plough/</loc>
		<lastmod>2009-03-09T15:29:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 691: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/06/free-antibiotics-giveaways-give-rise-to-criticism/</loc>
		<lastmod>2009-03-06T21:49:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 690: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/06/health-canada-warns-on-bowel-preps/</loc>
		<lastmod>2009-03-06T21:48:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 689: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/06/fda-issues-advisory-on-wearing-certain-patches-during-mri/</loc>
		<lastmod>2009-03-06T09:58:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 688: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/06/supreme-court-ruling-raising-eyebrows/</loc>
		<lastmod>2009-03-06T01:31:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 687: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/05/state-juries-can-award-for-drug-injuries-supreme-court-rules/</loc>
		<lastmod>2009-03-05T19:53:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 686: Comments: 161 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/04/dead-mice-found-at-pca-plant/</loc>
		<lastmod>2009-03-04T19:43:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 685: Comments: 144 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/04/ppis-increase-risk-for-second-heart-attack-in-plavix-users/</loc>
		<lastmod>2009-03-04T19:42:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 684: Comments: 164 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/04/johnson-johnson-must-pay-for-misleading-doctors-on-risperdal/</loc>
		<lastmod>2009-03-04T14:05:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 683: Comments: 148 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/04/stanford-borrowed-more-than-1-billion-on-own-assets/</loc>
		<lastmod>2009-03-04T03:19:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 682: Comments: 151 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/04/fed-investigation-focuses-on-payments-made-to-emory-univ-professor/</loc>
		<lastmod>2009-03-04T02:54:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 681: Comments: 160 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/04/fda-urged-from-within-to-better-monitor-dietary-supplements/</loc>
		<lastmod>2009-03-04T02:05:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 680: Comments: 171 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/03/jj-settles-ortho-evra-patch-lawsuits-in-canada/</loc>
		<lastmod>2009-03-03T16:46:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 679: Comments: 161 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/03/fda-says-avodart-ads-are-misleading/</loc>
		<lastmod>2009-03-03T01:51:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 678: Comments: 168 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/02/whistleblower-suit-filed-against-amgen/</loc>
		<lastmod>2009-03-02T17:29:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 677: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/02/astrazeneca%e2%80%99s-seroquel-effectiveness-questioned/</loc>
		<lastmod>2009-03-02T17:26:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 676: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/27/astrazeneca-hid-seroquel-risks/</loc>
		<lastmod>2009-02-27T19:26:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 675: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/27/stomach-medication-may-cause-irreversible-movement-disorders/</loc>
		<lastmod>2009-02-27T19:25:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 674: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/27/ranbaxy-production-halted-because-it-falsified-data/</loc>
		<lastmod>2009-02-27T10:40:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 673: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/26/hrt-could-lead-to-melanoma/</loc>
		<lastmod>2009-02-26T15:08:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 672: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/25/oral-contraceptives-may-be-linked-to-breast-cancer/</loc>
		<lastmod>2009-02-25T16:54:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 671: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/25/seizure-drug-could-lead-to-blood-disorder/</loc>
		<lastmod>2009-02-25T03:17:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 670: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/25/cuomo-subpoenas-merck-schering-plough-on-vytorin-records/</loc>
		<lastmod>2009-02-25T02:52:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 669: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/24/fda-says-not-including-dr-in-panel-was-a-mistake/</loc>
		<lastmod>2009-02-24T19:54:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 668: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/24/epilepsy-drug-causes-blood-disorder-says-fda/</loc>
		<lastmod>2009-02-24T19:51:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 667: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/23/vaccine-manufacturers%e2%80%99-lawsuit-immunity-questioned/</loc>
		<lastmod>2009-02-23T20:27:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 666: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/20/lawmaker-seeks-additional-vytorin-documents/</loc>
		<lastmod>2009-02-20T16:39:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 665: Comments: 27 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/20/outsourcing-of-clinical-trials-raises-concerns/</loc>
		<lastmod>2009-02-20T16:38:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 664: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/20/fed-accuses-scios-seeks-damages-for-natrecor-off-label-use/</loc>
		<lastmod>2009-02-20T16:37:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 663: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/20/raptiva-linked-to-rare-brain-infection/</loc>
		<lastmod>2009-02-20T11:29:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 662: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/20/pfizer-finds-way-around-chantix-side-effects/</loc>
		<lastmod>2009-02-20T01:34:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 661: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/18/arthritis-drugs-could-lead-to-shingles/</loc>
		<lastmod>2009-02-18T19:44:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 660: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/16/federal-board-will-compare-drug-treatments/</loc>
		<lastmod>2009-02-16T13:49:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 659: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/13/spain-halts-gardasil-after-two-girls-fall-ill/</loc>
		<lastmod>2009-02-13T13:10:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 658: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/13/one-in-seven-suffer-adverse-drug-reaction-at-hospital/</loc>
		<lastmod>2009-02-13T00:42:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 657: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/11/pneumonia-risk-for-those-with-copd/</loc>
		<lastmod>2009-02-11T16:05:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 656: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/10/pfizer-to-disclose-payments-made-to-doctors-researchers/</loc>
		<lastmod>2009-02-10T17:21:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 655: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/10/bayer-settles-charges-over-yaz-ads/</loc>
		<lastmod>2009-02-10T16:00:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 654: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/09/fda-and-cdc-study-dramatic-rise-in-opioid-overdoses/</loc>
		<lastmod>2009-02-09T13:49:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 653: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/06/ethex-expands-recall-on-defective-medicines/</loc>
		<lastmod>2009-02-06T14:39:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 652: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/06/kv-pharmaceutical-co-issues-fourth-recall-in-three-months/</loc>
		<lastmod>2009-02-06T03:26:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 650: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/05/study-shows-combination-of-2-drugs-worsen-colon-cancer/</loc>
		<lastmod>2009-02-05T17:19:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 649: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/05/fda-reviews-xigris-bleeding-risk/</loc>
		<lastmod>2009-02-05T17:18:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 648: Comments: 150 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/04/celebrex-ibuprofen-other-nsaids-linked-to-heart-disease-and-death/</loc>
		<lastmod>2009-02-04T20:00:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 647: Comments: 154 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/03/gardasil-complications-arise-in-young-girls/</loc>
		<lastmod>2009-02-03T16:38:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 646: Comments: 143 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/03/judge-sends-drug-counterfeiter-dietary-supplement-ceo-to-prison/</loc>
		<lastmod>2009-02-03T13:49:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 643: Comments: 162 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/30/texas-woman-files-suit-against-digitek-after-double-dose-death/</loc>
		<lastmod>2009-01-30T12:47:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 642: Comments: 173 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/29/massive-lots-of-pills-recalled-because-they-were-manufactured-under-poor-conditions/</loc>
		<lastmod>2009-01-29T20:04:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 641: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/29/eli-lilly%e2%80%99s-lawsuits-over-zyprexa-not-over/</loc>
		<lastmod>2009-01-29T17:39:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 640: Comments: 140 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/29/fda-warns-against-another-dietary-supplement-with-dangerous-undeclared-drug/</loc>
		<lastmod>2009-01-29T00:44:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 639: Comments: 149 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/28/pfizer-settles-bextra-investigation-for-23-billion/</loc>
		<lastmod>2009-01-28T20:13:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 638: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/27/heartburn-drugs-genetics-may-affect-plavix-effectiveness/</loc>
		<lastmod>2009-01-27T19:23:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 637: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/23/gao-report-cites-fda-weaknesses/</loc>
		<lastmod>2009-01-23T19:24:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 636: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/23/lilly-pleads-guilty-over-zyprexa-marketing/</loc>
		<lastmod>2009-01-23T12:58:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 634: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/22/steroids-could-stunt-growth-not-help-wheezing-children/</loc>
		<lastmod>2009-01-22T17:58:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 633: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/22/negative-clinical-trials-rarely-get-published/</loc>
		<lastmod>2009-01-22T16:28:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 632: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/21/non-drug-ingredients-in-medicines-harmful-to-preemies/</loc>
		<lastmod>2009-01-21T16:16:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 631: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/21/children-being-given-too-many-prescriptions-german-study-finds/</loc>
		<lastmod>2009-01-21T13:23:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 630: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/19/fda-alerts-public-about-topical-anesthetics/</loc>
		<lastmod>2009-01-19T23:12:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 629: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/15/lilly-will-pay-record-settlement-over-zyprexa-marketing/</loc>
		<lastmod>2009-01-15T21:30:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 628: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/15/newer-antipsychotic-drugs-not-any-safer/</loc>
		<lastmod>2009-01-15T16:56:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 627: Comments: 187 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/15/glaxo-may-have-misled-on-avandia/</loc>
		<lastmod>2009-01-15T01:00:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 626: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/14/canadian-botox-labels-to-contain-new-risks/</loc>
		<lastmod>2009-01-14T16:01:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 625: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/13/fda-allows-drugmakers-to-distribute-articles-describing-off-label-uses/</loc>
		<lastmod>2009-01-13T21:18:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 624: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/13/vicks-vaporub-harmful-to-young-children/</loc>
		<lastmod>2009-01-13T12:30:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 622: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/12/fda-neglects-to-consider-financial-bias-in-approvals/</loc>
		<lastmod>2009-01-12T21:20:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 621: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/12/gardasil-approval-for-older-women-delayed/</loc>
		<lastmod>2009-01-12T12:13:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 620: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/09/drug-safety-crusader-appointed-to-fda/</loc>
		<lastmod>2009-01-09T15:50:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 619: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/09/anti-psychotics-a-lethal-risk-for-alzheimers-patients/</loc>
		<lastmod>2009-01-09T12:38:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 618: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/08/brazilian-diet-pills-pose-serious-health-risks/</loc>
		<lastmod>2009-01-08T15:38:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 617: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/07/use-caution-when-giving-children-cold-medicine/</loc>
		<lastmod>2009-01-07T09:21:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 616: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/07/merck-seeks-fda-approval-of-gardasil-use-for-men/</loc>
		<lastmod>2009-01-07T09:20:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 615: Comments: 151 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/06/drug-sponsored-novelties-a-thing-of-the-past/</loc>
		<lastmod>2009-01-06T21:17:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 614: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/06/tendon-injuries-from-overprescribed-antibiotics-finally-getting-attention/</loc>
		<lastmod>2009-01-06T00:26:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 613: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/05/fosamax-may-cause-jawbone-death/</loc>
		<lastmod>2009-01-05T16:46:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 612: Comments: 186 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/02/duragesic-pain-relief-patches-recalled-due-to-leak/</loc>
		<lastmod>2009-01-02T18:51:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 611: Comments: 172 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/02/osteoporosis-drugs-may-cause-esophageal-cancer/</loc>
		<lastmod>2009-01-02T18:49:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 610: Comments: 149 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/02/defective-drug-subject-to-recall/</loc>
		<lastmod>2009-01-02T02:15:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 609: Comments: 165 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/31/cosmetic-treatment-results-in-birth-defects/</loc>
		<lastmod>2008-12-31T14:19:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 608: Comments: 146 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/31/gadolinium-contrast-agent-approved-for-mra-use/</loc>
		<lastmod>2008-12-31T02:15:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 607: Comments: 175 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/30/fda-tells-actavis-to-shut-down-plants/</loc>
		<lastmod>2008-12-30T16:54:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 606: Comments: 191 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/30/harvard-researcher-tied-to-money-from-anti-aging-supplement-maker/</loc>
		<lastmod>2008-12-30T02:44:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 605: Comments: 172 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/26/older-patients-who-mix-drugs-at-risk/</loc>
		<lastmod>2008-12-26T22:23:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 604: Comments: 158 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/24/fda-says-humira-ad-is-misleading/</loc>
		<lastmod>2008-12-24T11:00:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 603: Comments: 166 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/24/single-lot-of-hydromorphone-hcl-2-mg-tablets-recalled/</loc>
		<lastmod>2008-12-24T10:58:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 602: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/24/hedge-fund-managers-who-invested-heavily-in-madoff-sued-by-investors/</loc>
		<lastmod>2008-12-24T04:31:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 601: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/24/weight-loss-drugs-have-undeclared-active-ingredients-fda-warns/</loc>
		<lastmod>2008-12-24T04:05:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 600: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/23/fraud-investigation-results-in-nemeroff-removal-as-chair/</loc>
		<lastmod>2008-12-23T16:23:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 599: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/23/journal-that-published-wyeth-articles-will-probe-senate-claims/</loc>
		<lastmod>2008-12-23T02:41:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 598: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/23/avastin-tied-to-eye-injuries/</loc>
		<lastmod>2008-12-23T02:18:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 597: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/22/whistle-blower-claims-against-sanofi-aventis-dismissed/</loc>
		<lastmod>2008-12-22T20:58:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 596: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/19/astrazeneca-investigated-in-nobel-prize-case/</loc>
		<lastmod>2008-12-19T16:15:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 595: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/19/canada-releases-new-safety-information-for-tarceva/</loc>
		<lastmod>2008-12-19T16:14:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 594: Comments: 138 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/18/fda-requires-heart-risk-tests-for-new-diabetic-drugs/</loc>
		<lastmod>2008-12-18T16:36:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 593: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/18/fda-requires-suicide-risk-warning-on-epilepsy-medication/</loc>
		<lastmod>2008-12-18T09:22:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 592: Comments: 31 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/18/fda-adds-stern-warning-to-colonoscopy-pills/</loc>
		<lastmod>2008-12-18T09:20:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 591: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/18/case-made-for-public-funding-of-clinical-trials/</loc>
		<lastmod>2008-12-18T02:50:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 590: Comments: 24 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/18/fda-report-finds-new-rx-info-from-pharmacies-confusing/</loc>
		<lastmod>2008-12-18T02:38:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 589: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/16/sex-life-affected-by-anti-depressants-more-than-once-thought/</loc>
		<lastmod>2008-12-16T23:25:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 588: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/16/wyeth-hired-firm-to-develop-reports-on-premarin-prempro/</loc>
		<lastmod>2008-12-16T04:35:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 587: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/12/cdc-reports-on-heparin-contamination/</loc>
		<lastmod>2008-12-12T17:15:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 586: Comments: 44 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/12/visicol-and-osmoprep-get-black-box-warnings-for-kidney-injury/</loc>
		<lastmod>2008-12-12T17:12:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 585: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/12/avandia-actos-linked-to-high-risk-of-bone-fractures/</loc>
		<lastmod>2008-12-12T05:52:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 584: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/12/bar-code-error-leads-to-recall-of-injection/</loc>
		<lastmod>2008-12-12T05:40:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 583: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/11/fda-panel-considers-asthma-drug-risks/</loc>
		<lastmod>2008-12-11T16:46:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 582: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/10/safe-dosage-guidelines-on-pseudoephedrine-needed/</loc>
		<lastmod>2008-12-10T02:28:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 581: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/10/cvs-sued-rite-aid-settles-on-charges-they-sold-expired-products-again/</loc>
		<lastmod>2008-12-10T01:56:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 580: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/09/starcaps-dietary-supplements-recalled/</loc>
		<lastmod>2008-12-09T17:06:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 579: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/09/byetta-review-delayed/</loc>
		<lastmod>2008-12-09T17:04:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 578: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/08/asthma-drug-risks-get-fda-attention/</loc>
		<lastmod>2008-12-08T13:15:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 577: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/05/seroquel-marketing-criticized-by-fda/</loc>
		<lastmod>2008-12-05T14:20:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 576: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/05/woman-claims-orthoevra-patch-responsible-for-blood-clots/</loc>
		<lastmod>2008-12-05T14:05:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 575: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/05/trasylol-studies-nearly-condemn-drug-on-international-markets/</loc>
		<lastmod>2008-12-05T03:22:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 574: Comments: 134 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/04/tamoxifen-breast-cancer-drug-may-cause-tumors-to-spread/</loc>
		<lastmod>2008-12-04T18:02:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 573: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/04/new-report-says-generic-heart-drugs-just-as-good-as-designer-counterparts/</loc>
		<lastmod>2008-12-04T01:52:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 572: Comments: 217 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/03/aggressive-drug-marketing-criticized/</loc>
		<lastmod>2008-12-03T23:40:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 571: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/03/tinzaparin-dangerous-for-the-elderly/</loc>
		<lastmod>2008-12-03T23:28:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 570: Comments: 212 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/03/antibiotics-leading-cause-of-drug-induced-liver-injury/</loc>
		<lastmod>2008-12-03T16:23:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 569: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/02/epilepsy-drug-valproate-linked-to-autism-in-babies-born-to-mothers-on-the-drug-while-pregnant/</loc>
		<lastmod>2008-12-02T15:02:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 568: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/02/eli-lilly-pulls-application-to-use-cymbalta-for-pain/</loc>
		<lastmod>2008-12-02T01:56:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 567: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/01/cedax-side-effects-risks-downplayed-in-marketing-fda-warning-letter-says/</loc>
		<lastmod>2008-12-01T13:37:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 566: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/28/chantix-champix-woes-continue-in-uk/</loc>
		<lastmod>2008-11-28T13:39:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 565: Comments: 26 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/26/supplements-recalled-for-potentially-deadly-ingredients/</loc>
		<lastmod>2008-11-26T16:17:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 564: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/26/fda-drug-side-effects-hotline-considered-for-tv-ads/</loc>
		<lastmod>2008-11-26T15:38:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 563: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/26/epilepsy-drugs-linked-to-skin-problems-for-asians/</loc>
		<lastmod>2008-11-26T01:49:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 562: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/25/antidepressants-prozac-and-paxil-linked-to-heart-birth-defects/</loc>
		<lastmod>2008-11-25T18:08:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 561: Comments: 219 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/25/more-avandia-side-effects-heart-attack-risk-of-death/</loc>
		<lastmod>2008-11-25T17:59:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 560: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/24/combo-therapy-warning-issued-for-mabcampath-other-leukemia-drugs/</loc>
		<lastmod>2008-11-24T18:12:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 559: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/24/unapproved-drugs-unknowingly-used-by-millions/</loc>
		<lastmod>2008-11-24T16:52:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 558: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/21/verdict-in-accutane-lawsuits-over-inflammatory-bowel-disease/</loc>
		<lastmod>2008-11-21T16:59:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 557: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/21/drugs-heart-risks-side-effects-to-be-considered-by-fda/</loc>
		<lastmod>2008-11-21T16:39:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 556: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/21/lawmaker-wants-heparin-investigation/</loc>
		<lastmod>2008-11-21T16:11:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 555: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/21/more-research-requested-on-antipsychotics-in-children/</loc>
		<lastmod>2008-11-21T02:48:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 554: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/21/nevada-sues-wyeth-and-pfizer-for-deception-over-hormone-treatment/</loc>
		<lastmod>2008-11-21T02:31:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 553: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/20/three-actavis-facilities-face-closure/</loc>
		<lastmod>2008-11-20T03:40:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 552: Comments: 24 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/19/avastin-black-box-warning-recommended/</loc>
		<lastmod>2008-11-19T23:20:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 551: Comments: 183 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/18/pediatric-warnings-for-zyprexa-lamasil-recommended-by-fda-staff/</loc>
		<lastmod>2008-11-18T17:06:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 550: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/14/cvs-accused-of-pushing-expensive-drugs/</loc>
		<lastmod>2008-11-14T17:42:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 549: Comments: 227 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/14/acne-cream-infected-with-bacteria-recalled-at-three-stores/</loc>
		<lastmod>2008-11-14T14:40:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 548: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/14/avandia-fails-to-prevent-plaque-build-up-problems-mount/</loc>
		<lastmod>2008-11-14T02:01:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 547: Comments: 211 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/13/vytorin-cancer-risk-debated/</loc>
		<lastmod>2008-11-13T23:57:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 546: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/13/gardasil-mandates-opposed/</loc>
		<lastmod>2008-11-13T04:23:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 545: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/13/second-heart-attack-death-twice-as-likely-if-taking-ibuprofen-celebrex/</loc>
		<lastmod>2008-11-13T04:12:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 544: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/12/beta-blockers-in-non-heart-surgery-questioned/</loc>
		<lastmod>2008-11-12T22:35:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 543: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/12/off-label-prescriptions-should-be-disclosed-to-patients-by-doctors/</loc>
		<lastmod>2008-11-12T22:30:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 542: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/12/plavix-heatburn-drugs-mixed-may-cause-heart-attack-or-stroke/</loc>
		<lastmod>2008-11-12T22:27:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 541: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/12/gas-relief-drops-subject-of-recall/</loc>
		<lastmod>2008-11-12T00:13:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 540: Comments: 28 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/11/chantix-linked-to-10-british-suicides/</loc>
		<lastmod>2008-11-11T12:21:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 539: Comments: 214 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/11/ethex-recalls-more-generic-drugs-for-overdose-risk/</loc>
		<lastmod>2008-11-11T12:17:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 538: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/10/big-pharma-liable-for-generic-injuries-too/</loc>
		<lastmod>2008-11-10T22:41:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 537: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/07/new-study-explains-how-hiv-vaccine-increased-infection/</loc>
		<lastmod>2008-11-07T17:15:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 536: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/07/contaminated-heparin-seized-by-fda/</loc>
		<lastmod>2008-11-07T17:09:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 535: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/07/fluoride-debate-continues/</loc>
		<lastmod>2008-11-07T15:57:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 534: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/06/interest-grows-in-obamas-recommendation-for-head-of-fda/</loc>
		<lastmod>2008-11-06T23:19:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 533: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/06/fen-phen-causes-lasting-damage/</loc>
		<lastmod>2008-11-06T15:36:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 532: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/06/minnesota-joins-states-in-zyprexa-suit/</loc>
		<lastmod>2008-11-06T01:36:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 531: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/05/vytorin-marketing-probed/</loc>
		<lastmod>2008-11-05T18:28:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 530: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/05/new-byetta-version-data-rejected-by-fda/</loc>
		<lastmod>2008-11-05T18:25:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 529: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/04/fda-warns-generic-drug-maker-caraco-pharmaceutical-laboratories/</loc>
		<lastmod>2008-11-04T14:23:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 528: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/04/aspirin-plant-closing-sign-of-troubling-times/</loc>
		<lastmod>2008-11-04T01:25:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 527: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/03/preemption-case-to-be-heard-today-over-amputee-botched-drug-injection/</loc>
		<lastmod>2008-11-03T15:33:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 526: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/31/avandia-linked-to-liver-failure/</loc>
		<lastmod>2008-10-31T14:49:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 525: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/31/patients-on-sedative-propofol-at-risk/</loc>
		<lastmod>2008-10-31T13:18:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 524: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/31/probe-finds-dissent-at-fda-over-pharmaceuticals-immunity-from-lawsuits/</loc>
		<lastmod>2008-10-31T02:30:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 523: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/30/another-pml-case-linked-to-tysabri/</loc>
		<lastmod>2008-10-30T16:43:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 522: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/29/link-between-osteoporosis-drugs-and-heart-side-effect-made/</loc>
		<lastmod>2008-10-29T23:35:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 521: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/29/bayer-warned-on-aspirin-products/</loc>
		<lastmod>2008-10-29T17:21:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 520: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/29/gardasil-gets-vote-of-confidence-but-not-from-everyone/</loc>
		<lastmod>2008-10-29T02:45:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 519: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/28/diabetes-drugs-more-expensive-perhaps-not-more-effective/</loc>
		<lastmod>2008-10-28T15:53:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 518: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/27/supreme-court-to-hear-preemption-cases-to-affect-future-drug-lawsuits/</loc>
		<lastmod>2008-10-27T15:36:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 517: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/24/tysabri-side-effects-concern-weakens-sales/</loc>
		<lastmod>2008-10-24T16:07:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 516: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/24/chantix-heparin-spur-record-number-of-adverse-reaction-reports/</loc>
		<lastmod>2008-10-24T01:33:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 515: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/23/chantix-side-effects-reports-prompt-fda-review/</loc>
		<lastmod>2008-10-23T14:29:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 514: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/23/latest-crib-recall-shows-cpsc-focus-on-older-products/</loc>
		<lastmod>2008-10-23T02:15:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 513: Comments: 225 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/23/chantix-sales-way-off-last-years-pace-lipitor-slow-too/</loc>
		<lastmod>2008-10-23T00:41:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 512: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/22/safety-of-biological-drugs-questioned/</loc>
		<lastmod>2008-10-22T15:01:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 511: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/21/infant-vaccines-linked-to-asthma/</loc>
		<lastmod>2008-10-21T16:31:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 510: Comments: 27 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/20/gardasil-marketing-questioned-as-sales-drop/</loc>
		<lastmod>2008-10-20T22:56:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 509: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/20/prescription-opiates-dangerous-for-kids/</loc>
		<lastmod>2008-10-20T14:31:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 508: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/17/bextra-celebrex-lawsuits-settlements-to-come/</loc>
		<lastmod>2008-10-17T15:02:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 507: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/17/risks-highlighted-in-updated-raptiva-label/</loc>
		<lastmod>2008-10-17T14:02:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 506: Comments: 26 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/17/oversized-drugs-recalled/</loc>
		<lastmod>2008-10-17T01:50:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 505: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/16/vytorin-lawsuit-to-be-filed-by-new-haven/</loc>
		<lastmod>2008-10-16T16:38:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 504: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/15/risks-from-vioxx-linger-after-treatment-stops/</loc>
		<lastmod>2008-10-15T22:01:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 503: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/15/byetta-problems-weigh-on-amylin/</loc>
		<lastmod>2008-10-15T16:55:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 502: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/15/johnson-johnson-pays-millions-to-settle-ortho-evra-cases/</loc>
		<lastmod>2008-10-15T01:37:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 501: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/14/drug-company-political-donations-no-longer-favor-republicans/</loc>
		<lastmod>2008-10-14T18:02:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 500: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/13/fda-pushed-for-limits-on-kids-cold-drugs/</loc>
		<lastmod>2008-10-13T11:56:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 499: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/10/gardasil-hpv-cervical-cancer-vaccine-given-to-25-percent-of-us-girls/</loc>
		<lastmod>2008-10-10T14:21:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 498: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/10/canada-investigates-5-botox-deaths-more-injuries/</loc>
		<lastmod>2008-10-10T12:26:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 497: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/10/georgia-lawsuit-aimed-at-thimerosal/</loc>
		<lastmod>2008-10-10T00:13:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 496: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/09/pfizer-accused-of-suppressing-neurontin-study/</loc>
		<lastmod>2008-10-09T23:37:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 495: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/09/eli-lilly-joins-ranks-of-those-who-illegally-marketed-a-drug/</loc>
		<lastmod>2008-10-09T00:16:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 494: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/03/fda-refuses-to-ban-potentially-dangerous-kids-cold-medicines/</loc>
		<lastmod>2008-10-03T16:18:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 493: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/02/paxil-lawsuit-settle-40-million/</loc>
		<lastmod>2008-10-02T16:36:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 492: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/01/new-gardasil-requirement-for-us-citizenship-protested-by-advocates/</loc>
		<lastmod>2008-10-01T16:46:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 491: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/01/warfarin-linked-to-increased-bleeding-in-brain/</loc>
		<lastmod>2008-10-01T16:36:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 490: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/01/cephalon-will-pay-for-its-marketing/</loc>
		<lastmod>2008-10-01T16:30:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 489: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/30/strict-heparin-rules-needed-at-hospitals-regulators-say/</loc>
		<lastmod>2008-09-30T15:40:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 488: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/30/canadian-woman-accuses-gardasil-doesnt-do-enough-to-warn-girls-of-side-effects/</loc>
		<lastmod>2008-09-30T03:40:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 487: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/29/anemia-drugs-linked-to-deaths-in-stroke-patients/</loc>
		<lastmod>2008-09-29T14:22:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 486: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/26/inflammatory-eye-disease-caused-by-bisphosphonates-osteoporosis-drugs/</loc>
		<lastmod>2008-09-26T13:47:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 485: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/26/antidepressants-harmful-to-sperm/</loc>
		<lastmod>2008-09-26T09:06:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 484: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/25/tysabri-pml-patients-update/</loc>
		<lastmod>2008-09-25T21:50:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 483: Comments: 203 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/24/fda-cracks-down-on-unapproved-drugs/</loc>
		<lastmod>2008-09-24T16:49:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 482: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/24/tarceva-warning-label-updated-following-two-deaths-from-liver-failure/</loc>
		<lastmod>2008-09-24T16:46:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 481: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/23/drug-overdose-deaths-up/</loc>
		<lastmod>2008-09-23T17:18:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 480: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/23/most-drugs-prescribed-to-children-shouldnt-be/</loc>
		<lastmod>2008-09-23T02:01:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 479: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/22/denture-cream-may-cause-hypocupremia-and-neurologic-disease/</loc>
		<lastmod>2008-09-22T13:48:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 478: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/22/clinical-trials-improved-by-quality-assurance-programs/</loc>
		<lastmod>2008-09-22T13:09:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 477: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/19/cancer-drug-linked-to-leukemia/</loc>
		<lastmod>2008-09-19T16:25:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 476: Comments: 30 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/18/gardasil-to-be-forced-on-immigrants/</loc>
		<lastmod>2008-09-18T15:44:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 475: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/18/vytorin-analysis-defended/</loc>
		<lastmod>2008-09-18T15:36:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 473: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/17/old-and-unwanted-drug-disposal-mystery-lingers/</loc>
		<lastmod>2008-09-17T17:30:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 474: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/17/generic-drug-imports-from-ranbaxy-laboratories-banned-by-fda/</loc>
		<lastmod>2008-09-17T17:03:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 472: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/16/new-antipsychotics-side-effects-put-youth-at-risk/</loc>
		<lastmod>2008-09-16T17:33:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 471: Comments: 207 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/15/viagra-online-ad-campaigns-gets-pfizer-noticed/</loc>
		<lastmod>2008-09-15T15:18:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 470: Comments: 258 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/12/rituxan-death-sparks-new-warning/</loc>
		<lastmod>2008-09-12T14:16:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 469: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/11/hormones-increase-gerd-risk-in-women/</loc>
		<lastmod>2008-09-11T23:28:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 468: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/11/fda-puts-oxycontin-cymbalta-on-watch-list-for-adverse-reactions/</loc>
		<lastmod>2008-09-11T21:18:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 467: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/11/journals-med-schools-fight-industry-influence/</loc>
		<lastmod>2008-09-11T13:36:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 466: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/10/ibuprofen-mars-cancer-screenings/</loc>
		<lastmod>2008-09-10T23:58:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 465: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/10/topamax-may-raise-uric-acid-levels/</loc>
		<lastmod>2008-09-10T14:51:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 464: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/10/byetta-bad-for-business-forbes-says/</loc>
		<lastmod>2008-09-10T14:20:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 463: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/09/vytorin-gets-some-relief-but-still-recommended-as-last-resort/</loc>
		<lastmod>2008-09-09T01:54:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 462: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/08/zyprexa-documents-unsealed-by-judge/</loc>
		<lastmod>2008-09-08T13:54:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 461: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/08/drugs-being-investigated-to-be-listed-by-fda/</loc>
		<lastmod>2008-09-08T13:39:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 460: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/05/vytorin-safety-investigation-widens/</loc>
		<lastmod>2008-09-05T15:11:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 459: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/05/arthritis-drugs-get-stronger-warnings-for-potentially-fatal-fungal-infections/</loc>
		<lastmod>2008-09-05T14:42:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 458: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/05/pfizer-remodels-its-lipitor-campaign/</loc>
		<lastmod>2008-09-05T12:47:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 457: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/03/vytorin-study-raises-ethical-questions/</loc>
		<lastmod>2008-09-03T16:45:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 456: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/03/gardasil-allergic-reactions-highest-among-kid-vaccines/</loc>
		<lastmod>2008-09-03T16:33:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 455: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/02/beware-sound-alike-drug-names/</loc>
		<lastmod>2008-09-02T14:48:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 454: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/29/chantix-side-effects-muted-with-sneaky-no-name-marketing/</loc>
		<lastmod>2008-08-29T14:56:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 453: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/28/vytorin-cancer-link-not-taken-seriously-enough/</loc>
		<lastmod>2008-08-28T14:28:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 452: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/27/glucose-therapy-could-be-dangerous-not-helpful/</loc>
		<lastmod>2008-08-27T19:48:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 451: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/27/four-more-byetta-deaths/</loc>
		<lastmod>2008-08-27T16:43:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 450: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/26/despite-warnings-antipsychotics-still-prescribed-to-elderly/</loc>
		<lastmod>2008-08-26T15:14:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 449: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/26/fda-wants-tougher-tysabri-warnings/</loc>
		<lastmod>2008-08-26T15:09:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 448: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/26/fda-will-issue-new-guidelines-for-childrens-cough-meds-could-pull-from-market/</loc>
		<lastmod>2008-08-26T01:58:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 447: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/25/viagra-cialis-levitra-get-amnesia-notice/</loc>
		<lastmod>2008-08-25T13:59:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 446: Comments: 24 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/21/vioxx-payments-begin-aug-28/</loc>
		<lastmod>2008-08-21T21:27:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 445: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/21/merck-study-was-ploy-to-sell-more-vioxx/</loc>
		<lastmod>2008-08-21T21:02:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 444: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/21/accutane-lawsuit-over-inflammatory-bowel-disease-mulled-over-in-appeals-court/</loc>
		<lastmod>2008-08-21T15:24:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 443: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/21/gardasil-not-always-worth-the-cost/</loc>
		<lastmod>2008-08-21T14:30:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 442: Comments: 26 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/20/fda-issues-byetta-warning-in-wake-of-two-deaths/</loc>
		<lastmod>2008-08-20T14:06:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 441: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/18/gardasil-linked-to-pancreas-disease/</loc>
		<lastmod>2008-08-18T16:36:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 440: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/18/ranbaxy-gets-approval-despite-investigation/</loc>
		<lastmod>2008-08-18T02:29:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 439: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/15/hrt-drug-tibolone-increases-stroke-risk-in-older-women/</loc>
		<lastmod>2008-08-15T13:25:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 438: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/14/adverse-reactions-to-antibiotics-send-140000-to-hospital-per-year/</loc>
		<lastmod>2008-08-14T16:09:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 437: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/13/alcoholism-drug-vivitrol-causes-severe-skin-reactions-gets-fda-warning/</loc>
		<lastmod>2008-08-13T12:16:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 436: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/13/michigan-woman-suffers-after-receiving-gardasil-shot/</loc>
		<lastmod>2008-08-13T02:14:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 435: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/13/reflux-drugs-tied-to-fractures/</loc>
		<lastmod>2008-08-13T01:20:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 433: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/12/fentanyl-patches-recalled-by-watson-laboratories/</loc>
		<lastmod>2008-08-12T12:13:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 432: Comments: 219 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/11/fda-warns-consumers-about-potential-problems-at-two-baltimore-pharmacies/</loc>
		<lastmod>2008-08-11T11:53:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 431: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/11/simvastatin-and-amiodarone-linked-to-muscle-injury/</loc>
		<lastmod>2008-08-11T11:50:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 430: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/08/vioxx-bextra-increase-stroke-risk/</loc>
		<lastmod>2008-08-08T12:40:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 429: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/08/cipro-side-effects-outlast-anthrax-attacks/</loc>
		<lastmod>2008-08-08T12:33:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 428: Comments: 27 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/07/baxters-drug-promo-misleading-fda-says/</loc>
		<lastmod>2008-08-07T14:20:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 426: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/06/fda-announces-disclosure-conflict-policy-updates/</loc>
		<lastmod>2008-08-06T23:44:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 425: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/06/wyeth-subject-to-further-subpoenas-in-wyeth-pricing-scandal/</loc>
		<lastmod>2008-08-06T23:24:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 424: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/06/ortho-biotech-recalls-oprocritr-epoetin-alfa-lot-number-p114942a/</loc>
		<lastmod>2008-08-06T15:51:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 423: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/06/after-actavis-generic-drug-recall-ceo-steps-down/</loc>
		<lastmod>2008-08-06T15:47:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 422: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/05/two-more-tysabri-patients-develop-brain-disease-biogen-idec-says/</loc>
		<lastmod>2008-08-05T07:04:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 421: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/05/actavis-totowa-announces-voluntary-recall-at-the-retail-level-of-all-drug-products-manufactured-at-its-little-falls-new-jersey-facility/</loc>
		<lastmod>2008-08-05T07:04:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 420: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/04/mirapex-lawsuit-over-compulsive-gambling-won/</loc>
		<lastmod>2008-08-04T14:48:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 419: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/01/fda-orders-amgen-to-change-anemia-drug-labels/</loc>
		<lastmod>2008-08-01T03:16:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 418: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/30/mirapex-controls-tremors-causes-odd-adverse-reaction/</loc>
		<lastmod>2008-07-30T23:24:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 417: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/30/novantrone-congestive-heart-failure-warning-issued-by-fda/</loc>
		<lastmod>2008-07-30T13:54:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 416: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/30/viapro-recalled-by-eg-labs-for-potentially-harmful-ingredient/</loc>
		<lastmod>2008-07-30T13:33:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 415: Comments: 31 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/29/fosamax-femur-fractures-a-growing-concern/</loc>
		<lastmod>2008-07-29T07:02:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 414: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/28/all-lots-of-rize-2-the-occasion-capsules-and-rose-4-her-capsules-recalled-by-jack-distribution-llc/</loc>
		<lastmod>2008-07-28T13:21:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 413: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/28/chantix-no-more-effective-than-nicotine-patch-for-long-term-smoking-cessation-study-shows/</loc>
		<lastmod>2008-07-28T11:45:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 412: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/28/genetic-tests-needed-before-ziagen-is-given/</loc>
		<lastmod>2008-07-28T01:02:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 411: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/25/dangerous-painkiller-fentanyl-responsible-for-1000-deaths-in-a-year/</loc>
		<lastmod>2008-07-25T14:22:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 410: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/25/potentially-dangerous-erectile-dysfunction-supplements-seized-by-fda/</loc>
		<lastmod>2008-07-25T13:48:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 408: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/25/cdc-declares-gardasil-safe/</loc>
		<lastmod>2008-07-25T00:36:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 406: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/23/alabama-digitex-lawsuit-filed-over-permanent-damage-caused-by-recalled-heart-drug/</loc>
		<lastmod>2008-07-23T11:31:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 404: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/22/topamax-birth-defects-a-risk-for-pregnant-epilepsy-and-migraine-patients/</loc>
		<lastmod>2008-07-23T11:26:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 405: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/23/woman-suffers-stroke-after-gardasil-shot/</loc>
		<lastmod>2008-07-23T01:08:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 403: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/21/sandoz-eye-drops-recalled-in-canada/</loc>
		<lastmod>2008-07-21T14:20:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 402: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/18/microbubble-contrast-agents-get-updated-warnings/</loc>
		<lastmod>2008-07-18T16:51:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 401: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/18/death-of-texas-twins-could-be-heparin-related/</loc>
		<lastmod>2008-07-18T03:25:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 400: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/16/justice-dept-cracking-down-on-ranbaxy/</loc>
		<lastmod>2008-07-16T20:55:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 399: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/16/genetech-stops-clinical-trial-of-avastin-combination/</loc>
		<lastmod>2008-07-16T01:47:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 398: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/15/roxane-laboratories-recalls-sodium-polystyrene-sulfonate-suspension/</loc>
		<lastmod>2008-07-15T07:02:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 395: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/14/fosamax-linked-to-femur-fracture/</loc>
		<lastmod>2008-07-14T23:35:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 397: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/14/avastin-and-sunitinib-malate-combined-linked-to-microangiopathic-hemolytic-anemia-maha/</loc>
		<lastmod>2008-07-14T14:49:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 396: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/14/american-psychiatric-association-questioned-over-drug-company-funding-conflicts-of-interest/</loc>
		<lastmod>2008-07-14T14:38:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 394: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/11/heparin-overdoses-in-texas-kill-second-baby/</loc>
		<lastmod>2008-07-11T13:09:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 393: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/11/epilepsy-drugs-suicide-warning-denied-by-fda-advisory-panel/</loc>
		<lastmod>2008-07-11T12:43:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 392: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/11/chantix-lawsuit-filed-by-widow-of-chantix-suicide-victim/</loc>
		<lastmod>2008-07-11T12:38:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 391: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/10/mirapex-lawsuit-filed-over-compulsive-gambling-caused-by-drug/</loc>
		<lastmod>2008-07-10T12:15:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 390: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/10/fda-changes-drug-application-response-letters/</loc>
		<lastmod>2008-07-10T12:01:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 388: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/10/antibiotics-need-stronger-black-box-warnings/</loc>
		<lastmod>2008-07-10T02:17:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 387: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/09/gardasil-side-effects-merck-responds-to-cdc-report/</loc>
		<lastmod>2008-07-09T16:35:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 386: Comments: 24 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/09/heparin-overdose-causes-infant-death-in-texas/</loc>
		<lastmod>2008-07-09T15:40:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 385: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/08/fda-wants-strongest-warning-on-epilepsy-drugs/</loc>
		<lastmod>2008-07-08T23:52:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 384: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/08/va-doctors-had-concerns-over-chantix-last-year/</loc>
		<lastmod>2008-07-08T23:46:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 383: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/08/cdc-releases-gardasil-side-effect-report/</loc>
		<lastmod>2008-07-08T23:37:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 382: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/08/lyrica-other-epilepsy-drugs-suicide-warnings-sought-by-fda/</loc>
		<lastmod>2008-07-08T08:09:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 381: Comments: 27 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/07/hpv-vaccine-gardasil-linked-to-teen-paralysis/</loc>
		<lastmod>2008-07-07T14:27:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 380: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/03/heparin-lawsuit-filed-by-parents-of-leukemia-patient/</loc>
		<lastmod>2008-07-03T16:42:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 379: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/02/family-says-pfizer-money-led-to-daughters-suicide/</loc>
		<lastmod>2008-07-02T20:09:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 378: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/02/rize-2-the-occasion-and-rose-4-her-capsules-recalled-for-potentially-dangerous-ingredients/</loc>
		<lastmod>2008-07-02T15:36:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 377: Comments: 24 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/02/avandia-side-effects-heart-attacks-cardiologist-urges-fda-to-test-diabetes-drugs-for-heart-risk/</loc>
		<lastmod>2008-07-02T14:10:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 376: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/01/gardasil-unsafe-for-older-women/</loc>
		<lastmod>2008-07-01T01:34:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 375: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/30/cellcept-warning-label-updated-for-progressive-multifocal-leukoencephalopathy-pml-risks/</loc>
		<lastmod>2008-06-30T16:50:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 374: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/30/avandia-heart-attacks-prompt-fda-to-consider-new-standards-for-diabetes-drugs/</loc>
		<lastmod>2008-06-30T16:07:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 373: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/27/stronger-warnings-for-aranesp-epogen-procrit-backed-by-europe/</loc>
		<lastmod>2008-06-27T12:56:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 372: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/27/big-pharma-really-knows-how-to-lobby/</loc>
		<lastmod>2008-06-27T02:25:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 371: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/26/canadians-warned-about-chantix-champix/</loc>
		<lastmod>2008-06-26T03:19:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 370: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/25/definity-and-optison-heart-imaging-agent-risks-require-more-studies/</loc>
		<lastmod>2008-06-25T15:36:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 368: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/23/definity-and-optison-side-effects-still-include-death-despite-warnings/</loc>
		<lastmod>2008-06-23T12:07:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 367: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/20/neurontin-side-effects-warning-by-neurologist-ignored/</loc>
		<lastmod>2008-06-20T12:22:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 366: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/20/chantix-suicide-risks-finally-to-be-revealed-to-veterans/</loc>
		<lastmod>2008-06-20T11:56:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 365: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/20/ru486-companion-drug-can-be-deadly/</loc>
		<lastmod>2008-06-20T01:54:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 364: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/19/enbrel-for-child-psoriasis-approval-recommended-by-fda-panel/</loc>
		<lastmod>2008-06-19T13:11:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 363: Comments: 30 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/18/fake-cancer-cures-get-fda-warning/</loc>
		<lastmod>2008-06-18T16:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 362: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/18/fda-china-offices-may-open-by-year-end/</loc>
		<lastmod>2008-06-18T16:44:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 361: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/17/iraq-afghanistan-vets-being-used-to-test-dangerous-drugs/</loc>
		<lastmod>2008-06-17T23:43:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 360: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/17/older-antipsychotics-linked-to-death-too/</loc>
		<lastmod>2008-06-17T23:19:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 359: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/17/legal-drugs-killing-more-than-illegal-in-florida/</loc>
		<lastmod>2008-06-17T22:07:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 358: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/17/motrin-blamed-for-causing-blindness/</loc>
		<lastmod>2008-06-17T21:50:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 357: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/17/morphine-tablets-recalled-for-overdose-risk/</loc>
		<lastmod>2008-06-17T07:12:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 356: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/16/chantix-side-effects-concerns-brushed-aside-last-year/</loc>
		<lastmod>2008-06-16T12:35:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 355: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/13/fda-to-outsource-drug-inspections-overseas/</loc>
		<lastmod>2008-06-13T14:44:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 354: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/13/sen-grassley-wants-more-info-on-paxil/</loc>
		<lastmod>2008-06-13T11:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 353: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/13/two-more-european-women-die-after-receiving-gardasil-vaccine/</loc>
		<lastmod>2008-06-13T03:51:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 351: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/12/pfizer-issues-warning-on-somavert/</loc>
		<lastmod>2008-06-12T04:27:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 350: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/12/avandia-trial-halted-because-of-deaths/</loc>
		<lastmod>2008-06-12T04:18:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 349: Comments: 29 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/11/ketek-fraudulent-clinical-trials-prove-fda-not-doing-its-job-congress-says/</loc>
		<lastmod>2008-06-11T17:38:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 347: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/10/ketek-fraud-doctor-and-others-barred-from-drug-trials/</loc>
		<lastmod>2008-06-11T11:23:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 348: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/10/adhd-patch-daytrana-recalled/</loc>
		<lastmod>2008-06-10T06:58:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 346: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/09/dangers-of-antipsychotic-drugs-for-children-pushed-aside-for-undisclosed-consulting-fees/</loc>
		<lastmod>2008-06-09T11:25:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 345: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/09/regranex-gel-increases-cancer-death-risk-for-diabetics-fda-warns/</loc>
		<lastmod>2008-06-09T11:08:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 344: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/09/epilepsy-drug-makers-face-more-scrutiny/</loc>
		<lastmod>2008-06-09T01:57:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 343: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/06/blinding-infections-from-renu-with-moistureloc-contact-lens-solutions-prompt-fda-review/</loc>
		<lastmod>2008-06-06T15:41:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 342: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/06/pfizer-defends-chantix-side-effects-and-suicides-says-drug-ok-for-mentally-ill/</loc>
		<lastmod>2008-06-06T15:35:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 341: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/06/arthritiscrohns-drugs-probed-for-link-to-childteen-cancer/</loc>
		<lastmod>2008-06-06T11:44:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 340: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/05/femur-fractures-in-fosamax-patients/</loc>
		<lastmod>2008-06-05T20:54:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 339: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/05/could-levitra-be-linked-to-amnesia/</loc>
		<lastmod>2008-06-05T00:44:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 338: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/04/acomplia-linked-to-five-deaths-in-uk/</loc>
		<lastmod>2008-06-04T13:08:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 337: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/04/botox-maker-allergan-seeks-fda-approval-for-eyelash-growth-treatment/</loc>
		<lastmod>2008-06-04T13:04:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 336: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/04/anti-rejection-drug-linked-to-diabetes/</loc>
		<lastmod>2008-06-04T01:48:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 335: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/03/erythropoietin-anemia-drugs-for-cancer-patients-may-speed-tumor-growth/</loc>
		<lastmod>2008-06-03T14:29:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 334: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/03/abbott-recalls-infant-formula-for-oxidation-may-cause-illness/</loc>
		<lastmod>2008-06-03T14:09:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 332: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/29/pfizer-will-blitz-media-on-chantix-pros/</loc>
		<lastmod>2008-06-02T15:02:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 331: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/29/truckers-bus-drivers-banned-from-using-chantix/</loc>
		<lastmod>2008-05-29T21:49:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 330: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/29/new-drug-labels-for-pregnant-women-proposed-by-fda/</loc>
		<lastmod>2008-05-29T16:44:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 329: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/28/even-john-mccain-traded-vytorin-for-generic-statin/</loc>
		<lastmod>2008-05-29T00:53:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 328: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/28/xiadafil-vip-tabs-recall-requested-by-fda/</loc>
		<lastmod>2008-05-29T00:47:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 327: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/27/chantix-linked-to-traffic-accidents/</loc>
		<lastmod>2008-05-27T22:37:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 326: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/27/antipsychotic-medications-dangerous-for-elderly-with-dementia/</loc>
		<lastmod>2008-05-27T14:16:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 325: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/23/pharmacy-mistakes-making-colorado-residents-sick/</loc>
		<lastmod>2008-05-23T12:31:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 324: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/23/chantix-banned-from-pilots-air-traffic-control/</loc>
		<lastmod>2008-05-23T01:24:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 323: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/23/merck-to-cough-up-58-million-for-deceptive-ad/</loc>
		<lastmod>2008-05-23T01:19:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 322: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/22/chantix-smoking-cessation-drug-banned-by-faa/</loc>
		<lastmod>2008-05-22T17:59:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 321: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/21/facial-filling-material-linked-to-painful-side-effects/</loc>
		<lastmod>2008-05-21T23:27:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 320: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/21/big-pharma-showered-minnesota-doctors-with-millions/</loc>
		<lastmod>2008-05-21T23:16:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 319: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/20/fda-warns-of-birth-defects-death-if-taking-transplant-drugs/</loc>
		<lastmod>2008-05-20T23:26:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 318: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/20/cardinal-mouthwash-recalled-expanded-by-hydrox-labs/</loc>
		<lastmod>2008-05-20T22:30:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 317: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/16/heparin-recalls-raise-costs/</loc>
		<lastmod>2008-05-20T17:28:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 316: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/16/migraine-medicines-cause-serotonin-syndrome/</loc>
		<lastmod>2008-05-16T21:15:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 315: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/15/heparin-shortage-disrupts-protocol-endangers-patients/</loc>
		<lastmod>2008-05-15T18:42:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 314: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/15/fda-finally-asks-for-more-money-for-overseeing-drug-safety/</loc>
		<lastmod>2008-05-15T16:58:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 313: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/14/politics-skews-heparin-probe/</loc>
		<lastmod>2008-05-14T23:06:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 312: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/14/bayer-trasylol-remains-removed-from-market/</loc>
		<lastmod>2008-05-14T22:34:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 311: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/14/thimerosal-autism-from-childhood-vaccines-has-parents-back-to-testify/</loc>
		<lastmod>2008-05-14T22:26:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 310: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/14/dutch-study-links-acrylamide-to-renal-cancer/</loc>
		<lastmod>2008-05-14T15:56:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 309: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/13/vytorin-faces-justice-department-investigation/</loc>
		<lastmod>2008-05-13T16:07:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 308: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/12/fentora-overdose-risks-lead-fda-panel-to-deny-expanded-use-recommendation/</loc>
		<lastmod>2008-05-12T07:12:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 307: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/09/wellbutrin-lawsuit-gets-class-action-status/</loc>
		<lastmod>2008-05-09T12:33:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 306: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/09/gardasil-researcher-speaks-out/</loc>
		<lastmod>2008-05-09T09:00:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 305: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/08/deadly-ortho-evra-side-effects-warrant-pulling-patch-from-market/</loc>
		<lastmod>2008-05-08T18:00:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 304: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/08/suicide-as-side-effects-to-singulair-chantix-tamiflu-accutane-and-more/</loc>
		<lastmod>2008-05-08T17:05:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 303: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/08/chantix-side-effects-suicide-depression/</loc>
		<lastmod>2008-05-08T16:27:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 302: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/08/china-baxter-point-fingers-in-heparin-debacle/</loc>
		<lastmod>2008-05-08T08:56:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 300: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/07/cardinal-health-mouthwash-recalled-by-hydrox-labs-for-b-cepacia-contamination/</loc>
		<lastmod>2008-05-07T07:00:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 301: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/06/debate-over-fentora-use/</loc>
		<lastmod>2008-05-06T22:54:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 299: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/06/ssri-antidepressants-linked-to-premature-births/</loc>
		<lastmod>2008-05-06T16:45:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 298: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/06/onj-fosamax-and-biofilms/</loc>
		<lastmod>2008-05-06T11:22:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 297: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/05/bextra-and-celebrex-lawsuits-settlements-negotiated-by-pfizer-finally/</loc>
		<lastmod>2008-05-05T13:52:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 296: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/02/enbrel-side-effects-get-black-box-warning-for-deadly-infections/</loc>
		<lastmod>2008-05-02T16:07:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 295: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/02/merck-warned-on-vaccine-plant/</loc>
		<lastmod>2008-05-02T11:09:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 294: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/01/total-body-supplements-hazardous-chromium-results-disclosed-by-fda/</loc>
		<lastmod>2008-05-01T17:42:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 293: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/01/pediatric-clinical-trials-dangerous-due-to-inappropriate-assessment-measurements/</loc>
		<lastmod>2008-05-01T17:20:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 292: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/30/fosamax-could-cause-atrial-fibrillation/</loc>
		<lastmod>2008-04-30T21:28:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 291: Comments: 24 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/30/hormone-replacement-therapy-hrt-increases-stroke-risk/</loc>
		<lastmod>2008-04-30T18:58:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 290: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/30/epilepsy-drug-dilantin-side-effects-include-higher-osteoporosis-risk/</loc>
		<lastmod>2008-04-30T18:43:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 289: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/29/cephalon-provigil-lawsuit-moved-to-pa/</loc>
		<lastmod>2008-04-29T21:59:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 288: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/29/blood-substitutes-faulted-in-study/</loc>
		<lastmod>2008-04-29T21:57:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 287: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/29/another-teenage-death-by-duragesic-pain-patch/</loc>
		<lastmod>2008-04-29T07:03:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 286: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/28/digitek-subject-of-class-i-recall/</loc>
		<lastmod>2008-04-28T16:15:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 285: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/28/baxter-ceo-and-fda-to-testify-over-contaminated-heparin/</loc>
		<lastmod>2008-04-28T14:27:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 284: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/28/78-trasylol-lawsuits-filed-over-kidney-damage-and-death/</loc>
		<lastmod>2008-04-28T12:02:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 283: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/25/heparin-deaths-us-blames-china/</loc>
		<lastmod>2008-04-25T17:07:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 282: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/25/fda-inspection-uncovers-49-problems-at-merck-vaccine-plant/</loc>
		<lastmod>2008-04-25T15:40:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 281: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/24/antipsychotic-drugs-cause-pneumonia-in-elderly-nursing-home-patients/</loc>
		<lastmod>2008-04-24T18:57:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 280: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/24/heparin-research-provides-clues-to-deadly-reactions/</loc>
		<lastmod>2008-04-24T15:20:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 279: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/23/heparin-recall-and-deaths-spark-more-criticism-of-fda-commissioner/</loc>
		<lastmod>2008-04-23T16:56:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 278: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/23/chinese-complete-tour-of-baxter-heparin-factory/</loc>
		<lastmod>2008-04-23T16:04:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 277: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/22/defective-heparin-in-11-other-countries/</loc>
		<lastmod>2008-04-22T22:09:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 276: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/22/are-observational-cancer-drugs-studies-biased/</loc>
		<lastmod>2008-04-22T19:17:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 275: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/22/fda-objects-to-viagra-advertising/</loc>
		<lastmod>2008-04-22T19:07:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 274: Comments: 27 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/21/firms-hired-by-drug-makers-to-conduct-clinical-trials-often-unregulated/</loc>
		<lastmod>2008-04-21T22:26:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 273: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/21/dangerous-diabetes-drug-avandia-gets-its-maker-more-heat-from-fda/</loc>
		<lastmod>2008-04-21T07:00:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 272: Comments: 128 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/18/ghostwritten-vioxx-articles-make-fdas-off-label-medical-article-plan-look-even-worse/</loc>
		<lastmod>2008-04-18T18:51:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 271: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/18/incontinence-drugs-may-cause-memory-problems-in-the-elderly/</loc>
		<lastmod>2008-04-18T17:08:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 270: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/18/alzheimers-drug-a-bust-for-elan-wyeth/</loc>
		<lastmod>2008-04-18T15:25:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 269: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/18/formaldehyde-exposure-increases-risk-of-lou-gehrigs-disease/</loc>
		<lastmod>2008-04-18T00:29:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 266: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/16/cymbalta-suicides-concealed-by-fda-side-effects-outweigh-the-benefits/</loc>
		<lastmod>2008-04-17T23:47:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 268: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/17/budeprion-xl-generic-wellbutrin-xl-not-as-effective-as-name-brand-research-shows/</loc>
		<lastmod>2008-04-17T23:47:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 267: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/17/fda-considers-new-way-to-test-experimental-drugs/</loc>
		<lastmod>2008-04-17T15:56:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 265: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/16/drugs-in-the-water-epa-takes-heat-at-public-senate-hearing/</loc>
		<lastmod>2008-04-16T18:38:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 264: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/16/merck-manipulated-vioxx-studies/</loc>
		<lastmod>2008-04-16T15:13:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 263: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/15/fda-set-to-open-branch-in-china/</loc>
		<lastmod>2008-04-15T15:19:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 262: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/14/cancer-drug-trials-ended-too-soon-to-be-ethical-or-safe/</loc>
		<lastmod>2008-04-14T18:16:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 261: Comments: 12 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/14/vytorin-makers-face-heat-over-meeting-minutes/</loc>
		<lastmod>2008-04-14T15:16:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 251: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/08/medication-mixups-and-adverse-reactions-effect-1-in-15-kids-hospitalized/</loc>
		<lastmod>2008-04-11T17:26:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 260: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/11/herbal-science-international-recalls-dangerous-dietary-supplements/</loc>
		<lastmod>2008-04-11T17:09:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 259: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/11/champixchantix-suicide-side-effect-in-canada/</loc>
		<lastmod>2008-04-11T16:31:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 258: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/11/easy-access-to-cold-medicine-sends-thousands-of-kids-to-the-er/</loc>
		<lastmod>2008-04-11T14:52:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 257: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/10/exubera-may-cause-lung-cancer/</loc>
		<lastmod>2008-04-10T15:55:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 256: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/10/cellcept-and-myfortic-under-fda-investigation-for-causing-progressive-multifocal-leukoencephalopathy/</loc>
		<lastmod>2008-04-10T15:15:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 255: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/10/relenza-another-unsafe-flu-medicine/</loc>
		<lastmod>2008-04-10T14:00:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 254: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/10/total-body-supplements-contain-hazardous-levels-of-selenium-fda-warns/</loc>
		<lastmod>2008-04-10T13:45:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 253: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/09/heparin-death-toll-exceeds-100/</loc>
		<lastmod>2008-04-09T15:37:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 252: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/08/payments-to-seroquel-study-author-questioned/</loc>
		<lastmod>2008-04-08T21:13:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 250: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/07/johnson-johnson-other-drug-makers-seek-protection-from-lawsuits/</loc>
		<lastmod>2008-04-07T13:36:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 249: Comments: 28 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/04/botox-may-cause-brain-damage/</loc>
		<lastmod>2008-04-04T18:41:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 248: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/04/antipsychotics-wont-help-alzheimers-patients/</loc>
		<lastmod>2008-04-04T16:08:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 247: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/03/relenza-gets-new-warnings/</loc>
		<lastmod>2008-04-03T15:49:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 246: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/03/chantix-suicide-risk-calls-for-black-box-warning/</loc>
		<lastmod>2008-04-03T13:18:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 245: Comments: 25 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/02/insurance-co-debate-vytorin-coverage/</loc>
		<lastmod>2008-04-02T13:15:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 244: Comments: 27 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/01/vytorin-and-zetia-study-results-cause-major-drop-in-shares/</loc>
		<lastmod>2008-04-01T17:16:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 243: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/01/high-dose-celebrex-risky/</loc>
		<lastmod>2008-04-01T15:45:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 242: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/31/statins-better-choice-than-vytorin-cardiology-docs-say/</loc>
		<lastmod>2008-03-31T15:38:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 241: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/31/combining-aspirin-and-ibuprofen-side-effects-could-cause-stroke/</loc>
		<lastmod>2008-03-31T15:35:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 239: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/28/more-bad-news-for-merck-and-fda-probes-singulair-safety-link/</loc>
		<lastmod>2008-03-28T17:52:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 240: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/28/fda-warns-total-body-supplements-cause-hair-loss-other-side-effects/</loc>
		<lastmod>2008-03-28T17:51:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 238: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/28/anti-hiv-drugs-linked-to-heart-attack/</loc>
		<lastmod>2008-03-28T15:56:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 237: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/28/regranex-linked-to-cancer-deaths/</loc>
		<lastmod>2008-03-28T15:39:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 236: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/27/unsafe-drug-recalls-linked-to-tight-fda-approval-deadlines/</loc>
		<lastmod>2008-03-27T17:01:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 235: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/27/free-drug-samples-cost-patients/</loc>
		<lastmod>2008-03-27T15:21:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 233: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/26/zyprexa-lawsuit-settled-for-15m/</loc>
		<lastmod>2008-03-27T15:09:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 234: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/26/european-countries-recall-heparin/</loc>
		<lastmod>2008-03-26T16:48:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 232: Comments: 24 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/26/oral-sodium-phosphate-kidney-damage-in-elderly/</loc>
		<lastmod>2008-03-26T16:26:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 231: Comments: 30 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/26/erectile-dysfunction-products-blue-steel-and-hero-may-pose-health-risks-fda-warns/</loc>
		<lastmod>2008-03-26T00:42:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 230: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/26/cholesterol-drug-vytorin-data-delay-means-more-heat-for-merck/</loc>
		<lastmod>2008-03-26T00:33:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 229: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/25/fda-denies-heparin-shortage/</loc>
		<lastmod>2008-03-25T16:50:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 228: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/24/baxter-anesthesia-drug-suprane-responsible-for-cardiac-arrest-in-children/</loc>
		<lastmod>2008-03-24T17:53:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 227: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/24/b-braun-issues-heparin-recall/</loc>
		<lastmod>2008-03-24T16:25:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 185: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/27/fdas-new-drug-plan-finally-puts-safety-first/</loc>
		<lastmod>2008-03-24T12:26:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 186: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/27/antidepressants-dubbed-useless-yet-again/</loc>
		<lastmod>2008-03-24T12:25:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 226: Comments: 26 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/21/fosamax-bone-fractures-rare-but-serious-side-effect-of-osteoporosis-drugs/</loc>
		<lastmod>2008-03-21T21:56:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 225: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/21/neupro-patches-recalled/</loc>
		<lastmod>2008-03-21T15:36:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 224: Comments: 26 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/21/american-health-packaging-recalls-heparin-as-part-of-broader-baxter-recall/</loc>
		<lastmod>2008-03-21T11:49:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 223: Comments: 7 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/20/counterfeiters-possibly-responsible-for-contaminated-heparin/</loc>
		<lastmod>2008-03-20T19:43:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 222: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/20/gardasil-cervical-cancer-vaccine-granted-priority-fda-review-to-expand-marketing/</loc>
		<lastmod>2008-03-20T18:33:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 221: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/19/fda-confirms-animal-cartilage-substance-in-tainted-heparin/</loc>
		<lastmod>2008-03-19T16:52:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 220: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/18/enbrel-gets-black-box-on-tuberculosis-infections/</loc>
		<lastmod>2008-03-18T19:22:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 219: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/18/spiriva-may-cause-stroke/</loc>
		<lastmod>2008-03-18T17:18:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 218: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/17/heparin-overdose-has-dennis-quaid-riled-up-about-medical-mistakes/</loc>
		<lastmod>2008-03-17T17:03:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 217: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/14/despite-heparin-injuries-and-deaths-drug-makers-stand-by-china/</loc>
		<lastmod>2008-03-14T14:40:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 216: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/14/ex-eli-lilly-drug-rep-exposes-sleazy-sales-tactics/</loc>
		<lastmod>2008-03-14T13:41:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 215: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/13/botox-injecting-poison-into-the-body/</loc>
		<lastmod>2008-03-13T20:14:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 214: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/13/new-fda-drug-evaluation-and-research-director-appointed/</loc>
		<lastmod>2008-03-13T20:12:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 213: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/13/anemia-drug-dangers-for-cancer-patients-get-fda-attention/</loc>
		<lastmod>2008-03-13T20:12:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 212: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/13/prezista-linked-to-liver-injury/</loc>
		<lastmod>2008-03-13T16:55:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 211: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/12/tussionex-warning/</loc>
		<lastmod>2008-03-12T15:26:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 210: Comments: 10 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/11/drinking-water-polluted-with-drugs/</loc>
		<lastmod>2008-03-11T16:07:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 209: Comments: 24 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/10/fda-chief-accused-of-perjury-as-ketek-liver-damage-continues/</loc>
		<lastmod>2008-03-10T20:10:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 208: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/10/new-safety-information-added-to-anemia-drugs/</loc>
		<lastmod>2008-03-10T14:58:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 207: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/08/childhood-vaccine-settlement-leads-parents-to-speak-out/</loc>
		<lastmod>2008-03-08T11:44:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 206: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/08/contaminated-heparin-deaths-put-spotlight-on-fda-drug-safety-loopholes/</loc>
		<lastmod>2008-03-08T11:42:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 205: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/08/eli-lilly-hid-zyprexa-risks/</loc>
		<lastmod>2008-03-08T11:41:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 204: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/07/100-heparin-reactions-reported-in-germany/</loc>
		<lastmod>2008-03-07T15:32:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 203: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/07/fda-reviewing-asthma-drugs/</loc>
		<lastmod>2008-03-07T13:54:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 201: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/06/airborne-false-advertising-lawsuit-settled/</loc>
		<lastmod>2008-03-07T13:54:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 202: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/07/vioxx-settlement-passes-milestone/</loc>
		<lastmod>2008-03-07T13:54:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 200: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/06/government-concedes-in-childhood-vaccine-injury-case/</loc>
		<lastmod>2008-03-06T17:52:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 199: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/06/omniscan-lawsuit-filed-over-nsf-caused-by-gadolinium-contrast-dye/</loc>
		<lastmod>2008-03-06T17:51:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 198: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/06/leavitt-folds-on-ketek-documents-avoids-contempt-charge/</loc>
		<lastmod>2008-03-06T09:59:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 197: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/05/hormone-replacement-therapy-and-breast-cancer-risk/</loc>
		<lastmod>2008-03-05T17:32:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 196: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/05/supreme-court-deadlocks-rezulin-lawsuit-to-go-on/</loc>
		<lastmod>2008-03-05T10:13:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 195: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/04/tamiflu-may-cause-delirium-and-abnormal-behavior-leading-to-injury/</loc>
		<lastmod>2008-03-04T17:07:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 193: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/03/apire-supplements-recalled/</loc>
		<lastmod>2008-03-03T16:10:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 194: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/03/fentanyl-patches-recalled-by-actavis/</loc>
		<lastmod>2008-03-03T16:08:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 192: Comments: 357 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/29/spiriva-and-foradil-capsules-shouldnt-be-swallowed-fda-warns/</loc>
		<lastmod>2008-02-29T17:05:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 191: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/29/injectable-zyprexa-get-a-no-from-fda/</loc>
		<lastmod>2008-02-29T17:03:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 190: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/29/baxter-heparin-recall-finally-goes-forward/</loc>
		<lastmod>2008-02-29T17:01:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 189: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/28/tysabri-liver-injury-risk-prompts-warning-letter-to-physicians/</loc>
		<lastmod>2008-02-28T17:04:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 188: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/28/does-lipitor-make-women-stupid/</loc>
		<lastmod>2008-02-28T12:59:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 187: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/28/amgen-johnson-johnson-anemia-drugs-linked-to-blood-clots/</loc>
		<lastmod>2008-02-28T11:31:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 184: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/26/denture-cleaning-side-effects-prompt-fda-warnings/</loc>
		<lastmod>2008-02-26T17:10:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 183: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/25/avastin-approval-could-signal-change-at-fda/</loc>
		<lastmod>2008-02-25T17:07:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 182: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/22/baxter-clueless-in-heparin-debacle/</loc>
		<lastmod>2008-02-22T16:22:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 181: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/21/more-trasylol-troubles/</loc>
		<lastmod>2008-02-21T17:01:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 180: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/20/hrt-judgement-against-wyeth-cut-in-half-in-nevada/</loc>
		<lastmod>2008-02-20T16:23:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 179: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/20/lawmaker-assails-fda-over-drug-safety-record/</loc>
		<lastmod>2008-02-20T16:19:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 178: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/19/lipitor-alternatives-less-expensive-effective/</loc>
		<lastmod>2008-02-19T17:11:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 177: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/19/fda-inspected-wrong-plant-in-baxter-heparin-mess/</loc>
		<lastmod>2008-02-19T17:05:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 176: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/18/another-pain-patch-recall/</loc>
		<lastmod>2008-02-18T16:47:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 175: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/15/trasylol-blamed-for-22000-deaths/</loc>
		<lastmod>2008-02-15T15:38:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 174: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/14/defective-baxter-heparin-came-from-chinese-plant-never-inspected-by-fda/</loc>
		<lastmod>2008-02-14T16:45:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 173: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/14/vytorin-probe-gains-steam/</loc>
		<lastmod>2008-02-14T16:41:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 172: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/13/duregesic-patch-recalled-due-to-overdose-dangers/</loc>
		<lastmod>2008-02-13T16:20:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 171: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/12/baxter-heparin-problems-could-lead-to-shortage-of-vital-drug/</loc>
		<lastmod>2008-02-12T14:45:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 170: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/12/botox-warning/</loc>
		<lastmod>2008-02-12T14:41:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 169: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/12/puerto-rican-drug-factories-fail-on-safety/</loc>
		<lastmod>2008-02-12T14:39:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 168: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/11/icy-hot-recalled-following-burn-reports/</loc>
		<lastmod>2008-02-11T15:23:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 167: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/11/nucel-recalls-eye-drops-eyeear-wash/</loc>
		<lastmod>2008-02-11T15:22:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 166: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/08/tysabri-suspect-in-two-melanoma-cases/</loc>
		<lastmod>2008-02-08T16:03:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 165: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/07/deaths-end-drug-trials/</loc>
		<lastmod>2008-02-07T15:21:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 164: Comments: 14 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/07/plavix-a-dangerous-drug-to-quit/</loc>
		<lastmod>2008-02-07T10:46:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 163: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/06/fosamax-other-osteoporosis-drugs-linked-to-bone-necrosis/</loc>
		<lastmod>2008-02-06T13:55:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 162: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/05/fda-budget-increase-won%e2%80%99t-amount-to-much/</loc>
		<lastmod>2008-02-05T11:58:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 161: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/04/chantix-users-warned-on-suicide/</loc>
		<lastmod>2008-02-04T12:54:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 160: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/04/epilepsy-drugs-linked-to-suicide/</loc>
		<lastmod>2008-02-04T12:52:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 159: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/01/ketek-subpoenas-go-out/</loc>
		<lastmod>2008-02-01T13:35:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 158: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/01/suicide-warning-for-epilepsy-drugs/</loc>
		<lastmod>2008-02-01T13:30:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 157: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/31/avandia-study-leaked-to-glaxo/</loc>
		<lastmod>2008-01-31T14:49:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 156: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/31/hundreds-left-out-of-vioxx-settlement/</loc>
		<lastmod>2008-01-31T09:52:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 154: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/30/drug-mix-ups-can-be-tragic/</loc>
		<lastmod>2008-01-30T12:56:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 153: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/29/fosamax-lawsuit-ads-to-merck-woes/</loc>
		<lastmod>2008-01-29T16:43:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 152: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/29/connecticut-ag-goes-after-vytorin/</loc>
		<lastmod>2008-01-29T12:51:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 151: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/29/cold-medicines-send-thousands-of-kids-to-er/</loc>
		<lastmod>2008-01-29T11:52:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 150: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/28/ambien-dangers-highlighted-by-health-ledger-death-uk-fatalities/</loc>
		<lastmod>2008-01-28T15:51:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 149: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/28/celebrex-may-induce-arrhythmia-study-finds/</loc>
		<lastmod>2008-01-28T15:47:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 148: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/25/botox-kills-sixteen-sparks-calls-for-tougher-warnings/</loc>
		<lastmod>2008-01-25T17:02:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 147: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/25/leukine-sargramostim-liquid-formulation-of-drug-withdrawn-from-the-market/</loc>
		<lastmod>2008-01-25T17:00:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 146: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/24/vytorin-scripts-fall-after-study-finding-it-ineffective/</loc>
		<lastmod>2008-01-24T17:45:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 145: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/24/experimental-bowel-drug-entereg-poses-heart-risk/</loc>
		<lastmod>2008-01-24T17:43:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 144: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/23/are-otc-cough-medicines-worth-the-expense/</loc>
		<lastmod>2008-01-23T18:10:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 143: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/23/avandia-responsible-for-husbands-liver-problems-wife-says/</loc>
		<lastmod>2008-01-23T18:08:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 142: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/22/nexavar-raises-blood-pressure/</loc>
		<lastmod>2008-01-22T17:32:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 141: Comments: 27 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/22/champix-linked-to-second-suicide-in-uk-as-chantix-gets-suicide-warning-label-in-usa/</loc>
		<lastmod>2008-01-22T17:30:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 140: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/21/vioxx-settlement-tiff-resolved/</loc>
		<lastmod>2008-01-21T17:44:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 139: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/21/ortho-evra-patch-blood-clot-risk-information-updated/</loc>
		<lastmod>2008-01-21T17:42:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 138: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/21/chantix-gets-tougher-suicide-warning/</loc>
		<lastmod>2008-01-21T17:40:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 137: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/18/vytorin-cover-up-sparks-lawsuit/</loc>
		<lastmod>2008-01-18T16:59:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 136: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/18/nonprescription-cough-and-cold-medicine-not-for-kids-under-age-2/</loc>
		<lastmod>2008-01-18T16:54:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 135: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/17/manufacturers-of-antidepressants-only-report-positive-studies/</loc>
		<lastmod>2008-01-17T18:05:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 134: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/17/mistaking-edetate-calcium-disodium-for-edetate-disodium-can-be-deadly/</loc>
		<lastmod>2008-01-17T18:02:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 133: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/16/alli-weight-loss-drug-users-see-embarrassing-%e2%80%93-sometimes-dangerous-%e2%80%93-side-effects/</loc>
		<lastmod>2008-01-16T21:38:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 132: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/16/do-calcium-supplements-up-heart-attack-risk/</loc>
		<lastmod>2008-01-16T17:18:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 131: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/16/prilosec-may-prevent-anticlot-medicine-needed-by-stent-patients-from-working/</loc>
		<lastmod>2008-01-16T17:16:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 130: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/15/fda-drug-fast-track-program-scrutinized/</loc>
		<lastmod>2008-01-15T16:07:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 129: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/15/free-drug-samples-not-going-to-poor-turn-out-to-be-just-another-drug-co-marketing-scheme/</loc>
		<lastmod>2008-01-15T16:06:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 128: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/15/vytorin-cuts-cholesterol-but-causes-more-heart-attacks/</loc>
		<lastmod>2008-01-15T16:03:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 127: Comments: 17 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/14/merck-vioxx-settlement-challenged/</loc>
		<lastmod>2008-01-14T17:36:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 126: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/14/cialis-approved-for-daily-use-a-catastrophe-waiting-to-happen/</loc>
		<lastmod>2008-01-14T17:35:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 124: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/11/judge-calls-celebrex-evidence-unreliable/</loc>
		<lastmod>2008-01-14T10:26:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 125: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/11/former-enbrel-reps-say-amgen-marketing-campaign-violated-patient-privacy/</loc>
		<lastmod>2008-01-11T17:12:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 123: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/10/e-coli-risk-tied-to-use-of-distillers-grain-as-animal-feed/</loc>
		<lastmod>2008-01-10T17:38:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 122: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/10/bankrupt-topps-assets-sold-for-125-million/</loc>
		<lastmod>2008-01-10T17:36:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 121: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/10/83000-heart-attacks-caused-by-avandia/</loc>
		<lastmod>2008-01-10T17:34:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 120: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/10/fda-takes-action-against-compounded-menopause-hormone-therapy-drugs/</loc>
		<lastmod>2008-01-10T17:31:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 119: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/09/no-lipitor-bone-benefit-study-saysno-lipitor-bone-benefit-study-says/</loc>
		<lastmod>2008-01-09T17:27:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 118: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/09/ads-for-bone-density-drugs-dont-mention-disabling-pain-as-a-side-effect-and-neither-do-most-doctors/</loc>
		<lastmod>2008-01-09T17:24:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 117: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/09/antidepressant-warning-debated/</loc>
		<lastmod>2008-01-09T17:23:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 116: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/08/bisphosphonates-may-cause-severe-and-sometimes-incapacitating-bone-joint-andor-muscle-pain-fda-warns/</loc>
		<lastmod>2008-01-08T17:39:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 115: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/07/gardasil-cervical-cancer-vaccine-painful-for-teens-may-cause-fainting/</loc>
		<lastmod>2008-01-07T16:27:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 114: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/07/sunitinib-sutent-may-cause-high-blood-pressure-in-kidney-cancer-patients/</loc>
		<lastmod>2008-01-07T16:26:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 113: Comments: 8 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/07/renu-moistureloc-debacle-still-haunts-bausch-lomb/</loc>
		<lastmod>2008-01-07T11:29:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 112: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/04/fda-reports-new-risks-posed-by-anemia-drugs/</loc>
		<lastmod>2008-01-04T17:05:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 111: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/04/drugs-offer-no-benefit-in-curbing-aggression-study-finds/</loc>
		<lastmod>2008-01-04T17:03:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 110: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/03/novartis-updates-warnings-for-exjade-tablets-for-oral-suspension/</loc>
		<lastmod>2008-01-03T17:19:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 109: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/03/fda-receives-new-data-on-risks-of-anemia-drugs/</loc>
		<lastmod>2008-01-03T17:17:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 107: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/02/some-lawyers-seeking-change-to-vioxx-settlement/</loc>
		<lastmod>2008-01-02T17:12:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 106: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/02/avandia-among-2007s-top-health-stories/</loc>
		<lastmod>2008-01-02T17:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 105: Comments: 6 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/31/shangai-sexual-enhancement-supplements-may-be-dangerous-fda-warns/</loc>
		<lastmod>2007-12-31T13:02:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 104: Comments: 15 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/31/ortho-evra-lawsuit-ohio-supreme-court-upholds-pain-and-suffering-cap/</loc>
		<lastmod>2007-12-31T13:00:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 103: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/28/hearing-loss-%e2%80%93-a-viagra-side-effect-most-men-havent-heard-of/</loc>
		<lastmod>2007-12-28T16:16:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 102: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/28/fentora-off-label-use-dangerous-overdose-potentially-deadly/</loc>
		<lastmod>2007-12-28T16:14:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 101: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/27/sierra-pre-filled-lawsuit-filed-after-heparin-filled-syringes-sicken-40/</loc>
		<lastmod>2007-12-27T17:56:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 100: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/27/chantix-stop-smoking-drug-may-cause-suicidal-thoughts-fda-investigating-100-cases/</loc>
		<lastmod>2007-12-27T17:54:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 99: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/26/trasylol-license-suspended/</loc>
		<lastmod>2007-12-26T16:33:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 98: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/26/duragesic-pain-patchs-dangerous-side-effects-include-death-fda-issues-another-safety-alert/</loc>
		<lastmod>2007-12-26T16:30:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 96: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/26/pfizer-is-sued-over-lipitor-marketing/</loc>
		<lastmod>2007-12-26T10:28:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 95: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/26/data-about-zetia-risks-was-not-fully-revealed/</loc>
		<lastmod>2007-12-26T10:24:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 94: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/20/adhd-kids-on-stimulants-experienced-increased-cardiac-symptoms/</loc>
		<lastmod>2007-12-20T17:15:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 93: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/20/over-the-counter-contraceptives-to-include-new-warning-fda-mandates/</loc>
		<lastmod>2007-12-20T17:10:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 92: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/19/gadolinium-based-contrast-agents-used-in-ct-scan-and-mri-may-cause-kidney-failure/</loc>
		<lastmod>2007-12-19T19:27:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 91: Comments: 16 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/19/avandia-marketing-for-treatment-of-alzheimers-disease-delayed/</loc>
		<lastmod>2007-12-19T19:25:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 90: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/18/cancer-drug-sunitinib-may-be-associated-with-cardiac-toxicity/</loc>
		<lastmod>2007-12-18T17:30:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 89: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/18/effexor-ad-misleading-fda-says/</loc>
		<lastmod>2007-12-18T17:26:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 88: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/17/european-union-wants-more-side-effects-warning-for-pfizers-chantix/</loc>
		<lastmod>2007-12-17T17:44:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 86: Comments: 20 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/14/government-advisers-reject-mercks-mevacor-for-over-the-counter-use/</loc>
		<lastmod>2007-12-14T17:47:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 82: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/12/avandia-diabetes-drug-poses-heart-risk-for-older-patients/</loc>
		<lastmod>2007-12-12T16:46:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 80: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/11/prilosec-and-nexium-linked-to-hip-fracture-risk/</loc>
		<lastmod>2007-12-11T16:31:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 78: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/10/anemia-drugs-aranesp-no-help-for-breast-cancer-patients/</loc>
		<lastmod>2007-12-10T18:05:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 77: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/07/prempro-caused-breast-cancer-says-valley-city-state-university-president-in-her-wyeth-lawsuit/</loc>
		<lastmod>2007-12-07T16:56:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 75: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/06/avastin-rejected-as-breast-cancer-drug-by-us-advisory-panel/</loc>
		<lastmod>2007-12-06T17:16:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 73: Comments: 5 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/05/dennis-quaid-sues-baxter-for-his-twins-blood-thinner-overdose/</loc>
		<lastmod>2007-12-05T17:25:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 71: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/04/avandia-bone-fracture-risk-for-diabetics-explained-by-new-study/</loc>
		<lastmod>2007-12-04T16:00:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 68: Comments: 41 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/30/ortho-evra-maker-johnson-johnson-allegedly-altered-birth-control-patch-data-to-hide-risks/</loc>
		<lastmod>2007-11-30T15:42:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 66: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/29/ketek-lawsuit-filed-by-47-claimants/</loc>
		<lastmod>2007-11-29T16:51:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 64: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/28/myfortic-delayed-release-tablets-taken-during-pregnancy-may-cause-miscarriage-congenital-malformations/</loc>
		<lastmod>2007-11-28T17:21:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 62: Comments: 19 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/27/tamiflu-flu-drug-side-effects-dangerous/</loc>
		<lastmod>2007-11-27T16:16:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 60: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/26/serevent-and-advair-potentially-unsafe-for-children-fda-reports/</loc>
		<lastmod>2007-11-26T16:23:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 58: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/23/zyprexa-side-effects-may-be-deadly/</loc>
		<lastmod>2007-11-23T16:11:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 56: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/21/vioxx-lawsuit-settled-for-485-billion/</loc>
		<lastmod>2007-11-21T16:09:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 54: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/20/glaxos-handling-of-physician-criticized/</loc>
		<lastmod>2007-11-20T18:19:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 51: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/19/sanofi-aventis-anti-obesity-drug-acomplia-linked-to-depression-anxiety-suicidal-thoughts/</loc>
		<lastmod>2007-11-19T16:58:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 49: Comments: 11 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/16/cephalon-off-label-marketing-maker-of-fentora-and-actiq-to-pay-425-million-to-resolve-claims-of-illegal-marketing/</loc>
		<lastmod>2007-11-16T16:16:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 46: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/15/baxter-colleague-infusion-pumps-defective-again/</loc>
		<lastmod>2007-11-15T17:04:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 45: Comments: 13 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/14/accutane-linked-to-depression-moodiness-in-teens/</loc>
		<lastmod>2007-11-14T15:28:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 42: Comments: 4 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/13/viagra-may-cause-hearing-loss-fda-warns/</loc>
		<lastmod>2007-11-13T17:01:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 40: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/12/ketek-fraud-fda-slams-aventis-for-fraudulent-clinical-trial-of-ketek-liver-failure-linked/</loc>
		<lastmod>2007-11-12T16:04:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 38: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/09/trasylol-unsafe-trasylol-trial-halted-sales-suspended-as-fda-investigates/</loc>
		<lastmod>2007-11-09T15:50:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 36: Comments: 9 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/08/experimental-aids-vaccine-v520-raises-hiv-risk/</loc>
		<lastmod>2007-11-08T15:44:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 35: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/07/birth-control-pill-linked-to-artery-clogging-plaque/</loc>
		<lastmod>2007-11-07T17:25:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 33: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/07/hartz-vitamin-care-for-cats-recalled-salmonella-contamination/</loc>
		<lastmod>2007-11-07T10:51:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 31: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/05/fda-wants-a-recall-of-true-man-sexual-energy-tablets-and-energy-max-energy-supplements/</loc>
		<lastmod>2007-11-05T16:10:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 30: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/02/ambien-abuse-by-teens-a-new-concern-for-parents/</loc>
		<lastmod>2007-11-02T12:38:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 29: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/01/budeprion-xl-side-effect-complaints-prompt-fda-investigation/</loc>
		<lastmod>2007-11-01T12:39:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 27: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/01/johnson-johnson-to-pay-125-million-settlement-for-teenager%e2%80%99s-death-due-to-ortho-evra-birth-control-patch/</loc>
		<lastmod>2007-11-01T12:37:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 25: Comments: 23 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/31/prevacid-approved-for-young-children-but-perhaps-prescribed-unnecessarily/</loc>
		<lastmod>2007-10-31T13:13:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 23: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/30/children%e2%80%99s-dimetapp-and-robitussin-to-be-recalled-and-relabeled-due-to-infant-overdoses/</loc>
		<lastmod>2007-10-30T12:51:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 22: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/26/ketek-clinical-trial-fraud-gets-sanofi-aventis-a-warning-from-fda/</loc>
		<lastmod>2007-10-26T16:40:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 21: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/26/trasylol-clinical-trial-ended-due-to-bleeding-deaths/</loc>
		<lastmod>2007-10-26T08:55:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 20: Comments: 22 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/25/provigil-linked-to-life-threatening-skin-rashes-mental-problems/</loc>
		<lastmod>2007-10-25T10:25:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 19: Comments: 18 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/24/avandia-to-get-black-box-warning-on-heart-attacks/</loc>
		<lastmod>2007-10-24T21:35:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 18: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/24/gadolinium-based-mri-contrast-agents-linked-to-nsf-again/</loc>
		<lastmod>2007-10-24T21:32:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 17: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/24/zithromax-liver-failure-side-effects-can-be-serious-even-fatal/</loc>
		<lastmod>2007-10-24T21:30:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 16: Comments: 3 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/24/over-the-counter-cold-medicines-no-good-for-young-kids/</loc>
		<lastmod>2007-10-24T21:28:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 15: Comments: 77 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/24/viagra-cialis-levitra-get-sudden-hearing-loss-warning/</loc>
		<lastmod>2007-10-24T21:26:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 14: Comments: 1 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/24/fda-changes-accutane-ipledge-program/</loc>
		<lastmod>2007-10-24T21:24:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 13: Comments: 21 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/24/avandia-off-va-drug-formulary/</loc>
		<lastmod>2007-10-24T21:21:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 12: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/24/judge-tells-fda-to-turn-over-vioxx-files/</loc>
		<lastmod>2007-10-24T21:19:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 11: Comments: 2 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/2007/08/08/fda-feeling-pressure-to-end-drug-company-conflicts-of-interest/</loc>
		<lastmod>2007-08-08T10:41:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 9: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/case-evaluation/</loc>
		<lastmod>2007-05-07T12:32:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 4: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/archive/</loc>
		<lastmod>2007-05-02T17:22:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 5: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/resources/</loc>
		<lastmod>2007-05-02T17:22:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: Priority report of postID 7: Comments: 0 of 17608 = 0 points -->
	<url>
		<loc>http://www.druginjuryblog.com/other-blogs/</loc>
		<lastmod>2007-05-02T17:22:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.1</priority>
	</url>
<!-- Debug: End Postings -->
<!-- Debug: Start Cats -->
	<url>
		<loc>http://www.druginjuryblog.com/category/uncategorized/</loc>
		<lastmod>2012-02-02T17:20:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/category/blogroll/</loc>
		<lastmod>2008-06-11T17:38:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.5</priority>
	</url>
<!-- Debug: End Cats -->
<!-- Debug: Start Archive -->
	<url>
		<loc>http://www.druginjuryblog.com/2012/02/</loc>
		<lastmod>2012-02-02T17:20:39+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2012/01/</loc>
		<lastmod>2012-01-31T04:44:52+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/12/</loc>
		<lastmod>2011-12-30T22:46:35+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/11/</loc>
		<lastmod>2011-11-30T16:20:03+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/10/</loc>
		<lastmod>2011-10-28T17:06:12+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/09/</loc>
		<lastmod>2011-09-29T14:43:56+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/08/</loc>
		<lastmod>2011-08-31T15:57:50+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/07/</loc>
		<lastmod>2011-07-29T15:58:21+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/06/</loc>
		<lastmod>2011-06-30T20:55:09+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/05/</loc>
		<lastmod>2011-05-30T16:12:29+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/04/</loc>
		<lastmod>2011-04-29T15:13:32+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/03/</loc>
		<lastmod>2011-03-30T02:34:51+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/02/</loc>
		<lastmod>2011-02-25T13:18:07+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2011/01/</loc>
		<lastmod>2011-01-31T23:36:46+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/12/</loc>
		<lastmod>2010-12-29T05:18:01+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/11/</loc>
		<lastmod>2010-11-30T16:51:22+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/10/</loc>
		<lastmod>2010-10-29T12:57:13+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/09/</loc>
		<lastmod>2010-09-30T20:48:42+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/08/</loc>
		<lastmod>2010-08-31T16:31:15+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/07/</loc>
		<lastmod>2010-07-30T20:16:57+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/06/</loc>
		<lastmod>2010-06-30T00:20:39+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/05/</loc>
		<lastmod>2010-05-28T21:25:56+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/04/</loc>
		<lastmod>2010-04-28T15:50:44+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/03/</loc>
		<lastmod>2010-03-31T23:43:35+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/02/</loc>
		<lastmod>2010-02-26T14:56:24+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2010/01/</loc>
		<lastmod>2010-01-29T15:29:00+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/12/</loc>
		<lastmod>2009-12-31T04:50:57+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/11/</loc>
		<lastmod>2009-11-30T17:15:39+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/10/</loc>
		<lastmod>2009-10-29T22:27:09+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/09/</loc>
		<lastmod>2009-09-29T22:33:16+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/08/</loc>
		<lastmod>2009-08-28T02:33:33+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/07/</loc>
		<lastmod>2009-07-31T11:39:00+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/06/</loc>
		<lastmod>2009-06-30T23:24:17+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/05/</loc>
		<lastmod>2009-05-29T16:44:57+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/04/</loc>
		<lastmod>2009-04-30T18:09:40+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/03/</loc>
		<lastmod>2009-03-31T22:35:37+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/02/</loc>
		<lastmod>2009-02-27T19:26:52+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2009/01/</loc>
		<lastmod>2009-01-30T17:24:06+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/12/</loc>
		<lastmod>2008-12-31T14:19:27+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/11/</loc>
		<lastmod>2008-11-28T13:39:50+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/10/</loc>
		<lastmod>2008-10-31T14:49:23+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/09/</loc>
		<lastmod>2008-09-30T15:40:53+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/08/</loc>
		<lastmod>2008-08-29T14:56:18+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/07/</loc>
		<lastmod>2008-07-30T23:24:10+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/06/</loc>
		<lastmod>2008-06-30T16:50:54+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/05/</loc>
		<lastmod>2008-05-29T22:13:07+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/04/</loc>
		<lastmod>2008-04-30T21:28:57+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/03/</loc>
		<lastmod>2008-03-31T15:38:36+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/02/</loc>
		<lastmod>2008-02-29T17:05:54+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2008/01/</loc>
		<lastmod>2008-01-31T14:49:17+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2007/12/</loc>
		<lastmod>2007-12-31T13:02:18+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2007/11/</loc>
		<lastmod>2007-11-30T15:41:24+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2007/10/</loc>
		<lastmod>2007-10-31T13:13:32+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2007/08/</loc>
		<lastmod>2007-08-08T10:41:38+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
	<url>
		<loc>http://www.druginjuryblog.com/2007/04/</loc>
		<lastmod>2007-04-30T19:21:11+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.5</priority>
	</url>
<!-- Debug: End Archive -->
<!-- Debug: Start Custom Pages -->
<!-- Debug: End Custom Pages -->
<!-- Debug: Start additional urls -->
<!-- Debug: End additional urls -->
</urlset>
